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Abstract
Chromatin Assembly Factor 1 (CAF-1) is the only known replication dependant histone
chaperone, responsible for the deposition of the histone H3/H4 tetramer onto DNA. Found in
all eukaryotes, CAF-1 consists of three subunits, p150, p60 and p48. Since its identification
work on CAF-1 has mainly focused on in vivo studies due to the lack of a reliable method to
produce large quantities of recombinant protein for biochemical studies.
Herein the cloning, production and purification of the three subunits of recombinant CAF-
1 is described. The proteins were expressed as complexes and individually in insect cells
and Escherichia coli, optimised protocols are described for maximum protein recovery and
purity. Constructs of p150 and p60 were also produced and used to analyse the binding
regions and modes of both the p48 and p60 proteins to p150. It is shown that the two smaller
subunits of CAF-1 do not interact in the absence of p150 and that the p150 subunit of CAF-1
acts as a scaffold for assembly of the complex, binding directly to both p48 and p60. The
stoichiometry of the CAF-1 complex was also investigated and a basis for further work,
including structural studies, discussed.
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Chapter 1
Introduction
1.1 Chromatin
The DNA content of one human cell is approximately 2 meters long. This has to be packed
into a nucleus a few micrometres in diameter whilst remaining accessible for transcription
and untangled to allow efficient replication. This dense, ordered packing is achieved by the
formation of an ordered structure known as chromatin. Double stranded DNA is wound
around a protein core, forming a nucleosome (Kornberg, 1977; Luger et al., 1997). Nucle-
osomes are traditionally thought to then condense to form fibres that coil further and pack
into a super-structure known as a chromosome, as illustrated in Figure 1.
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Figure 1: Traditional View of Chromatin Packing.
Naked DNA is wrapped around nucleosomes to form a loose structure with a beads-on-a-
string structure. These are traditionally thought to pack closely to form a 30 nm fibre which
winds up into a less well defined structure which packs further to form a chromosome.
In a nucleosome, 146 bp for DNA is packed around a protein octamer (the nucleosome
core), consisting of four duplicated subunits, histones H2A, H2B, H3 and H4 (Figure 2).
This core is assembled by the deposition onto naked DNA of a H3/H4 tetramer followed by
two H2A/H2B dimers. The crystal structure of the nucleosome particle has been solved and
shows a globular core surrounded by DNA with the N- and C-terminal ’tails’ of the histones
on the outside of this compact structure (Luger et al., 1997), (as shown in Figure 2).
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Figure 2: Structure of the Nucleosome.
Representation of the crystal structure of the nucleosome, showing DNA encircling a nucle-
osome core. DNA is shown as a double helix in orange and green. Histone H3 is red, H4
yellow, H2A blue, H2B green. Figure produced using PyMol (http://www.pymol.org/), PDB
ID 1AOI (Luger et al., 1997).
Nucleosomes can then be capped by the linker histone H1 to make a chromatosome, enga-
ging 167 bp of DNA in a more tightly wound structure. Electron microscopy shows that
many chromatosomes incorporated over a strand of DNA resemble “Beads on a String”,
known as the 10 nm filament (Tremethick, 2007; Staynov, 2008). A higher order structure
was also observed in early work, known as the 30 nm fibre, discussed in greater detail below.
The 30 nm fibre was believed to coil further to form chromosomes, which are diffuse, loosely
packed structures during growth phases and DNA replication but heavily structured, densely
packed constructs during cell division (Staynov, 2008; Robinson and Rhodes, 2006).
1.1.1 The 30 nm Fibre
The compact 30 nm fibre has long been thought to be the first level of compaction for silent
DNA. The structure and indeed, existence of the ’30 nm fibre’ is still under debate, despite
being initially reported in the late ‘70s as it could not be crystallised due to the heterogeneous
nature of chromatin with fibres of diameter 33 and 44 nm initially observed (Staynov, 2008).
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Figure 3: Two Models of the 30 nm Fibre. The one start model can have a number of
arrangements of DNA within the solenoidal stack of nucleosomes, whereas the two start
model has a zigzag arrangement, indicated by the thick black line. The red line indicates the
stacking of nucleosomes, Based on a Figure from Staynov (2008)
There have been several models proposed for the structure of the 30 nm fibre, illustrated in
Figure 3. These can be divided into two categories defined by the presence of one or two start
helices. In the two start model the DNA zigzags across between two stacks of nucleosomes
binding one in each stack alternately, with the result resembling the DNA double helix. In
the one start helix the nucleosomes form a single solenoid, with the DNA running between
histones sequentially in the simplest model, similar to a coiled spring. More complex one
start models have the same helical nucleosome arrangement but with the DNA crossing the
helix to bind the opposite rather than the sequential nucleosome. Chromatin arranged in both
the one and two start models has been observed under different in vitro conditions (Robinson
and Rhodes, 2006; Wu et al., 2007).
Reconstitution of chromatin using strongly positioned nucleosomes (see section 1.2) allowed
(Schalch et al., 2005) to crystallise a tetranucleosome (four nucleosomes on a stretch of
DNA). This structure was obtained using a high concentration of salt and lacks the H1 linker
histone. The result appears to follow the two-start model. The one start helix arrangement
was visualised by electron microscopy (Robinson et al., 2006) of fibres formed in the pres-
ence of H1 and with variable lengths of DNA between histones.
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To reconcile the discrepancy between these different results it was proposed that the structure
of the fibre varies depending on the environment, with shorter linkers between nucleosomes
resulting in more compact ribbons and the two start helix (Robinson and Rhodes, 2006).
Very recently, further data utilising SAXS and cryo-EM measurements has suggested that
the 30 nm fibre is an artefact of chromatin purification in many human cells. A fibre of
diameter around 30 nm, consistent with a model of a two-start helix was observed in the
transcriptionally silent chicken erythrocyte cells. However 30 nm structures in mitotic HeLa
cells were shown to be due to ribosomal aggregation rather than chromatin packing (Nishino
et al., 2012), indicating that the 30 nm fibre may not even exist in the majority of cells.
Given the most recent data, the 30 nm fibre appears to be a highly specific case seen in cells
with no active chromatin or as an artefact of regularly spaced nucleosomal arrays formed in
vitro. The compact fibre appears to be totally absent exist in at least one human cell line.
The lack of this defined structure in potentially any transcriptionally active cell may explain
why the finer details of the fibre have remained elusive for so long.
1.1.2 Heterochromatin
There are two major types of chromatin, identified initially by their different staining pat-
tern with dyes such as DAPI (Zink et al., 2003). Euchromatin is lightly staining, diffuse
chromatin which is usually gene rich and undergoing active transcription. Heterochromatin
is darkly staining, generally inactive, compact chromatin associated with gene repression.
Euchromatin tends to be enriched in acetylated histones H3 and H4 along with methylation
at H3 K4 (H3 lysine 4), whereas heterochromatin is hypoacetylated and contains methylated
histones including H3 K9 and H3 K27 as well as methylated DNA (Noma et al., 2001; Jenu-
wein and Allis, 2001; Tamaru, 2010). Histone variants and their modifications are discussed
in detail in section 1.1.3.
There are two types of heterochromatin: constitutive and facultative. Constitutive hetero-
chromatin is repressed in all of an organism’s cells, generally containing highly repetitive
sequences such as telomeres and centromeric regions, which interact with cohesin proteins
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during cell division, as well as transposable elements, preventing them from destabilising
the genome (Zeng et al., 2010). Facultative chromatin can be silenced by repressor pro-
teins and RNA, both of which recruit repressor complexes to induce histone modifications
(Beisel and Paro, 2011). The best studied model of faculative chromatin formation is that
of X-chromosome inactivation which prevents gene dosage problems in mammalian fe-
males(Beisel and Paro, 2011). Here repression is is the result of silencing via the Xist RNA,
which spreads across the chromosome and recruits proteins such as the Polycomb complexes,
causing enrichment of repressive marks such as trimethylation of H3 K27 and DNA methyl-
ation (Basu and Zhang, 2011) and repressive histone variants such as macroH2A (Costanzi
and Pehrson, 1998).
Constitutive heterochromatin contains methylated DNA and methylated H3 K9 which re-
cruits HP1, the major repressor protein. HP1 is found in almost all eukaryotes with the ex-
ception of S. cerevisiae which utilises a SIR protein based repression system instead (Kwon
and Workman, 2011). HP1 (Swi6 in S. pombe) is critical for maintenance of heterochromatin
and consists of three main isoforms in mammals: HPa which localises to heterochromatin,
HP1b found in hetero and euchromatin and HP1g mainly seen on euchromatin, where it
fulfils functions other than heterochromatin formation. All the HP1 variants contain a chro-
modomain and a chromo shadow domain. The chromodomain binds methylated H3 K9 to
localise the protein to heterochromatin and the chromo shadow domain provides a bind-
ing site for heterochromatin associated proteins and for self-association of HP1 (Kwon and
Workman, 2011; Zeng et al., 2010; Murzina et al., 2008).
Once HP1a or b has bound to a H3 K9 methylation motif it can propagate the heterochro-
matic state. Studies utilising Swi6 have indicated that this is facilitated by self-association
of HP1 with four HP1 monomers binding to a H3 K9 modified mononucleosome, leaving
two chromoshadow domains free to recruit the next modified nucleosome and so causing the
propagation of HP1 binding (Canzio et al., 2011). HP1 is also capable of recruiting other
chromatin associated proteins such as the methylase Suv39h1, which methylates H3 K9,
inducing a feedback loop of HP1 recruitment (Maison and Almouzni, 2004; Probst et al.,
2009). This may also be important during replication of heterochromatin to allow reproduc-
tion of the repressive histone modifications.
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Upon replication of heterochromatin the ISWI-type complex ACF (ATP-utilising chromatin
assembly and remodelling factor, see section 1.2.5.2) is recruited to heterochromatin along
with the replication machinery including the MCM complex (see section 1.4) to provide
local destabilisation of the heterochromatin to allow passage of the replication fork (Collins
et al., 2002). Behind the replication fork, nucleosomes are replaced by the action of the
CAF-1 (Chromatin Assembly Factor 1, the focus of this study) complex and other histone
chaperones (See section 1.3). The p150 subunit of the CAF-1 complex is known to bind
HP1 independently to the action of CAF-1 during replication (Murzina et al., 2008). This
interaction may recruit HP1 and therefore Suv39h1 to newly replicated heterochromatin,
allowing re-establishment of epigenetic marks (Maison and Almouzni, 2004).
To prevent the spread of the heterochromatic state throughout the genome, proteins known
as insulators form boundary sites. Proteins containing the JmjC domain such as DMM1
in Neurospora and Epe1 in S. pombe bind to chromatin and prevent further methylation
and spread of HP1/Swi6 (Tamaru, 2010). The CTCF protein binds to cHS4 DNA elements
and defines chromatin boundaries by looping out sections of DNA (Phillips and Corces,
2009). This can block the spread of heterochromatin and also prevents the interaction of
transcription promoters and enhancers in active DNA (Gaszner and Felsenfeld, 2006).
1.1.3 Histones
There are two types of histone proteins, those that make up the nucleosome, i.e. the core
histones (histones H2A, H2B, H3 and H4) and the linker histones, e.g. H1 and H5 which
are involved in chromatin compaction. The linker histones function by binding to the nucle-
osome to stabilise the interaction between the DNA and core histones and allow packing to
form higher order structures (Happel and Doenecke, 2009).
The core histones are highly charged, highly conserved proteins, only found in the cell bound
to histone chaperones or DNA. Histones H3 and H4 are the first to be deposited onto DNA
during chromatin formation, followed by H2A and H2B. These histones exist as dimers and
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occasionally tetramers when bound to chaperones in the cell, forming an octamer containing
two copies of each core histone (Luger et al., 1997).
Whilst histones are highly conserved across species there are variant forms of some of them.
Within the H3/H4 dimer, H4 is invariant whereas histone H3 has several common variants.
Canonical histone H3, also known as H3.1 is the most abundant histone H3 type in replicat-
ing cells and is deposited on newly replicated DNA by CAF-1 (Tagami et al., 2004). Histone
H3.2 only differs from H3.1 at one amino acid and is also replication dependent but may
have a role in chromatin based silencing (Hake and Allis, 2006). Histone H3.3 is the ma-
jor H3 variant outside replication and is the most abundant histone in non-replicating cells
(Henikoff and Ahmad, 2005). It differs from H3.1 by four residues and marks DNA undergo-
ing transcription (Tagami et al., 2004). During transcription H3.3 is retained on the daughter
chromatin and is thought to act as an epigenetic marker of active chromatin. It is deposited
by HIRA (HIstone Regulatory homolog A) after disruption of chromatin by the transcription
machinery. Recently H3.3 has also been found to be enriched in silent chromatin, opening
its role up to debate (Szenker et al., 2011). The final major variant of H3 is CENP-A, found
at centromeres and vital for stable centromere and kinetochore formation. It is thought to
be deposited by the histone chaperone RbAp48 (Retinoblastoma Associated protein 48 kDa,
discussed in more detail in section 1.5.2.3) in a replication independent manner (Hake and
Allis, 2006; Smith, 2002; Furuyama et al., 2006).
Within the H2A/H2B dimer, H2B does not have any major variants but several versions of
H2A have been discovered. H2A.X is a damage associated histone deposited by INO80 (see
section 1.2.5) and is found at sites of chromatin remodelling. H2A.X is phosphorylated at
sites of double strand breaks and this event recruits the DNA repair machinery (Henikoff
et al., 2004; Talbert and Henikoff, 2010; Pusarla and Bhargava, 2005). The H2A.Z variant
is essential in animals but not in S. cerevisiae, it is found at most gene promoters and has
divergent roles in both activation and silencing of genes. It is added to the nucleosome
by replacement of a H2A/H2B dimer by Swr1 (Henikoff and Ahmad, 2005). H2A.Z is
enriched near transcription start sites where it defines nucleosome positioning as it is present
in the +1 and -1 nucleosomes around the start site (Mito et al., 2007; Guillemette et al.,
2005) (see section 1.2). The role of H2A.Z in gene silencing is thought to be a contribution
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to heterochromatin packing via interactions with HP1 (Pusarla and Bhargava, 2005). The
mechanism by which H2A.Z fulfils both these functions is currently under debate. Other
variants of H2A include macroH2A, found in constitutive heterochromatin on the inactive
X-chromosome and H2A-Bbd, a vertebrate specific variant associated with active chromatin
(Henikoff and Ahmad, 2005).
Histones are subject to a variety of post-translational modifications, thought to be the basis of
epigenetic inheritance, determining gene regulation. Known modifications include methyla-
tion, acetylation, phosphorylation, ubiquitination, sumoylation, ADP ribosylation, deamina-
tion and proline isomerisation, with the first three being the best studied (Kouzarides, 2007).
A few examples of how modifications of histones can affect chromatin are discussed below.
The acetylation state of histones is mediated by histone acetyl transferases (HATs) and his-
tone deacetylases (HDACs) which specifically modify lysine (K) residues in the core his-
tones tails. This modification is generally correlated with activation of transcription. Some
acetylated lysines function by recruiting other proteins via recognition by a bromodomain,
however acetylation also results in a change in the overall charge of histones, which can
loosen the structure of chromatin and increase DNA accessibility (Anderson et al., 2002).
The acetylation of histone H3 at K56 by Rtt109 in S. cerevisiae, seen on many newly synthes-
ised histones, is correlated with activation of transcription (Williams et al., 2008; Masumoto
et al., 2005) and DNA damage repair (Masumoto et al., 2005). This modification is unusual
as it is within the core of H3 and increases nucleosome breathing (Neumann et al., 2009),
which will allow easier access to DNA for the transcription and DNA repair machinery (see
section 1.2.4). Modification of a more canonical site is that of histone H4 K16 where acet-
ylation inhibits nucleosome compaction as well as preventing the action of the chromatin
remodeller ACF (Shogren-Knaak et al., 2006). Acetylation is also an important marker of
histone age with newly synthesised histones acetylated at H4 K5 and H4 K12 (Sobel et al.,
1995), this modification is added by the HAT1 complex, consisting of the chaperone RbAp46
and the HAT1 acetyltransferase (Jasencakova et al., 2010).
Methylation was originally regarded as a non-reversible mark of silencing. However with
further investigation revealing the existence of demethylases, methylation has been shown
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to have a mixed role in gene expression, which is dependent on position and environment
(Bannister and Kouzarides, 2005). Methylation can occur at lysine and arginine residues
with mono, di and tri methylation possible on lysine residues and mono, di-symmetric or di-
asymmetric methylation on arginine residues. Recognition of methylated histone tails occurs
via chromodomain, PHD and MBT containing proteins (Bártová et al., 2008). Repressive
methylation is exemplified on the inactive X-chromosome where trimethylation at H3 K27
and dimethylation at H3 K9 are common, along with DNA methylation. H3 K9 is known to
recruit HP1, an essential component of heterochromatin (Chambeyron and Bickmore, 2004).
The combination of acetylation at H3 K9 and dimethylation at H3 K4 are activating modi-
fication which causes chromatin decondensation allowing access by transcription machinery
(Bártová et al., 2008).
Phosphorylation of serine and threonine residues is mediated by various kinases, including
touseled-like kinase (tlk) which is involved in phosphorylation of H3 S10 (Li et al., 2001).
Generally considered to be an activatory mark, phosphorylated tails are recognised by 14-3-3
domain containing proteins (Macdonald et al., 2005). Phosphorylation changes the charge
on the histone molecule and may have a direct impact on chromatin condensation. The role
of this modification in chromatin is complex with phosphorylation of serine 10 required for
chromatin condensation during segregation and cell division (Wei et al., 1999) and activ-
ation of certain genes (Kouzarides, 2007). Phosphorylation of H3 S10 is inhibited by the
repressive H3 K9 methylation mark (Rea et al., 2000). Conversely where present H3 S10
phosphorylation reduces the binding of HP1 to H3 K9 (Fischle et al., 2005), which destabil-
ises heterochromatin, possibly allowing access to S-phase proteins.
All these modifications are essential for the maintenance of correct gene expression and
therefore when DNA is replicated the marks on histones must also be retained to maintain
gene expression patterns and prevent aberrant protein expression.
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1.2 Nucleosome Positioning
The overall pattern of nucleosomes on DNA is not simply a repeating unit along the whole
molecule. In recent years, genome-wide studies of nucleosome locations have confirmed
previous results and trends in nucleosome binding patterns.
The position of nucleosomes was mapped in S. cerevisiae (Yuan et al., 2005; Lee et al., 2007)
using micrococcal nuclease (MNase) to digest linker DNA and microarrays to identify DNA
sequences that were protected by nucleosomes (i.e. those that remained after digestion).
This technique has been refined and Solexa sequencing has allowed the investigation of
larger genomes such as human cell lines (Schones et al., 2008). Whilst the data obtained
is reproducible between methods, the reliance on MNase to generate mononucleosomes is
known to introduce a bias towards terminal A/T bases cleavage sites and some promoters are
thought to be unstably bound to histones under experimental conditions (Arya et al., 2010).
Although other methods are still required to confirm these observations, there are general
trends, discussed below.
The nucleosome content of DNA is non-uniform. Nucleosomes on a length of DNA can be
either well positioned, protecting a specific strand of DNA from degradation by MNase or
“fuzzy”, where a less specific protective effect is observed. In S. cerevisiae nearly 70% of
nucleosomes are well positioned (Lee et al., 2007) with the percentage seen to be lower in
multicellular organisms (Johnson et al., 2006; Schones et al., 2008; Mavrich et al., 2008b).
Specific regions of DNA exhibit characteristic nucleosome positioning patterns. Telomeric
DNA tends to be nucleosome depleted, whereas centromeres exhibit higher occupancy. Cod-
ing regions of DNA tend to be highly occupied by nucleosomes, with the exception of the
most highly transcribed genes such as the ribosomal subunits (Yuan et al., 2005; Lee et al.,
2007; Bernstein et al., 2004).
The pattern of nucleosomes in the promoter region of a gene tends to indicate the basal
level of transcription. Activity transcribed gene promoters contain a nucleosome free region
followed by a very strongly positioned nucleosome, known as the +1 nucleosome. The exact
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position of this nucleosome in relation to the transcription start site varies between organisms
and may be related to the composition of the transcription machinery (Mavrich et al., 2008a;
Yuan et al., 2005). Stress response genes such as those controlled by TATA boxes, (which
are usually repressed) do not contain this nucleosome free region and require other proteins
to remove the nucleosomes to allow binding of the transcription machinery and activation of
the gene (Yuan et al., 2005).
Initial observations of the periodicity of histones led to the mathematical prediction that
with one boundary point and a set linker length one would see a string of positioned nucle-
osomes with increased “fuzziness” as distance from the boundary point increases(Kornberg
and Stryer, 1988). This is the case with many nucleosomal arrangements in the genome,
exemplified by the +1 nucleosome at genetic promoters, indicating that many nucleosomes
are not positioned by specific elements, rather by their interactions with the surrounding
nucleosomes (Yuan et al., 2005). More recently, strongly positioned nucleosomes have been
found at the 5’ end of some genes and are thought to fulfil similar functions to those at the 3’
end (Mavrich et al., 2008b). This specific nucleosome positioning is thought to depend on
several factors which work in concert to position nucleosomes, discussed below.
1.2.1 DNA Sequence and Modifications
Whilst nucleosomes will bind to any section of DNA, they do have different affinities for
different nucleotide sequences. Work reconstituting nucleosomes on synthetic DNA showed
that long runs of poly A/T have a lower affinity for nucleosomes compared to G/C or mixed
elements. In the latter cases, it is thought that the sequences are rendered less flexible, which
makes wrapping around nucleosomes unfavourable and generally destabilises nucleosome
binding. This is thought to contribute to creating the nucleosome free region seen at con-
stitutively active gene promoters (Nelson et al., 1987; Segal and Widom, 2009a).
The sequence of the DNA bound to the nucleosome has also been shown to affect its position.
This is due to the requirement for DNA to bend sharply around the nucleosome, with the
grooves in the double helix compressed on the inside of the turn (Travers et al., 2009).
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The presence of an A/T dimer every 10 bp, seen in many nucleosomes, creates a flexible
sequence that easily winds around the nucleosome and centres the nucleosome on an AT
dimer (Thaström et al., 1999; Johnson et al., 2006). The preference for a flexible DNA
sequence is also seen in the binding of histone H1, indicating a role in higher order chromatin
structure as well as nucleosome positioning (Cui and Zhurkin, 2009). This specification is
thought to contribute to strongly positioned nucleosomes such as the +1 nucleosome.
This reduction of DNA flexibility is also seen with DNA methylation (Nathan and Crothers,
2002), although as proteins containing MBDs (methyl binding domains) such as MeCP2
are known to bind to methylated DNA (Lewis et al., 1992), this modification may have a
secondary effect at reducing histone occupancy.
1.2.2 Histones and Higher Order Structure
The histone composition of the nucleosome is thought to influence DNA binding (Arya et al.,
2010). However nucleosomes containing H2A.Z have been observed to position in a similar
manner to normal H2A containing nucleosomes (Mito et al., 2007). The details of this and
any specific sequence preferences remain to be investigated. It is possible that the modific-
ations seen on histones will have some effect on the nucleosome spacing, however as these
modifications function to recruit effector proteins, it is more likely that any change in posi-
tioning is due to protein binding (Segal, 2008).
It is also possible that the 3-dimensional structure of chromatin influences the histone ar-
rangement, however dissecting cause from effect is particularly difficult here, as the distance
between nucleosomes may influence the 3D structure as well as vice versa, making inter-
pretation of results difficult.
1.2.3 DNA Binding Proteins
Nucleosomes are not the only found protein bound to DNA. Transcription factors often wrap
around the DNA helix sterically excluding nucleosomes. Many transcription factor binding
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sites occur in the nucleosome free region of gene promoters (Yuan et al., 2005; Segal and
Widom, 2009a), although some are known to bind to regions normally associated with nuc-
leosomes. To do this they must access DNA normally bound to nucleosomes, moving or
displacing them in response to cell signalling pathways, which can drastically change the
pattern of nucleosome binding within a cell following gene activation (Schones et al., 2008).
Once a transcription factor has bound to a previously nucleosomal region of DNA, it can
facilitate the binding of further factors. For example the S. cerevisiae transcription factor
RAP1 is known to be required for activation of HIS4 (involved in the amino acid biosynthetic
pathway), by the associated transcription factor GCN4 upon amino acid starvation. The
binding of RAP1 creates a nucleosome free region which then allows GCN4 to bind, when
alone neither is sufficient to activate the gene. RAP1 is found throughout the yeast genome
where it is thought to fulfil a similar function with other transcription factors and is therefore
known as a general regulatory factor (Yarragudi et al., 2004; Yu and Morse, 1999; Bernstein
et al., 2007). Remodellers are required for the correct positioning of nucleosomes at most
promoters, indicating that intrinsic positioning sequences alone are not sufficient (Korber
and Hörz, 2004).
In addition to transcription factors the binding of RNA polymerase II (PolII) causes a change
in nucleosome arrangement. Binding to promoter regions induces a downstream shift for
the +1 nucleosome (Schones et al., 2008; Mavrich et al., 2008a). It is thought that some
components of the polymerase pre-initiation complex such as TATA binding protein bind
to DNA dissociated during nucleosome ‘breathing’ and bend the DNA which then perturbs
re-binding of the nucleosome (Godde et al., 1995). This is a feedback mechanism as the
initial presence of PolII on the DNA is likely to be dependent on nucleosome positioning
and modifications (Kireeva et al., 2002).
1.2.4 Accessibility of Nucleosomal DNA
The movement of nucleosomes on the DNA, hiding and revealing sequences, is thought to
occur by three main methods: nucleosomal breathing, histone turnover and remodelling of
14
chromatin by ATP-dependent enzymes.
1.2.4.1 Breathing
The spontaneous partial unwrapping of the DNA from nucleosomes as a consequence of
thermal dynamics is a process known as ‘breathing’ (Blossey and Schiessel, 2011). The
DNA partially dissociates from the nucleosome, where it can to bind to transcription factors
before it is re-captured by the nucleosome, without the need for ATP-dependent remodelling
(Segal and Widom, 2009b).
This breathing mechanism is also thought to create DNA loops, where the nucleosome re-
associates with DNA further along the sequence. This has the potential to allow nucleosome
translocation without dissociation from the DNA during processes such as RNA transcription
permitting the nucleosome to potentially process along the DNA (Anderson et al., 2002).
1.2.4.2 Turnover
Histones are removed and replaced on DNA as a consequence of transcription and replica-
tion. Histone chaperones and some remodelling proteins, as discussed below, are capable of
moving nucleosomes between strands of DNA as well as sliding them along. This provides
another route for access to the underlying DNA and also a route for removal of histone modi-
fications. Studies in S. cerevisiae demonstrated that different regions of DNA have different
rates of turnover with the highest rates being found in promoter sequences, particularly those
under active transcription (Dion et al., 2007; Lee et al., 2004). For example, the S. cerevisiae
PHO5 promoter loses nucleosomes upon transcription activation after hyperacetylation of the
histone tails. It then gains histones from the soluble pool on reassembly rather than sliding
nucleosomes around the DNA. This process requires the histone chaperones ASF1 and HIR1
as well as SWI/SNF remodellers and results in more strongly positioned nucleosomes than
what would be expected from random reassembly based on DNA sequence alone (Reinke
and Hörz, 2004).
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Turnover is also high at chromatin boundaries. It is thought that this removes histone modi-
fications, preventing the spread of active or repressed states over the whole chromosome
(Mito et al., 2007). The rates of turnover are observed to be lowest in coding regions, and
it is possible that histones are briefly disrupted by the passage RNA polymerase but are re-
turned to the same section of DNA rather than being removed and replaced (Dion et al.,
2007).
All of these factors mentioned above have an influence on nucleosome positioning and gene
accessibility. Current models favour a dynamically regulated system with a mixture of
factors contributing to the overall nucleosomal architecture of the cell (Segal and Widom,
2009b). Chromatin remodelling proteins and histone chaperones both play a key role in
maintaining the chromatin structure of the cell.
1.2.5 Chromatin Remodellers
When a cell changes its transcription pattern, only a tiny percentage of nucleosomes are
moved at the promoters of specific genes (Shivaswamy et al., 2008). Nucleosomes can be
translocated or removed from their binding site by remodelling factors. There are several
families of remodelling proteins, all of which contain an ATPase subunit and are subcatagor-
ised further based on the presence of additional subunits and domains. The major families
include ISWI, SWI/SNF, CHD and INO80 (Blossey and Schiessel, 2011).
Remodellers tend to be recruited to chromatin by specific histone modifications and their
function is often modulated by accessory proteins to the complex which can be tissue and
time specific. The general mechanism by which the remodellers move nucleosomes along
the DNA is thought to be by the generation of a loop of DNA, which moves around the
nucleosome, dissociating a few residues at a time, minimising the energetic cost (Lusser and
Kadonaga, 2003; Cairns, 2007).
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Figure 4: Model of loop based nucleosome movement along DNA. The red piece of DNA
is translocated around the nucleosome by the ’looping out’ of DNA, mediated by a remod-
eller protein (not shown). Based on information from (Gangaraju and Bartholomew, 2007;
Längst et al., 1999)
1.2.5.1 SWI/SNF Family
The SWI/SNF (SWItch/Sucrose Non-Fermentable) family of chromatin remodellers were
the first to be discovered. They are characterised by an ATPase domain along with a bro-
modomain, which binds histones acetylated at lysine residues. SWI/SNF type remodellers
are generally associated with activation of genes (Blossey and Schiessel, 2011), tend to ran-
domise linker distances of previously ordered nucleosome arrays (Cairns, 2007) and have the
ability to evict nucleosomes by moving them between strands of DNA (Phelan et al., 2000;
Lorch et al., 1999).
There are two common SWI/SNF-type complexes. In yeast, they are known as SWI/SNF
and RSC (Remodels the Structure of Chromatin). The mammalian equivalents are BAF and
PBAF, respectively. These are large multi-subunit complexes with S. cerevisiae SWI/SNF
containing around 11 subunits and RSC around 17, the exact composition has not been elu-
cidated and appears to vary between cell types (Cairns, 2005; Gangaraju and Bartholomew,
2007).
All SWI/SNF complexes include the catalytic Swi2/Snf2 (hBRM or BRG1 in mammals) sub-
unit and in higher organisms, tissue specific subunits such as BRACA1 which are thought
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to program the complex (Lusser and Kadonaga, 2003). SWI/SNF binds transiently to any
nucleosome near a promoter when recruited by transcription activators. However, where his-
tones have been acetylated by proteins such as SAGA and NuA4, the presence of SWI/SNF
is sustained by the interaction of the bromodomain of SWI/SNF with the histone tails and
causes more substantial remodelling of nucleosomes, allowing the access of further tran-
scription regulating proteins (Hassan et al., 2001). Other roles of SWI/SNF have also been
examined: the Brm subunit can interact with RNA polymerase II, reducing the rate at which
it transcribes DNA, allowing alternative splicing through less optimal sites (Batsché et al.,
2006). A role in silencing has also been examined as SWI/SNF is required for the silen-
cing of rRNA and at telomeres. However the exact mechanism of action has not yet been
identified (Dror and Winston, 2004).
The RSC complex is more abundant and efficient than SWI/SNF, it contains the Sth1 ATPase
and is an essential complex for development (Tang et al., 2010; Lorch et al., 1998, 1999).
RSC is required to position nucleosomes that flank the nucleosome free regions of gene pro-
moters (Wippo et al., 2011; Hartley and Madhani, 2009) and is also involved in the loading
of cohesins onto sister chromatid arms (Huang and Laurent, 2004).
Both SWI/SNF and RSC are involved in the repair of DNA double strand breaks. During ho-
mologous recombination they are recruited at different points in the process, with SWI/SNF
involved in strand invasion as part of the recombination process and RSC required after syn-
apsis to finish repair, which may be due to a requirement for cohesin recruitment at the end
of homologous recombination (Chai et al., 2005).
1.2.5.2 ISWI Family
The generally repressive ISWI-type complexes contain SANT and SLIDE domains which
bind histone tails and DNA respectively (Cairns, 2005; Blossey and Schiessel, 2011). They
generally function by sliding nucleosomes into evenly spaced arrays without eviction (Cairns,
2005). As with all remodellers, ISWI complexes are primarily recruited by histone post
translational modifications, with ISWI complexes containing a variety of recognition do-
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mains, including bromodomains, which recognise acetylated histone H3 tails and PHD do-
mains, which recognise tri-methylated lysines, also on H3 (Lusser and Kadonaga, 2003).
The mechanism by which ISWI remodellers choose where to move a nucleosome to is
thought to be based on DNA sequence, with different remodellers acting in different ways.
For example the ACF complex has been seen to move nucleosomes to a short (40 bp) se-
quence with high curvature (Rippe et al., 2007).
In yeast, there are two major ISWI-type proteins: Isw1 and Isw2. Both proteins move his-
tones into intergenic regions, against DNA sequence based positioning preferences (Wippo
et al., 2011). Isw1 in general moves nucleosomes onto coding regions and has the ability
to disrupt established nucleosomal arrays whereas Isw2 tends to remodel promoter regions.
Isw1 has two variant complexes: Isw1a and Isw1b. Both Isw1 complexes contain the same
ISWI activity but are seen to bind to different regions of DNA and nucleosomal subunits,
with Isw1a having a greater nucleosome sliding activity and Isw1b more efficiently spacing
nucleosomes over long stretches of DNA (Tsukiyama et al., 1999; Vary et al., 2003).
In multicellular organisms the variety of ISWI complexes is increased, due to their need
to interact with various different proteins. D. melanogaster contains only one protein with
ISWI activity but serves different purposes in the NURF, ACF and CHRAC complexes. Hu-
mans have two major ISWI subunits: Snf2H and Snf2L2, which are involved in a variety of
cellular processes including DNA replication, damage repair, nucleosome replacement and
centromere formation (Erdel and Rippe, 2011).
The role of the accessory proteins in these ISWI complexes is to determine function, both
by targeting and regulating the activity of the ISWI subunit. In the absence of accessory
proteins, D. melanogaster ISWI catalyses the sliding of nucleosomes towards the ends of
DNA. However when ISWI is contained within complexes such as NURF, ACF or CHRAC,
the nucleosomes are moved towards the middle of DNA fragments (Eberharter et al., 2001;
Vary et al., 2003).
The various multicellular ISWI complexes have different roles in the cell. NURF (Nuc-
leosome remodelling factor), the first ISWI complex to be identified (Tsukiyama and Wu,
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1995) is a ternary complex involved in both transcription activation and repression. It con-
sists of ISWI (Snf2L in humans), NURF-55 (RbAp46/48 in humans), BPTF/Nurf301 and
NURF-38 (Barak et al., 2003). RbAp48 is a histone chaperone protein found in many chro-
matin associated complexes (see section 1.5.2.3). BPTF is responsible for control of ISWI
activity and targeting of the complex to tri-methylated H3 K4 (marker of transcription start
sites) and acetylated H4 K16 via its PHD (Plant HomeoDomain) finger and bromodomain. A
complex of BPTF and ISWI is sufficient for nucleosome sliding (Xiao et al., 2001). NURF-
38 is an inorganic pyrophosphatase, and although this activity is dispensable for chromatin
remodelling, it may function in the wider context of NURF’s action, possibly helping to drive
RNA transcription reactions to completion (Gdula et al., 1998). The binding of transcrip-
tion factors such as Gal4 to DNA enhances NURF’s activity, allowing it to slide nucleosomes
over a larger area, revealing RNA polymerase binding sites (Mizuguchi et al., 1997; Hamiche
et al., 1999; Kang et al., 2002; Gangaraju and Bartholomew, 2007).
The targeting function of the BPTF domain of NURF is similar to that of the Acf1 subunit
seen in the ACF and CHRAC (Chromatin accessibility complex) complexes. Both ACF
and CHRAC utilise ISWI/Snf2h to remodel repressive chromatin, forming regularly spaced
histone arrays (Eberharter et al., 2001; Gangaraju and Bartholomew, 2007). ACF consists
of ISWI and Acf1 and is known to associate with HP1 and increase the affinity of HP1 for
methylated H3 K9, targeting both ACF and HP1 to heterochromatic regions (Eskeland et al.,
2007). CHRAC consists of both ACF subunits with CHRAC-14 and 15, which have histone-
like folds and facilitate nucleosome sliding under conditions where the ACF complex alone is
not sufficient (Corona et al., 2000; Kukimoto et al., 2004). The Acf1 targeting protein is also
multifunctional: as well as targeting its complex to chromatin, it acts as a binding scaffold
for other proteins, modulates the activity of ISWI by increasing ATP turnover and causing
nucleosome sliding towards the centre of DNA rather than towards ends (Varga-Weisz et al.,
1997; Eberharter et al., 2001; Kukimoto et al., 2004; Längst et al., 1999). ACF/CHRAC is
involved in DNA repair, as is the WICH complex.
WICH (WSTF–ISWI complex) is an activatory complex, targeted through its interaction
with PCNA (proliferating cell nuclear antigen, see section 1.4.2.1) to newly replicated DNA,
where it maintains an open chromatin structure and is involved in post-replication assembly
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of chromatin. It consists of Snf2h and WSTF (Williams Syndrome Transcription Factor),
which is similar to Acf1 in function (Poot et al., 2004), with the addition of a tyrosine kinase
activity that phosphorylates H2A.X Y142 at double strand breaks (Xiao et al., 2009).
As well as the above complexes acting on general chromatin, other ISWI complexes have
more specialised activities. The RSF (remodelling and spacing factor) ISWI complex, con-
sisting of Rsf1 and the Snf2h ISWI, it is involved in the maintenance of centromeric chro-
matin by facilitating the addition and spacing CENP-A containing nucleosomes after depos-
ition of the CENP-A containing nucleosomes (Perpelescu et al., 2009), and increasing DNA
accessibility during transcription initiation (LeRoy et al., 1998). The Snf2h ISWI subunit
loads cohesins via interaction with the cohesin hRad21 subunit (Hakimi et al., 2002). The
ISWI family includes many functional complexes with a general theme of moving histones
into ordered arrays, using accessory proteins to modify and target the various complexes to
their sites of action.
A further, mixed remodelling factor has been purified (Kitagawa et al., 2003).. WINAC
contains the Brg1/hBrm ATPase subunit of SWI/SNF, several BAF subunits from SWI/SNF
and RSC, the WSTF subunit seen in the ISWI-type WICH complex and the p150 subunit
of the replication dependent CAF-1 complex. This suggests that WINAC is localised to the
replication fork and indicates that although these complexes were isolated individually that
there may be more interplay between complex subunits in the cell than previously thought
1.2.5.3 CHD and INO80 Families
The CHD (Chromodomain-helicase DNA binding) family contains one or more chromodo-
mains in addition to the ATPase domain (Delmas et al., 1993). The chromodomain is seen
in many heterochromatin associated proteins such as HP1, however CHD-1 has both pos-
itive and negative effects on repression, with a preference for moving nucleosomes onto
low-affinity AT-tracts (see section 1.2). CHD-1 is located to very active sites of replication
in Drosophila but in contrast to SWI/SNF has not been seen to remove nucleosomes from
large areas of chromatin (Stokes and Perry, 1995; Stokes et al., 1996; Tran et al., 2000).
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Additionally, the CHD family member Hrp1 has been shown to be involved in transcription
termination, in contrast to the ISWI family which is involved in initiation events (Alén et al.,
2002). CHD family proteins are found in the Mi-2 and NURD complexes which are asso-
ciated with histone deacetylation and both contain the RbAp46/48 histone chaperones and
histone deacetylases (Zhang et al., 1999; Wade et al., 1998).
The INO80 family of remodellers differ from the other families as they are ’split’ ATPases.
As with other chromatin remodellers, these 14-15 subunit complexes are involved in all as-
pects of chromatin remodelling, replication, repair and transcription (Gangaraju and Bartho-
lomew, 2007) The S. cerevisiae INO80 family protein SWR1 has been shown to replace the
H2A/H2B dimer with H2A.Z/H2B dimer (Htz1/H2B in yeast) in a replication independent
manner (Mizuguchi et al., 2004).
The central theme of chromatin remodellers is the utilisation of one piece of central ma-
chinery - the catalytic subunit - to fulfil a variety of roles with the addition of modifying
factors which are either tissue or function specific to target the complex and modulate its
activity. There is a high degree of functional redundancy between remodellers, indicating
that whilst they are seen to be discrete complexes they have overlapping roles within the
cells (Tsukiyama et al., 1999; Havas et al., 2001). Remodellers are involved in all aspects of
a nucleosome’s life on DNA, from assisting in the incorporation into DNA after deposition
(discussed further in section 1.3), moving nucleosomes to sites based on epigenetic patterns
to eviction from DNA.
Histone chaperones, in contrast to chromatin remodellers, guide histones around the cell as
well as functioning in eviction and deposition, they are discussed below.
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1.3 Histone Chaperones
Histones are highly charged proteins and prone to aggregation. To prevent non-specific, dele-
terious aggregation, cells have developed a system of chaperones which bind histones when
they are not attached to DNA, guiding their placement and preventing unwanted interactions.
Histone chaperones have both histone binding and assembly properties, they generally chap-
erone a distinct histone pair (H2A/H2B or H3/H4) and many are known to deposit histones
directly onto DNA as well as facilitating the interaction of histones with modifying proteins.
Some histone chaperones have remodelling activity or interact with chromatin remodellers,
allowing a dynamic system of histone assembly, sliding and removal to provide access to
regions of DNA for transcription and replication.
1.3.1 H2A/H2B Chaperones
H2A/H2B dimers are found bound to Nap1 in the cytoplasm and during nuclear import. Gen-
erally cytoplasmic, Nap1 and its cargo relocate to the nucleus during replication, providing
a fresh pool of histones for assembly (Ito et al., 1996; Ransom et al., 2010; Zlatanova et al.,
2007). Nap1 from S. cerevisiae has also been seen to act as a nucleosome remodeller in vitro,
where the removal of H2A/H2B allows histone sliding, although the human equivalent does
not exhibit this activity. Human Nap1 appears to act just as a chaperone and can exchange
the histone variant H2A.Z/H2B for canonical H2A/H2B (Park et al., 2005). NAP1 has also
been seen to chaperone linker histones and can deposit H3/H4 onto DNA and is capable of
assembling nucleosomes in vitro, although its role in nucleosome assembly in vivo remains
under investigation (Zlatanova et al., 2007).
FACT, a dimer of hSpt16 and SSRP1, is also seen to chaperone H2A/H2B during DNA rep-
lication and transcription, where it is thought to aid the progression of the MCM helicase
or RNA polymerase by removing nucleosome ‘blocks’ ahead of the replication fork, acting
as both a chaperone and a remodeller (Rocha and Verreault, 2008; Tan et al., 2006; Belot-
serkovskaya et al., 2003).
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Histone chaperones are thought to work utilising thermodynamic principals for nucleosome
assembly. In the case of yeast NAP1 it has been shown that tetrameric H3/H4 has a higher af-
finity for DNA than for NAP1 (Andrews et al., 2008). NAP1 has a slightly higher affinity for
H2A/H2B and prevents unwanted interactions between these dimers and DNA, encouraging
nucleosome formation (Andrews et al., 2010).
1.3.2 H3/H4 Chaperones
The histone H3/H4 dimer has three major chaperones, ASF-1, HIRA and CAF-1. ASF1
is the major chaperone in eukaryotic cells, sequestering the H3/H4 dimer in the cytoplasm,
in a similar manner to Nap1, and allowing presentation of the histone dimer to modifying
enzymes such as Rtt109 and Hat1. The CAF-1 and HIRA chaperones have complementary
roles. CAF-1, discussed in detail in section 1.5 deposits H3.1/H4 in a replication dependent
manner, whereas HIRA is replication independent and deposits H3.3/H4 during nucleosome
turnover outside replication (Tagami et al., 2004).
1.3.2.1 ASF1
Originally identified as an S-phase expressed gene that de-repressed silenced loci in yeast
following over-expression (Le et al., 1997) Anti Silencing Factor 1 (ASF1, also known as
CIA1) (Munakata et al., 2000) chaperones all H3/H4 dimers not associated with DNA within
a cell (Kaufman et al., 1997; English et al., 2005). The complex of ASF1/H3/H4 has some
intrinsic chromatin assembly activity (Tyler et al., 1999), but appears to act mainly as a
histone chaperone for further complexes. ASF1 is essential in animals as it is required for
chromatin assembly during DNA replication, transcription and after double strand breaks
(Chen et al., 2008).
ASF1 is involved in a variety of histone processing steps. It presents the newly synthesised
H3/H4 dimer to Rtt109 (p300/CBP in animals) and HAT1 for acetylation at H3 K56 and H4
K12 respectively (Avvakumov et al., 2011; Miller et al., 2008; Parthun et al., 1996). ASF1
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is thought to be involved in both chromatin disassembly, removing parental histones ahead
of the replication/translation fork and assembly after the fork passes as it interacts with the
MCM helicase and RF-C, found at the front of the replication fork (See section 1.4.2.1)
(Groth et al., 2007b; Sanematsu et al., 2006; Adkins and Tyler, 2004) as well as both CAF-1
p60 subunit and HIRA, found behind (Malay et al., 2008; Linger and Tyler, 2005; Eitoku
et al., 2008). ASF1 has been shown to bind to the site of the H3/H3 interface in the H3/H4
tetramer which would allow it to disrupt the nucleosome during replication (Natsume et al.,
2007).
ASF1 binds a H3/H4 dimer (English et al., 2006). The H3/H4 dimer is seen bound to the side
of one ASF1 molecule at the opposite side to helix-1 of histone H4 seen bound in the p46 and
p55 crystal structures (Murzina et al., 2008; Song et al., 2008). This indicates a mechanism
that would allow both ASF1 and p48 to interact with the histone dimer concurrently. It
is thought that ASF1 brings the histone H3/H4 dimer to sites of DNA replication where it
passes the histones to an assembly chaperone, such as HIRA or CAF-1 which then deposits
the histones onto the DNA (Avvakumov et al., 2011; Corpet and Almouzni, 2009; Mello
et al., 2002; Ray-Gallet et al., 2007).
1.3.2.2 HIRA
HIRA deposits histone H3.3/H4 dimers onto DNA in a replication independent manner. The
HIRA complex consists of HIRA, ASF1, CABIN1, UBN1 and UBN2 (Rai et al., 2011) with
HIRA having homology to Hir1 and Hir2 complexes in S. cerevisiae. The HIRA protein
functions as a scaffold to recruit the other complex members, (along with ASF1), which is
thought to provide the histones for the complex, binding via HIRA’s C-terminal tail (Tang
et al., 2006). The other subunits are also recruited through their interaction with HIRA (Rai
et al., 2011). The interaction of HIRA with histones can be modulated by modifications:
phosphorylation of histone H4 S47 promotes the interaction of the ASF1 bound H3.3/H4
dimer with HIRA whilst decreasing the affinity for CAF-1 (Kang et al., 2011).
HIRA has been shown to posess several functions beyond chromatin assembly in mammals.
The Hir complex in S. cerevisiae acts as a transcriptional repressor of genes such as histones
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H2A and H2B, is involved in the formation of yeast heterochromatin and also activates other
genes via recruitment of the SWI/SNF remodelling complex (Green et al., 2005; Prochasson
et al., 2005). In mammals, HIRA has been shown to silence expression of histones H3.1 and
H3.2 (Rocha and Verreault, 2008). In S. pombe the HIRA homologue Hip1B is involved in
silencing genes and retrotransposons (Rai et al., 2011).
HIRA is a seven beta-propeller protein and interacts with the similarly structured chaperone
RbAp48 which allows recruitment of histone deacetylases HDAC1 and 2 (Ahmad et al.,
2004) and HP1 (Yamane et al., 2011). These interactions indicate a repressive role for HIRA
in multicellular organisms.
The multiple roles seen for HIRA in the cell illustrate the complex interplay between chap-
erones and other components of the chromatin assembly and modification system. These all
combine to assemble chromatin in either a replication dependent or independent manner, as
described below.
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1.4 Assembling Chromatin
The assembly of chromatin is the result of a network of histone chaperones, chromatin re-
modellers and enzymes that modify this structure. Chromatin is assembled either after DNA
replication or independent of replication, after events such as transcription or during histone
exchange. In general, histone chaperones provide and deposit the histones onto DNA and
a combination of intrinsic signals and remodelling proteins order nucleosome positioning,
whilst enzymes recruited by the assembly complex and existing histone modifications re-
constitute the pattern of modifications. The exact mechanism by which this is done is still
under debate although some pathways are known for the different forms of assembly.
1.4.1 Replication Independent Assembly
Replication independent assembly encompasses a variety of events. Histone exchange is
thought to happen on a localised scale but the pathways have not been well characterised,
it is thought some exchanges are in response to signals such as DNA damage (Jin et al.,
2005; Das and Tyler, 2012). However the major driver of histone replacement and assembly
outside of replication is the response to transcription.
During transcription the RNA polymerase complex requires the movement of nucleosomes
to allow passage along and reading of DNA. Both the H2A/H2B dimer and the H3/H4 dimer
have the potential to be replaced during these events (Jackson, 1990) and this can result in
a mixture of old and new histones incorporated into a single nucleosome, possibly making
the re-establishment of epigenetic marks easier (Xu et al., 2010) as well as incorporation of
histone H3.3, marking actively transcribed chromatin.
There are two methods by which RNA polymerase is thought to negotiate the nucleosome.
Firstly the nucleosome is not totally disassembled: RNA polymerase can negotiate nucle-
osomes with the loss of one dimer of H2A/H2B and no movement of the nucleosome, de-
scribed in in vitro systems (Kireeva et al., 2002). This may account for the higher rate of ex-
change observed for the H2A/H2B dimer compared with H3/H4 (Jackson, 1990). There are
27
several mechanisms by which the loss of the H2A/H2b dimer is thought to be accomplished.
The whole nucleosome presents a block to the passage of RNA polymerase II which has
been shown to be removed by the addition of FACT, which allows transcription elongation
without the need for ATP hydrolysis (Orphanides et al., 1998). The chromatin remodeller
RSC has also been shown to remove this block on recognition of acetylated histones, re-
quiring hydrolysis of ATP and indicating a mechanism by which acetylation increases gene
expression (Carey et al., 2006).
More actively transcribed genes show greater loss of the H3/H4 tetramer than those that are
less activly transcribed. It is thought that whilst RNA polymerase II can negotiate a reduced
nucleosome, (where increased speed is required) the whole nucleosome is disassembled and
reassembled behind the complex (Das and Tyler, 2012). Nucleosome eviction is also medi-
ated by a variety of complexes. The remodeller RSC, in the presence of the histone chaperone
Nap1 is capable of complete, ATP-mediated disassembly of the nucleosome (Lorch et al.,
2005). The remodeller Chd1 interacts with HIRA during D. melanogaster development to
incorporate H3.3 into chromatin (Konev et al., 2007). ASF1 is known to mediate both the
eviction and deposition of H3/H4 (Del Rosario and Pemberton, 2008; Schwabish and Struhl,
2006). HIRA (HIR1) and ASF1 appear to act in concert as in S. cerevisiae where ASF1
re-incorporates existing histones onto the DNA and HIR1 adds newly synthesised histones
(Kim et al., 2007).
Given the high rate of retention of old nucleosomes by the DNA it has been suggested that
the nucleosome components are localised to the site of eviction by interaction with the tran-
scribed RNA. H2A/H2B have a high affinity for RNA (20 times its affinity for DNA) and
on eviction by Nap1 may be temporarily deposited onto RNA before reassembly behind the
transcription complex. This also provides a way to localise H3/H4 to the fork if it is evicted
despite its lower affinity for RNA, through binding to H2A/H2B (Levchenko and Jackson,
2004). The interaction between histone chaperones and chromatin remodellers allows gene
transcription to take place in a controlled manner independent of DNA replication.
Other replication independent assembly events that have been studied indicate a close asso-
ciation between chaperones and remodellers. The the addition of CENP-A to nucleosomes
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near the centromere is a two-step process where deposited CENP-A interacts only weakly
with the nucleosome until it is remodelled by RSF into a robust complex (Perpelescu et al.,
2009). In vitro studies have also shown that, in concert with NAP1, the ACF remodelling
factor is required for the efficient deposition of histones onto DNA (Ito et al., 1999). His-
tones are deposited as a non-nucleosomal intermediate complex by NAP1, thought to be the
nucleosome proteins without the DNA properly positioned, requiring the action of a chro-
matin remodeller to form the final stable complex utilising an ATP driven process (Torigoe
et al., 2011). It is likely that a similar process is seen at all sites of chromatin assembly as
remodelling proteins have been shown to be involved in all aspects of nucleosome turnover.
1.4.2 Replication Coupled Assembly
1.4.2.1 DNA Replication
Replication of DNA is a highly regulated process. To prevent multiple rounds of replication
from the same point, cells ‘licence’ the many origins of DNA replication in a cell during
the G1 growth phase. This involves formation of the pre-replication complex by the ORC
(origin recognition complex) which recruits Cdc6 and Cdt1 followed by MCM helicase to
form the licensing complex, which remains on origins of replication until S-phase. This step
is heavily regulated by a combination of inhibitor protein and modifications to prevent the
re-initiation of fired origins (Li and Jin, 2010).
The pre-replication complex is then activated during S-phase in a step thought to involve
phosphorylation of the complex by the kinases Cdc7-Dbf4 and CDK2 (Talbert and Henikoff,
2010), reconfiguration of the MCM helicase and recruitment of other replication factors
including Cdc45, GINS and DNA polymerase a. This complex then contains the helicase
and primase required for DNA synthesis (Diffley, 2011).
During DNA synthesis, DNA polymerase a acts as a primase, generating a RNA primer
followed by a stretch of DNA. This primer is then bound by RF-C which loads PCNA, a
sliding clamp protein discussed below, onto the primer and displaces polymerase a. The loss
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of polymerase a allows the binding of DNA polymerase e, an enzyme with strong helicase
and proofreading activities which can then accurately synthesise DNA along the leading
strand template (Burgess et al., 2010).
DNA polymerases can only synthesise DNA in a 5’-3’ direction, where the leading strand
processes in this direction, but the lagging strand requires synthesis in the opposite direction
to the replication fork. To do this DNA polymerase a repeatedly synthesises short primers
which are each recognised as before by RF-C, permitting the loading of PCNA and recruit-
ment of DNA polymerase d. This last polymerase proofreads the primer and acts as the
elongation polymerase. To remove the multiple sections of RNA template either FEN1 or
Dnase1 is recruited. Once synthesis has finished DNA ligase joins the synthesised frag-
ments together (Burgers, 2009). Importantly, PCNA remains on the DNA after synthesis
and couples DNA replication to chromatin assembly (Naryzhny et al., 2005; Shibahara and
Stillman, 1999).
PCNA is a homotrimeric sliding clamp protein (Krishna et al., 1994) (Figure5) which in-
creases the processivity of DNA polymerase along DNA. Loaded by RF-C onto the DNA
primer template in the presence of ATP, it is conserved in structure across all species. PCNA
acts as a ’landing pad’ to recruit proteins associated with various aspects of the DNA replic-
ation and repair processes via a conserved motif known as a PIP (PCNA interaction peptide)
(Warbrick, 2000). DNA polymerase d p66 subunit, the FEN1 RNAse and DNA ligase all con-
tain PIP motifs, linking the major players in lagging strand synthesis (Bruning and Shamoo,
2004). The pre-initiation component Cdt1 is recruited to PCNA where it is ubiquitinated and
subsequently degraded, preventing re-initiation of replication (Diffley, 2011). PCNA also
plays a vital role in chromatin reformation, binding CAF-1 and a variety of DNA and his-
tone modifying proteins including the DNMT1 methyltransferase, HDAC1 deacetylase and
the nucleosome remodeller WSTF (Moldovan et al., 2007). It has been suggested that PCNA
may act as a double trimer to allow simultaneous binding of DNA polymerase and CAF-1 so
the processes of DNA replication and chromatin reformation are combined (Naryzhny et al.,
2005).
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Figure 5: Structure of the Human PCNA Homotrimer.
Cartoon representation of the structure of PCNA. Each monomer is coloured red, blue or
green. The proteins assembles around DNA which moves through the central gap. Rendered
in PyMol (Gulbis et al., 1996).
1.4.2.2 Chromatin Replication
During replication independent assembly, nucleosomes must be totally removed from the
DNA as the replication complex passes, deposited onto both daughter strands, the arrange-
ment of nucleosomes re-established and modifications of histone tails repeated. Whilst DNA
is replicated in a semi-conservative manner, with a single original strand retained by each
new molecule, the same does not appear to be true for nucleosomes. It is known from early
studies that both new and old histones are incorporated onto both strands (Sogo et al., 1986;
Jackson, 1988) and that the H3/H4 tetramer is not split , resulting in the paradox discussed
in section 1.4.2.3.
The disassembly process is thought to be caused by a combination of factors including direct
disruption by the replication machinery and chaperone/remodeller dependent disassembly.
ASF1 and FACT are thought to be involved as they have been seen to interact with the MCM
helicase at the front of the fork (Groth et al., 2007a; Rocha and Verreault, 2008; Tan et al.,
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2006). They are thought to chaperone histones to behind the replication fork where they are
deposited either directly or through association with CAF-1.
The process of deposition after replication is known to be mediated by CAF-1. Localised
to the replication fork through interaction with PCNA it deposits the H3.1/H4 tetramer (Shi-
bahara and Stillman, 1999). CAF-1 is known to preferentially (but not exclusively) bind to
histone H4 when the N-terminal tails are acetylated at lysine 5, 8 and 12 (Verreault et al.,
1996), these marks are added by HAT1, and denote newly synthesised histones (Worcel et al.,
1978; Sobel et al., 1995; Parthun et al., 1996). This indicates that the systems by which old
and new histones are transferred onto replicated DNA may be distinct. However, recent evid-
ence suggests that parental histones may also be acetylated during the removal/replacement
process leaving the question as to how CAF-1 recognises new histones open (Burgess et al.,
2010). Addition of the H2A/H2B dimers in a sequential manner to complete the nucleosome
is thought to be mediated by a combination of the FACT and Nap1 chaperones (Groth, 2009).
Re-establishment of nucleosome positioning is likely to be initially due to intrinsic nucle-
osome positioning sequences (see section 1.2) and finalised by the action of remodelling
enzymes recruited to the fork. WSTF, a component of the WICH and WINAC remodelling
complexes is known to interact with PCNA and WINAC has also been seen to interact with
CAF-1 (See section 1.2.5.2) (Groth et al., 2007b). It is possible that WINAC acts with CAF-
1 in a similar manner to the interaction of ACF with NAP1, maturing the deposited histone
proteins into nucleosomal form.
Further to the deposition and arrangement of histones following the replication fork, the
epigenetic marks must be reinstated on new nucleosomes. Both PCNA and CAF-1 remain on
new DNA for a significant amount of time which offers a window of recruitment for histone
modification activities (Taddei et al., 1999). The re-establishment of methylated DNA is
mediated by DNMT1 which uses hemimethylated DNA as a template and is recruited to the
replication fork by PCNA (Warbrick, 2000). This methylation can then act as the template
for the re-establishment of H3 K9 methylation. MBD1 binds to methylated DNA and recruits
the H3 K9 methylase SETDB1. The MBD1-SETDB1 complex also binds to CAF-1 p150
subunits where it could perform the same task during replication dependent assembly without
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DNA methylation (Sarraf and Stancheva, 2004). The Sas2 acetyltransferase also interacts
with CAF-1 p150 to acetylate H4 K16 after replication (Meijsing and Ehrenhofer-Murray,
2001).
Histone modifications are also implicated in their own duplication: Trimethylation of H3
K27 recruits the PRC2 methylase complex during S-phase, where it is thought to methylate
the newly synthesised histone neighbours of nucleosomes already showing the mark (Hansen
et al., 2008). Methylation of H3 K9 has the potential to act in a similar manner as it recruits
HP1 which in turn recruits the Suv39h1 methylase (Maison and Almouzni, 2004).
1.4.2.3 The Assembly Problem
The composition of the nucleosome, consisting of two copies of each protein, suggests two
possible methods of chromatin replication. Firstly, a semi-conservative mechanism may
exist, wherein the nucleosome is split in half, with each dimer separated onto a different
strand and a new histone dimer added. Secondly, conservative replication moving the whole
nucleosome from the front of the replication fork to behind it, with or without disassembly
but maintaining the nucleosome as a unit. During conservative replication, the nucleosomes
could be deposited onto either just one strand or onto both, in either an equal or stochastic
manner, as detailed in Figure 6 (Martin and Zhang, 2007). Early investigations used pulse
labelling experiments to show that whilst the H2A/H2B dimer appears to split from the
other H2A/H2B dimer and segregate into nucleosomes with newly synthesised H2A/H2B,
the H3/H4 tetramer does not appear to be split during the course of replication, leading
to nucleosomes containing either new or old H3/H4 tetramers with H2A/H2B dimers from
different sources (Jackson and Chalkley, 1981; Annunziato, 2005).
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Figure 6: Possible Chromatin Assembly Strategies.
Chromatin replication could be either semi-conservative or conservative. There are three
possible conservative replication mechanisms, alternate segregation of nucleosomes, asym-
metric or random. Current evidence favours the random segregation of nucleosomes. Old
histones H3 and H4 are indicated in grey, new histones H3 and H4 in brown. All H2A-H2B
dimers are blue.
Recently, this result has been investigated further and a new level of complexity added. Xu
and colleagues examined the histone H3 variants H3.1 and H3.3. Investigation of tagged
versions of both histones revealed that H3.1/H4 tetramers remain intact on replication, con-
firming previous results. However, they also discovered that H3.3/H4 tetramers, which are
formed in a replication independent manner, are split upon replication, incorporating a newly
synthesised H3.3/H4 molecule. This splitting of the tetramer was reduced when replication
was inhibited, indicating that it occurs when active chromatin is replicated. Whether this
splitting is histone variant specific or rather a result of modifications of the histones is cur-
rently unknown (Xu et al., 2010).
Structural evidence of histones H3 and H4 in complex with the chaperone ASF1 has revealed
that it binds a dimer of H3/H4 (English et al., 2006), and that ASF1 is capable of disrupting
the tetramer to extract the H3/H4 dimer (Natsume et al., 2007). Experiments using epitope
tagged H3 to purify H3 containing complexes such as the ASF1/H3/H4 and CAF-1/H3/H4
complexes from the cell did not reveal any untagged H3 protein in tagged H3 containing
complexes, despite the tagged protein being expressed at a low level, indicating again that
H3/H4 is held in a dimeric form in chaperone complexes in the cell (Nakatani et al., 2004;
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Tagami et al., 2004). Recent studies of of the association coefficients of H3 and H4 have
also indicated that at the normal concentration seen in the cell they will be present as dimers,
with association on DNA due to increased local concentration (Donham et al., 2011).
This information appears to be contradictory; histone tetramers are not split on chromatin
replication despite conditions in the cell tending towards dimers of H3/H4 and nearly all
histone containing complexes investigated at the molecular level appear to contain only a
H3/H4 dimer. How this paradox is resolved is currently under investigation. In this disser-
tation the CAF-1 complex, known to be involved in deposition of the H3.1/H4 dimer during
replication dependent nucleosome assembly is investigated. CAF-1 contains three subunits,
all potentially capable of binding histones, at least in a non-specific manner (Kaufman et al.,
1995), operating with an unknown oligomerisation state. These experiments aim to dissect
the interactions in the CAF-1 complex to provide insight into how it functions. A schem-
atic showing the current understanding of the role of CAF-1 during replication dependent
assembly is shown in Figure 7.
Figure 7: Schematic of the Role of CAF-1 in Chromatin Formation on Replicating DNA
Following the replication fork and the DNA Polymerase e via interaction with PCNA, CAF-1
deposits the H3/H4 tetramer onto the newly synthesised DNA via an unknown mechanism.
The nucleosome is completed by the addition of two H2A/H2B dimers. The source for the
newly synthesised H3/H4 dimer is ASF1. Old histones are known to be removed from in
front of the replication fork with the aid of ASF1, whether CAF-1 is also involved directly
in this process in unknown.
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1.5 Chromatin Assembly Factor 1
The existence of a replication dependent chromatin assembly factor was first shown in 1986,
using the Simian Virus 40 papovavirus (SV40) replication system which packages the 5.2 kb
circular viral genome into nucleosomes in a cell free system (Stillman, 1986; Li and Kelly,
1984). This system was later used as an assay to purify this chromatin assembly activity,
leading to the discovery of Chromatin Assembly Factor 1 (CAF-1) (Smith and Stillman,
1989).
CAF-1 purified to homogeneity from the 293-T human cell line was shown to consist of
three subunits of mass, as estimated by SDS-PAGE, of 150, 60 and 48 kDa and named p150,
p60 and p48 respectively (Smith and Stillman, 1989). These subunits, discussed individually
later, co-localise to the nucleus at sites of DNA synthesis and are responsible for depositing
H3/H4 onto replicated DNA (Verreault et al., 1996; Smith and Stillman, 1989, 1991). The
CAF-1 complex binds to either one or two histone H3(.1)/H4 dimers, with a preference
for newly synthesised histones (Sobel et al., 1995; Glowczewski et al., 2004). The exact
stoichiometry of the complex is currently unknown.
CAF-1 has been identified in all eukaryotic species investigated. D. melanogaster (d)CAF-1,
consisting of p180, p105 and p55, homologues of p150, p60 and p48 respectively (Kamakaka
et al., 1996; Tyler et al., 2001), was purified using a similar method to human (h)CAF-1 and
shows functional conservation between species (Song et al., 2007). CAF-1 has also been
identified in mouse, Xenopus laevis and chicken and has been shown to be essential for
development in all these organisms (Quivy et al., 2001; Takami et al., 2007; Houlard et al.,
2006).
Both plant and yeast CAF-1 have been identified, although they are not as essential to cell
survival as their animal counterparts. S. cerevisiae also appears to contain an activity that
partially compensates for loss of CAF-1. Whilst mutants appear normal under optimal
growth conditions they are sensitive to DNA damaging reagents such as ultraviolet (UV)
light and exhibit problems with gene repression (Kaufman et al., 1997; Linger and Tyler,
2005; Enomoto and Berman, 1998).
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Mutations of A. thaliana FASCIATA 1 (FAS-1), a p150 homologue, cause defects at both
stem and root meristems and in other processes requiring cell division, thought to be due to
reversion of silenced genes to active states (Kaya et al., 2001). Some FAS-1 mutant lines also
show increased numbers of copies of the genome (polyploidy), which is tolerated in plants
but not in other organisms, possibly providing an explanation as to why such mutations are
lethal to animals (Ono et al., 2006; Exner et al., 2006).
1.5.1 Functions of CAF-1
CAF-1 binds histones H3.1 and H4 to facilitate their deposition onto DNA. Whether the
H3/H4 tetramer is constructed within the CAF-1 complex and then deposited onto the DNA
or if two dimers are deposited individually is currently unknown. Dimers of H3/H4 have not
been observed on DNA (?), indicating that if they are assembled after deposition, it is a very
fast process. CAF-1 is not unique in binding to the H3/H4 dimer (see section 1.3). However
CAF-1’s unique feature is that it acts solely on recently replicated DNA (Lassle et al., 1992),
making it a marker for actively replicating cells, replication forks and sites of DNA repair
requiring synthesis (Polo et al., 2004).
Immunostaining of the p150 and p60 CAF-1 subunits show their localisation to the nucleus
(Smith and Stillman, 1991), mainly at replication foci (Krude, 1995). This complex dissoci-
ates during mitosis when p60 is hyper-phosphorylated (Marheineke and Krude, 1998). The
localisation of p48 is less well defined, it is seen at replication forks but also at other loca-
tions, associated with other proteins as part of various chromatin formation and re-modelling
complexes (Marheineke and Krude, 1998).
The role of CAF-1 in viral infection has also recently been noted: Human cytomegalovirus
(HCMV) recruits CAF-1 to package viral DNA via interaction of p150 with the HCMV IE2
protein which is required for HCMV DNA replication (Lee et al., 2011).
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1.5.1.1 Replication
As detailed in section 1.4.2 CAF-1 adds newly synthesised histone H3.1/H4 dimers to replic-
ated DNA. Depletion of CAF-1 causes replication to stall and induces activation of the DNA
damage checkpoint pathway, indicating that chromatin formation is critical for a cell under-
going replication of its DNA (Nabatiyan and Krude, 2004; Ye et al., 2003). The specificity
of CAF-1 for the replication fork is provided by its interaction with PCNA (Shibahara and
Stillman, 1999). CAF-1 can bind PCNA via two separate sites on p150. The classical PCNA
binding motif (PIP1) between residues 12-34 has the consensus sequence QXXhXXaa where
h is a hydrophobic (V/I/L/M) and a is an aromatic (F/Y/W/H) amino acid. The PIP2 site (aa
420-444) contains a substitution of the classical Q to K, which reduces the binding affinity to
PCNA but is required and sufficient for assembly of H3/H4 onto DNA (Moggs et al., 2000;
Ben-Shahar et al., 2009).
1.5.1.2 DNA Repair
Loss of CAF-1, lethal to animals, results in increased sensitivity to UV and gamma radiation
in plants and yeast with increased frequency of somatic homologous recombination events
and activation of S-phase DNA damage checkpoints, indicating a possible role in the repair
or prevention of DNA damage (Ye et al., 2003; Game and Kaufman, 1999; Endo et al., 2006;
Song et al., 2007). Mutation of CAF-1 induces activation of the S-phase and DNA damage
checkpoints in S. cerevisiae. It is thought that preventing chromatin reassembly leads to
replication fork stalling, which when resolved incorrectly creates double strand breaks (Ye
et al., 2003).
In quiescent cells, where CAF-1 levels are normally low, the complex is up-regulated in
response to damage such as double strand breaks (Nabatiyan et al., 2006) and complement-
ation assays have indicated a role for CAF-1 in the Rad6 mediated repair pathways of S.
cerevisiae (Martini et al., 1998; Ye et al., 2003; Game and Kaufman, 1999). Subsequent
work has shown that CAF-1 is involved in repackaging chromatin during the three DNA
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repair mechanisms requiring synthesis: Nucleotide excision repair (NER), homologous re-
combination (HR) and non-homologous end joining (NHEJ) (Linger and Tyler, 2005; Green
and Almouzni, 2003), outlined in Figure 8.
Figure 8: Schematic Representation of Replication Requiring DNA Repair Mechan-
isms.
Newly synthesised DNA is indicated in red. The DNA polymerase machinery allows recruit-
ment of CAF-1 for replication dependent chromatin formation.
NER is used to correct small, helix distorting lesions, such as thymine adducts caused by
UV light, cyclobutane pyrimidine dimers and 6-4 photoproducts (Escargueil et al., 2008).
Damage recognition of distortions of the DNA backbone is performed by the proteins RPA,
XPA and XPC-TFIIH which form a recruitment complex for the nucleases XPG and XPF.
TFIIH is a helicase which unwinds the DNA to allow access to the nucleases, which create
single strand breaks either side of the lesion (Sancar et al., 2004). The resulting single strand
break is then filled by DNA polymerase δ or ε using a recruitment pathway similar to that
of genomic DNA replication. This in turn recruits CAF-1 through its interaction with PCNA
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where it re-assembles the new DNA into chromatin (Green and Almouzni, 2003).
Double strand breaks are often caused by ionising radiation or as a result of genomic cros-
sover events. Breaks are marked by the phosphorylation of H2A.X which is required for
the recruitment of the repair machinery. These include the histone acetyltransferase NuA4
which relaxes chromatin, allowing access to the DNA (Tsukuda et al., 2005; Escargueil et al.,
2008). Chromatin is remodelled in response to double strand breaks in an INO80 dependent
manner, which results in the loss of nucleosomes from the damaged site, which must then be
replaced after damage repair (Tsukuda et al., 2005).
There are two main mechanisms of double strand break repair: HR and NHEJ. During HR
a single strand of DNA ’invades’ complementary DNA to allow recombination and retrieval
of the genetic information from the other strand. This results in a crossover event forming a
Holliday junction which is resolved as seen during meiosis. The resolution of the Holliday
junction requires DNA synthesis, which is likely to recruit CAF-1 to repair sites (Sancar
et al., 2004). If a template strand is not available then the damage can be crudely repaired
by ligating the ends together by insertion of a few bases followed by non-specific ligation by
XRCC4 ligase4 (NHEJ) (Dudasova et al., 2004; Linger and Tyler, 2005).
The role of CAF-1 in these events is not completely clear. Complexes containing extensively
phosphorylated p60 are recruited to sites of UV damage (Martini et al., 1998) in a PCNA de-
pendent manner (Moggs et al., 2000; Okano et al., 2003) and incorporate newly synthesised
histones into sites of repair. However, CAF-1 is not essential for activation of the checkpoint
or the repair itself and in NER it has been shown that chromatin assembly propagates from
the site of repair even when DNA synthesis is inhibited, (Gaillard et al., 1996). CAF-1 is re-
cruited late in the repair process, therefore it is thought to be required for the re-formation of
chromatin after damage repair and is likely to be recruited and function in a similar manner
to during genomic replication (Polo et al., 2006; Green and Almouzni, 2003).
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1.5.1.3 Heterochromatin
In S. cerevisiae loss of CAF-1 p150 results in a loss of maintenance of transcriptional silen-
cing, at both genes and telomeres indicating that in yeast CAF-1 is not directly involved in
the Sir-dependent establishment of heterochromatin (Enomoto and Berman, 1998; Monson
et al., 1997). This silencing can also be mediated by Hir proteins, indicating a mechanism
by which S. cerevisiae compensates for the loss of CAF-1, reversing the lethality observed
in animals (Kaufman et al., 1998). This loss of transcriptional silencing is also seen in A.
thaliana(Ono et al., 2006), with methylation of DNA acting as a partially redundant pathway
(Schönrock et al., 2006).
CAF-1 is also thought to contribute to kinetochore formation at centromeric chromatin dur-
ing mitosis; loss of CAF-1 p150 and Hir1 in S. cerevisiae causes S-phase arrest and a delay
in passing from G2 to M phase, coinciding with an increased number of chromosome mis-
segregation events and an alteration in the structure of centromeric chromatin (Sharp et al.,
2002).
In higher animals CAF-1 is seen to localise to heterochromatic replication foci following the
replication of euchromatin (Krude, 1995) and is required for replication of heterochromatin
structure (Quivy et al., 2004). Loss of p150 causes arrest in mouse embryos at the 16 cell
stage due to alterations in heterochromatin organisation (Houlard et al., 2006), results in
defects in nuclear organisation and cell death in Xenopus (Quivy et al., 2001) and is hem-
izygous lethal during D. melanogaster development with tissue-specific disruption causing
severe developmental defects (Song et al., 2007).
CAF-1 p150 can localise HP1 to heterochromatin via the interaction of the p150 MIR (MOD
interacting region) with HP1, an area of p150 dispensable for chromatin assembly function
(Murzina et al., 1999). Given the independent activity of the N and C terminal domains
of p150 one would expect that H3/H4 and HP1 can be bind concurrently. However when
examined in vivo whilst CAF-1 was seen to bind HP1 and histones it did not appear to bind
both simultaneously (Quivy et al., 2004).
As well as having a role in chromatin formation, it has been suggested that CAF-1 may aid
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in the destabilisation of heterochromatin. Depletion of CAF-1 in human cell lines results
in cell arrest prior to heterochromatin replication (Hoek and Stillman, 2003) and depletion
in Xenopus prevents pericentromeric heterochromatin replication, causing cell cycle arrest
(Quivy et al., 2008). In Xenopus this was shown to be a result of the loss of the interaction
between p150 and HP1, indicating a potential role for CAF-1 in the removal of HP1 before
chromatin deposition (Quivy et al., 2008).
1.5.1.4 Aberrant Expression
Correct function of CAF-1 is required for gene silencing. Cancer tissue is characterised by
aberrant gene expression. It therefore follows that there may be a link between the two.
Several studies have associated over expression of p60 with increased severity and poorer
outcomes of cancer (Staibano et al., 2007, 2009; Yang et al., 2002; Mascolo et al., 2010).
Conversely, depletion of p60 is tolerated by quiescent cells (Nabatiyan and Krude, 2004).
p150 is down regulated in a minority of cancers with low concentration associated with poor
outcomes (Kong et al., 2007; Pacifico et al., 2007; Staibano et al., 2007). As loss of p150
leads to massive chromosomal defects, a hallmark of late stage cancer, this is not unex-
pected (Ye et al., 2003; Endo et al., 2006; Song et al., 2007). RbAp48, the p48 subunit,
was originally discovered interacting with the tumour suppressor Rb and has been seen to
be down-regulated during cancer. The down regulation of p150 and p48 expression during
cancer indicates roles for these proteins as tumour suppressors. However, the seemingly
contradictory role of p60 ever-expression is not well understood as yet. Currently it is un-
known whether the change in levels of CAF-1 proteins is a cause or effect of disease, given
the complex nature of cancer both are possible as part of a larger network of expression
changes.
As well as its possible role in sporadic cancers, CAF-1 is associated with other proteins
implicated in diseases causing susceptibility to cancer or uncontrolled cell growth. The
BLM (Bloom) and WRN (Werner) RecQ family helicases are known to cause Bloom’s and
Werner syndromes respectively, when mutated. Both disorders are characterised by genomic
instability, Bloom’s patients have a high incidence of cancer whilst Werner patients exhibit
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premature ageing (Amor-Gueret, 2006; Jiao et al., 2004). The loss of either protein has
been shown to impair CAF-1 mediated chromatin assembly during DNA repair by decreased
mobilisation to sites of damage without affecting protein activity (Jiao et al., 2004, 2007).
PCNA and the p48 subunit of CAF-1 are known to be regulated by the genes TCS1 and 2,
mutations in which cause the disease Tuberous Sclerosis, characterised by the development
of tuberous, cancer-like growths throughout the body (Hengstschläger et al., 2003). These
diseases indicate how important the chromatin assembly pathway is for correct development
and control of cells.
1.5.2 CAF-1 Subunits
CAF-1 consists of three subunits, known in humans as p150, p60 and p48. Their basic
properties are shown in Table 1. All three proteins are found in the CAF-1 complex, how-
ever p150 and p48 are seen to perform other roles in the cell. The subunits are discussed
individually below.
CAF-1 Subunit p150 p60 p48
Number of Amino Acids 956 559 425
Theoretical Molecular Mass (kDa) 106.9 61.5 47.7
Theoretical pI 5.7 7.2 4.75
Major Structural Motif Small coiled coil WD repeat protein WD repeat protein
Location in Genome 19p13.3 21q22.13 1p35.1
Gene Length (kb) 42.8 31.4 29.4
Number of Introns 14 14 12
Splice Variants 2 None known None known
Table 1: Summary of the Properties of the Human CAF-1 Subunits.
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1.5.2.1 p150
The largest subunit of CAF-1 has little similarity to proteins other than its functional homo-
logues, which exhibit a great deal of sequence variation between species. Various features
have been identified by bioinformatic and experimental means, summarised in Figure 9. Ori-
ginally human p150 was thought to be 938 aa in length, however more recent bioinformatic
information revealed a further 18 aa at the N-terminus of the protein. This has required se-
quence information in older papers to be updated for Figure 9. p150 has been shown to bind
a variety of proteins associated with chromatin, as discussed below, but has very little pre-
dicted structure itself, the only motif seen by bioinformatic investigation of the sequence is
a coiled-coil region, a common motif involved in protein-protein interactions over a variety
of different cellular functions (Burkhard et al., 2001). This coiled-coil spans the KER region
of the protein thought to be involved with the interaction of p150 with histones (Kaufman
et al., 1995).
Figure 9: Map of the p150 Peptide.
PIPs 1 and 2 are PCNA Interaction Peptides, the PxVxL binds HP1, the coiled-coil region
is predicted from sequence identity. KER and ED regions are specified by the amino acid
sequence. Mutant isoforms have been shown to exist in certain cell lines but biological
importance remains unknown. Constructed using information from (Kaufman et al., 1995;
Dong et al., 2001; Quivy et al., 2001; Murzina et al., 1999; Moggs et al., 2000; Reese et al.,
2003; Ben-Shahar et al., 2009) with DOG 1.0 (Ren et al., 2009).
p150 has been shown to form a homodimer through a conserved 36 aa sequence motif which
is an absolute requirement for chromatin formation in vitro (Quivy et al., 2001). The di-
merisation event is regulated by phosphorylation of p150 by Cdc7-dbf4, a cyclin depend-
ent kinase required for the initiation of DNA synthesis, linking chromatin assembly to the
overall regulation of S-phase in the cell (Gerard et al., 2006). Unphosphorylated p150 ex-
ists in a monomer/dimer equilibrium which is driven to the monomer by phosphorylation.
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Monomeric p150 has an increased affinity for PCNA, facilitating binding to the replication
complex. However, only dephosphorylated p150 is active in chromatin assembly. Dephos-
phorylation is thought to be mediated by protein phosphatase 1, known to be necessary for
CAF-1 activity (Gerard et al., 2006; Keller and Krude, 2000). This two-sided regulation of
p150 allows fine-tuning of initiation of chromatin assembly within the cell.
Two additional splice variants of p150 have been identified by bioinformatic analyses and
RT-PCR. These C-terminal truncations have a tissue specific localisation, whereas full length
CAF-1 is ubiquitous; splice variant 2 is seen in the thymus, colon and small intestine whilst
all three variants are seen in the testes. If these variants have a function it is not yet under-
stood (Dong et al., 2001).
Mutations and deletions of p150 resulting in loss of nucleosome assembly activity results
in uncontrolled gene re-activation, increased transcription at repression sites, increases in
homologous recombination as well as more general structural defects in chromatin (Tchénio
et al., 2001; Kirik et al., 2006; Poleshko et al., 2010).
The major role of p150 is thought to be a scaffold, initially for the CAF-1 complex but
recent data has identified several roles in chromatin complexes. In the context of CAF-1
p150 binds p60 and p48 to PCNA, primarily using the non-classical PIP2 motif for binding
PCNA during chromatin assembly through a mechanism slightly different from the classical
motif (Tyler et al., 2001; Ben-Shahar et al., 2009). Experimental dissection of p150 has
revealed that the first 296 amino acids are not required in vitro for nucleosome assembly
or binding to p60. Despite the loss of this section being lethal in vivo it is thought that in
terms of function, p150 can be divided into two regions: the N-terminal third, important
for localising p150 and interactions with other, usually heterochromatic complexes and the
C-terminal two-thirds, containing the KER and ED regions as well as the C-terminus being
required for chromatin assembly (Kaufman et al., 1995).
The N-terminal portion of p150 has been shown to interact with a variety of proteins associ-
ated with chromatin. The HP1 family bind to the PxVxL motif which may target p150 and
subsequently CAF-1 to heterochromatin replication foci during late S-phase (Murzina et al.,
1999). When bound to HP1, p150 is also seen to bind MBD1, possibly forming a complex
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involved in the formation and maintenance of repressive complexes and remains bound until
late G2 (Reese et al., 2003). The presence of p150 in heterochromatin may explain why the
loss of CAF-1 results in destabilisation of silencing, as discussed earlier.
Other proteins seen to interact with p150 include the SUMO2/3 modifying protein which is
recruited to DNA replication foci, linking p150 the re-establishment of histone modifications
(Uwada et al., 2009), the Lim15/Dcm1 recombinase which may link p150 to homologous
recombination (Ishii et al., 2008) and Rtt106, a yeast histone chaperone also involved in
silencing heterochromatin (Huang et al., 2005). In contrast to its general theme of repression,
p150 has been seen to be involved in gene activation of the human cytomegalovirus major
immediate early promoter, binding to DNA via the KER domain and resulting in recruitment
of p300 histone acetyltransferase, although this function of p150 remains to be investigated
more thoroughly (Lee et al., 2009).
1.5.2.2 p60
CAF-1 p60 is the least well investigated of the components of CAF-1. Bioinformatic analysis
reveals seven WD repeats and a C-terminal PEST sequence with multiple phosphorylation
sites (Figure 10). p60 is known to bind the C-terminus of p150 but the p150 interacting
site on p60 is unknown. The unstructured C-terminal tail of p60 binds to ASF1 (Takami
et al., 2007; Tang et al., 2006). p60 is well conserved between species, exhibiting 47 %
sequence homology between human and yeast in the area of the WD repeats. Outside its
strict homologues p60 displays some sequence similarity to the HIRA histone chaperone
(Tang et al., 2006).
p60 is known to be a target for phosphorylation by Protein Kinase C, Casein Kinase and sev-
eral tyrosine kinases (Smith and Stillman, 1991). Hyperphosphorylation of p60 results in its
recruitment to p150, with dephosphorylated p60 less active when assembling chromatin after
DNA repair (Martini et al., 1998). The function of p60 within the CAF-1 complex remains
largely unknown, although the sequence similarity to HIRA indicates a direct involvement
in chromatin assembly.
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Figure 10: Map of the p60 Protein.
WD regions form the predicted beta-propeller structure. P indicates a phosphorylation site.
There is no current structure of p60.
1.5.2.3 p48
p48, also known as RbAp48, NURF55 (drosophila) or RBBP4 is a highly conserved protein
that binds H3/H4, identified in 1993 as a component of the Rb complex (Qian et al., 1993).
p48 is the best understood of the components of the CAF-1 complex, with the structure
solved by the SGC (Structural Genomics Consortium, PDB ID: 3GFC) and independently
by S. Lejon in this lab (Lejon et al., 2011). The structure of p48, shown in Figure 11, is
that of a seven repeat beta-propeller proteins, a common protein-protein interaction motif,
also predicted to be seen in p60. The structure of p48 is very similar to that of RbAp46,
a paralogous gene with 89 % identity. The structure of p46 was also solved in this lab, in
complex with a histone H4 peptide (Murzina et al., 2008). Both p46 and p48 appear to
have the same function - that of a H3/H4 chaperone but operate in different complexes. It is
thought that the distinction between the two proteins lies more in their physical location than
biochemical properties as they appear to function redundantly (Verreault et al., 1998).
The binding of p48 to H3/H4 is currently a topic under investigation. The structure of p46
with a H4 peptide indicates an atypical binding mode of the H4 peptide, as it is seen to
bind to the side of the protein rather than the top or bottom face, as is more usual for WD
repeat proteins (Murzina et al., 2008). More intriguingly, the binding pocket seen for the
H4 peptide is unable to accommodate a fully-folded histone H3/H4 molecule, indicating
that there is likely a conformational change in the histone structure on binding to p48 or 46
(Murzina et al., 2008). This feature is also seen in the structure of p55, the D.melanogaster
homologue of both p48 and p46 (Song et al., 2008).
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The histone binding function of p48 is utilised by the cell in many different contexts. As
well as assembling chromatin with HIRA and CAF-1, as previously mentioned it is involved
in histone assembly of CENP-A, with which it makes the minimal deposition complex (Fur-
uyama et al., 2006). The PRC2 (Polycomb repressive complex) demethylation complex
utilises p48 via its interaction with Suz12 to localise the complex to histones (Margueron
and Reinberg, 2011). p48 is also involved in acetylation of histones, binding to HAT1 in-
terchangeably with p46 to allow HAT1 to acetylate newly synthesised histones (Verreault
et al., 1998). The interaction of p48 with the deacetylase HDAC1 localises it to the Rb gene
repressor complex, which represses genes regulated by the E2F transcription factor (Nicolas
et al., 2000) and it is also part of the core deacetylase complex of NuRD and Sin3 with
HDAC1 and 2 (Zhang et al., 1999).
The NuRD complex is multifunctional and contains remodelling, deacetylase and demethylase
activities. Mi-2a/b (CHD3/4) in conjugation with p48, HDAC 1/2, and LSD 1 is responsible
for each of these respective activities. Other subunits of the complex include a methyl-
CpG binding domain (MBD2/3) subunit which binds to methylated DNA and the MTA1/2
deacetylase recruitment proteins (Ramírez and Hagman, 2009). Within various cell types a
number of transcription factors are known to interact with and target NuRD. The regulator
FOG1 (friend of GATA1, a nuclear transcription factor) is known to bind NuRD through
the p48 subunit via an interaction between FOG1’s N-terminal tail and p48’s top surface, a
canonical binding mode to WD proteins. This site is separate to the known H4 binding site
of the similar p55 and p46, indicating that p48 can bind to both proteins simultaneously, re-
cruiting proteins to histone H3/H4 (Lejon et al., 2011). This ability to bind both histones and
other proteins simultaneously is likely to be central to p48’s role in these diverse complexes,
allowing a diverse set of functions to be performed by the same protein.
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Figure 11: Structure of p48.
Crystallised and solved by S. Lejon in the EDL lab. The protein is rainbow coloured from
the N to C terminus. Figure compiled in PyMol
Chromatin assembly factor 1 is clearly an important complex in the cell, required for ac-
curate replication of the epigenetic state. Understanding how CAF1 functions will help our
understanding of this important part of chromatin dynamics.
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1.6 Aims of this Project
Whilst the function of CAF-1 has been widely investigated, the molecular mechanism by
which it deposits histones onto DNA and the molecular details of the interactions both within
the CAF-1 complex and with other proteins remain unknown.
The primary aim of this study was to produce and crystallise recombinant CAF-1 as well
as biochemically characterise the complex in terms of interactions and stoichiometry. To
do this CAF-1 had to be produced recombinantly using a new system that allowed reliable
co-expression of proteins in baculovirus and purified to homogeneity before crystallisation
was attempted.
Chapter 3 describes methods intended to co-express the CAF-1 complex, as a ternary co-
expression self-cleaving fusion protein and as a binary complex. The purification of both
complexes is also described but did not produce protein suitable for crystallisation. Alternat-
ive methods were used to produce individual subunits for further investigation as described
in chapter 4. The protein produced was still not sufficiently homogeneous for crystallisation
and so further investigation of the interactions between subunits and stoichiometry of the
complex was undertaken, as detailed in chapter 5.
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Chapter 2
Materials and Methods
2.1 Materials
Yeast Extract and Tryptone were from Duchefa Biochime, Protease Inhibitors were “Com-
plete Mini EDTA Free Protease Inhibitor Cocktail” tablets from Roche. All other chem-
icals were from Sigma-Aldrich unless otherwise specified. Phusion Polymerase and Taq
were from Finnzymes and Roche, respectively. Thrombin from Merck, In-Fusion kit from
Clontech and all other enzymes from New England Biolabs. Plasmid purification, PCR
clean-up and gel extraction kits were from Macherey-Nagel, MidiPrep kits from Qiagen and
oligos from MWG (now Eurofins). Protein Gels were run using the Nu-PAGE system from
Invitrogen. Ni-NTA resin was from Qiagen. All protein purification columns were from GE
Healthcare.
The MultiBac and iACEMBL systems were kindly provided by the Berger Laboratory (Gren-
oble), His-p48-pFBDM, His-p150-pFBDM, His-p150p-60-pFBDM and pFBDM-GST-p48
plasmids were previously made by Dr Murzina in this lab and pNIC-Bsa4 vector was a gift
from O. Gileadi (SGC, Oxford). The following E. coli strains were used: BW23474 and
BW23473 cells were from the Berger Lab; Top10 cells were from Invitrogen and Arctic-
Express from Stratagene. Anti-p60, anti-p48 and anti-Myc antibodies were from AbCam
(ab8133, ab38135 and ab9106 respectively). Anti-his and secondary antibodies (anti-mouse
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and anti-rabbit both conjugated to HRP) were from Sigma. FOG1 1-15 peptide was synthes-
ised by Auspep.
2.2 Methods
Buffer recipes are in Appendix B, Escherichia. coli genotypes in Appendix C, Plasmids in
Appendix D Primers in Appendix E and protein sequences in Appendix F. A benchtop Ep-
pendorf 5417R centrifuge was used for centrifugation of volumes up to 2 ml and a benchtop
Eppendorf 5810R centrifuge for volumes up to 50 ml. Larger volumes were spun in a Beck-
man J-26 XP centrifuge using a JLA10.500 rotor. High speed spins were performed in the
same centrifuge using a JA25.50 rotor.
2.2.1 DNA Manipulation
2.2.1.1 Growth and Purification of Plasmids
A single colony of E. coli containing the plasmid of interest was grown in 10 ml LB supple-
mented with relevant antibiotic overnight. Antibiotic concentrations are shown in Table 2.
The cells were spun down at 1,500 g and the supernatant discarded. To purify plasmids for
cloning experiments a miniprep was performed according to the manufacturer’s instructions.
Where this did not produce sufficient DNA a midiprep was tried, in the case of pUCDM the
alkaline lysis method was also used.
Abbreviation Full Name 1000x Stock Concentration (mg/ml)
Amp Ampicillin 100
Cm Chloramphenicol 34 (EtOH)
Gent Gentamicin 10
Kan Kanamycin 50
Tet Tetracycline 10 (EtOH)
Table 2: Concentrations of Antibiotics Used in this Study
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2.2.1.1.1 Alkaline Lysis Method 500 ml of LB enriched with appropriate antibiotic was
inoculated and grown overnight at 37 oC, 250 rpm. The cells were pelleted at 6700 g for
5 min at 4 oC. The pellet was washed with 100 ml ice cold TES buffer and re-suspended
in 28 ml alkaline lysis buffer with a few crystals of lysozyme. This was incubated at room
temperature for 10 min then 56 ml NaOH/SDS solution was added, the mixture shaken until
clear and incubated on ice for 10 min. 42 ml of ice-cold 5M potassium acetate was then
added, the mixture gently inverted and incubated on ice for 10 min. The solution was then
spun at 48,000 g for 30 min at 4 oC and the supernatant filtered. 72 ml isopropanol was added
and the mixture left at room temperature for 10 min. This was spun as before at 20 oC and
the supernatant removed. The remaining pellet was rinsed with 70 % EtOH and left to air
dry for 10 min. The pellet was re-suspended in 2.5 ml TE buffer with 2.5 ml of RNAse A at
10 mg/ml and incubated at 37 oC for 30 min, vortexing occasionally. The solution was then
phenol extracted by adding 2.5 ml Phenol:Chloroform solution, spun at 8,600 g for 15 min
at 20 oC and removing the aqueous (top) phase to a fresh tube. This was repeated 3-5 times,
making the aqueous phase up to 2.5 ml each time with TE buffer. The remaining DNA was
then ethanol precipitated by adding 0.1 volumes 3 M NaAc and 2.5 volumes ice-cold 100%
EtOH, then spun at 8,600 g for 15 min at 4 oC. The supernatant was removed and the pellet
washed in ice-cold 70 % EtOH. This was then air dried for about 10 min and re-suspended
in 0.5 ml water. The concentration and quality of DNA was checked as described in section
2.2.1.2 and the DNA stored at -20 oC.
2.2.1.2 Quantification of DNA
To calculate the amount of DNA in a sample a ND-1000 spectrophotometer (Nanodrop) was
used. The quantity of DNA is calculated based on its absorbance at 260 nm using the Beer-
Lambert law: A=ecl, where A is absorbance at 260 nm, e is the extinction coefficient, c is the
concentration and l is the path-length. The extinction coefficient for double stranded DNA
is 0.02 (ng/ml)-1 cm-1. The purity of the DNA (protein contamination) was assessed based
on the ratio of absorbance at 260 nm/280 nm. Pure DNA has a ratio of around 1.8. Protein
contaminated samples have a ratio of 1.6 and were discarded or re-purified.
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2.2.1.3 Chemically Competent E. coli: CaCl2/RbCl Method
An isolated cell colony was inoculated into 5 ml of LB and incubated at 37 oC, with shaking
at 250 rpm overnight. 1 ml of this culture was inoculated into 100 ml LB supplemented with
20 mM MgSO4. The media was then incubated at 37 oC, with shaking at 250 rpm until the
optical density at 600 nm (O.D.600) reached 0.4-0.6. The culture was then spun at 600 g,for
10 min at 4 oC. The pellet was re-suspended in 40 ml TFB1 and incubated on ice for 5 min.
This was spun down again, the supernatant discarded and the cells re-suspended in 4 ml
of TFB2. This was incubated on ice for 15-60 min then flash frozen in 100 ml aliquots in
pre-cooled 1.5 ml Eppendorf tubes and stored at -80 oC.
2.2.1.3.1 Transformation into Chemically Competent E. coli An aliquot of competent
cells was thawed on ice, 50-200 ng of plasmid solution added and incubated on ice for
30 min. The cells were then heat-shocked at 42 oC for 45 s and returned to ice for 2 min.
500 ml LB was then added and the tubes incubated at 37 oC with shaking at 250 rpm for
60 min. 20-500 ml of cell solution was then plated out onto LB-agar plates containing the
appropriate antibiotic and left at 37 oC overnight.
2.2.1.4 Electrocompetent E. coli
An isolated colony of the cells to be made competent was inoculated into 100 ml LB- +
antibiotic(s) and grown overnight at 37 oC, with shaking at 250 rpm. This was used to
inoculate 1 L LB-antibiotic which was grown to an O.D.600 of 0.5. Cells were then cooled
and spun down at 3000 g for 15 min at 4 oC. The cells were then re-suspended in 500 ml ice
cold 10% (v/v) glycerol solution (sterile) and spun as before. This was repeated with 250
and 50 ml 10% (v/v) glycerol solution and finally the cells were re-suspended in 2 ml 10%
(v/v) glycerol and 100 ml aliquots were flash-frozen in liquid nitrogen and stored at -80 oC.
2.2.1.4.1 Transformation into Electrocompetent E. coli An aliquot of competent cells
was thawed on ice, 0.5-2 ml of transformation mixture was added and the cells transferred
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into an ice-cold electroporation cuvette. The cuvette was placed in an EC100 electroporator
(E-C Apparatus Corporation) and a pulse of 1800V applied. 900 ml LB was then added
and the cells removed into a sterile 1.5 ml microtube which was incubated at 37 oC, with
shaking at 250 rpm for 60 min. 20-200 ml was then plated out onto LB-agar plates containing
appropriate antibiotic and left at 37 oC overnight.
2.2.1.5 Digestion of Plasmids
Restriction digestion of plasmids for cloning was performed in 50 ml of solution containing:
1 x NEB Enzyme buffer; 2 mM DTT; 100 mg/ml BSA; 1-3 mg of plasmid DNA and 10 U
(1 ml or to a maximum 0.5% total volume) enzyme(s). Reactions were incubated at 37 oC for
3 h, and analysed by agarose gel. If further digestion was required a further 10 U of enzyme
was added and the reaction incubated at 37 oC for 3-16 h. Digestions were inactivated by
incubation at 70 oC for 20 min. Short-term storage was at 4 oC. The product was checked by
agarose gel as above and purified by PCR clean-up or gel extraction as appropriate. Samples
were then stored long-term at -20 oC. Analytical digests were performed in 1/5 volume with
the same ratio of ingredients.
2.2.1.6 Agarose DNA Gels
Agarose gels were made up to 1 % (w/v) Agarose in 1x TAE containing 0.4 mg/ml ethidium
bromide. Samples were prepared by mixing sample with DNA running buffer to a final
concentration of 1x and 5-20 ml loaded per well (small comb) or up to 50 ml (large comb).
Gels were run in a tank containing 1x TAE for 30 min at 80 V. Bands were visualised by UV
using a SYNGENE Gene Genius gel-imaging system. Where bands were to be excised gels
were viewed using a Vilber Normad transilluminator with appropriate protective equipment
and the bands excised.
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2.2.1.7 Primers Design
In-Fusion cloning, Ligation Independent Cloning (LIC) and Sequence and Ligation Inde-
pendent Cloning (SLIC) primers were designed with a sequence overlap with both vector
and insert of 15 or 20 bp respectively, as illustrated in Figure 12. If a tag was to be inserted
this was incorporated into the primer between the vector sequence and restriction site. Spe-
cific primers are described in Appendix E. All these cloning methods work using a variant
of T7 DNA polymerase which in the absence of nucleotides exhibits an exonuclease activity.
This is used to provide long overhangs that are then annealed. Any missing amino acids and
strand breaks are removed by E. coli after transformation.
Figure 12: Design of In-fusion Primers.
Oligo design for an In-Fusion reaction at a BamHI restriction site. 15 bp of vector sequence
is followed by the restriction site then 15 bp of overlap with the insert sequence. 15 bp of
overlap each side is required for In-Fusion and LIC cloning, 20 bp for SLIC
2.2.1.8 Annealing of Oligos
All oligo stocks were made to 100 mM with 10 mM Tris-HCl, pH 8. To anneal two primers,
25 ml of 2 mM solution of each primer were combined in a PCR tube and plunged into 2 L
boiling water. This was left to cool to room temperature overnight and the oligos run on
an 8% (w/v) acrylamide-TBE gel (Invitrogen) with a 10 bp ladder (Invitrogen) to detect
fragments. The gel was run in the Nu-PAGE apparatus in 1x TBE buffer and soaked in TBE
supplemented with 0.4 mg/ml ethidium bromide for 30 min and visualised as for agarose gels.
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2.2.1.9 High Fidelity PCR
To generate gene inserts using Phusion Polymerase a 50 ml reaction containing: 1 x Reaction
buffer; 200 mM each dNTP; 0.5 mM forward and reverse primers; 0.5 ml miniprep of template
and 4U enzyme was prepared. The reaction was incubated as shown in Table 3. Finished re-
actions were stored at 4 oC until checked on an agarose gel, purified using a PCR purification
kit and used in SLIC reactions. Where it was important to remove template DNA 10 U of
DpnI was added to the PCR mixture before purification and incubated at 37 oC for 30 min,
then purified as before.
Step Temperature Time Step
1 98 oC 30 s Initial Denaturation
2 98 oC 10 s Denaturation
3 62 oC 20 s Annealing
4 72 oC 90 s Extension
5 Repeat 25-30 times
6 72 oC 5 min Final Extension
7 4 oC hold
Table 3: Program for High Fidelity PCR
2.2.1.10 Ligation
Fragments to be ligated were either double digested to have non compatible ends or treated
with 0.5 ml Antarctic phosphatase (NEB) and 1 ml 10 x Antarctic phosphatase buffer. Restric-
tion digested fragments were ligated together in 10 ml solution containing: 1 x NEB T4 ligase
buffer; 0.5 mM ATP (Amersham); 5 mM DTT; 20,000 U T4 ligase; 100 ng linear vector and
insert at 2 x, 4 x or 10 x molar vector concentration. The reaction was incubated at room
temperature for 3 h followed by transformation of 5 ml into competent E. coli. Antibiotic
resistant colonies were isolated and checked by colony PCR or analytical digestion.
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2.2.1.11 In-Fusion Cloning
In-Fusion dry-down cloning kits were used according to manufacturer’s instructions.
2.2.1.12 Ligation Independent Cloning (LIC)
The E. coli expression vector pNIC28-Bsa4 is suitable for LIC cloning. The vector contains
the suicide gene SacB, removed on digestion with BsaI, which is lethal in the presence of
sucrose. This is used as a selection marker in place of blue/white screening. Linearised
vector was combined with: 1 x T4 polymerase buffer; 5 mM DTT; 2.5 mM dGTP; 0.1 mg/ml
BSA and 8 U T4 polymerase. This was incubated at 22 oC for 30 min then inactivated at
75 oC for 20 min. Insert was treated as above but with dCTP in the place of dGTP. Vector and
insert were combined at a molar ratio of 2:1 and incubated at room temperature for 10 min
before transforming 3 ml into competent cells as above. Cells were plated onto LB-Kan,5 %
(w/v) sucrose.
2.2.1.13 Sequence and Ligation Independent Cloning (SLIC)
Vector and insert to be combined by SLIC were independently treated in a 20 ml reaction
containing: 1x T4 polymerase buffer; 5 mM DTT; 0.2 M Urea; 1-3 mg DNA (usually the
total purified from the previous step) and 3 U T4 DNA polymerase for 20 min at room
temperature. This reaction was arrested by addition of 25 mM EDTA pH 8.0 and inactivated
by incubation at 75 oC for 20 min. Half of each reaction was then combined and incubated at
65 oC for 10 min and cooled very slowly to room temperature. 5 ml mix was then transformed
into competent E. coli. Antibiotic resistant colonies were then checked by colony PCR or
analytical digestion.
2.2.1.14 Colony PCR
Colony PCR was used to check for insertion of the correct gene following ligation or SLIC.
One 20 ml reaction containing: 1 x Taq buffer; 0.2 mM each dNTP and 100 nM forward and
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reverse primers was inoculated with a colony from a transformation plate, which was also
patch plated. This was run according to the program shown in Table 4 The reaction was then
analysed by electroporation on an agarose gel.
Step Temperature Time
1 95 oC 5 min
2 Add 1 U Taq Polymerase
3 95 oC 1 min
4 55 oC 1 min
5 68 oC 1 min
6 Repeat 3-5 30 times
7 4 oC hold
Table 4: Program for Colony PCR
2.2.1.15 Sequencing
Sequencing was done in-house by the Department of Biochemistry DNA sequencing facility.
10 ml of 100 ng/ml DNA was sufficient for one reaction. The oligo used for sequencing was
dependent on the vector. All E. coli expression vectors were sequenced using the T7 oligo
and insect expression vectors were sequenced using the polH oligo (see Table 5).
Name Sequence
T7 TAATACGACTCACTATAGGG
PolH CTATAATATATTGTGTTGGG
Table 5: Oligos used for Sequencing.
2.2.1.16 Mutagenesis
Mutagenesis was done using the QuikChange II Site-Directed Mutagenesis Kit according to
manufacturer’s instructions.
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Primers were designed using PrimerX (http://www.bioinformatics.org/primerx/).
2.2.1.17 In Vitro Cre-Lox Recombination
To combine pUCDM and pFBDM-Lox a total of 0.25 mg DNA at 1:1 molar ratio was com-
bined in a 50 ml reaction with 1x Cre buffer and 1 U Cre recombinase. This was incubated
for 30 min at 37 oC, the reaction was stopped by incubation at 70 oC for 10 min and stored
at 4 oC. 5 ml was then transformed into Top10 competent cells. Cells were allowed to grow
for 3 hours after transformation before being plated onto LB-agar containing Cm and Amp
to allow selection for both antibiotic markers. Recombinant plasmids were then purified and
checked for characteristic digestion patterns calculated using the CreRecEMBL program
(Written for and used with permission of the Berger Lab). Correct plasmids were then used
for expression trials.
2.2.2 Protein Production
2.2.2.1 E. coli Expression
Production in E. coli is IPTG dependent for all vectors used in this study. For initial trial
expressions 10 ml of cell culture were grown in LB with appropriate antibiotic at 37 oC,
with shaking at 250 rpm until the O.D.600 reached 0.8, at which point they were cooled
and moved to a shaker at an appropriate temperature and IPTG added to 1 mM. To check
expression, cells were spun down, lysed using 50 ml BugBuster solution (Novagen) and spun
to remove insoluble debris. The insoluble pellet was re-suspended in an equal volume of
bugbuster. Total, soluble and insoluble fractions were taken to assess protein production.
For large scale expression 10 ml cells were grown overnight at 37 oC, with shaking at
250 rpm and used to inoculate up to 2 L LB-Antibiotic. Cells were grown to an OD600
of 0.8 and IPTG added to a concentration of 1 mM. Once induced constructs of p150 were
grown for 5 hours at 20 oC, with shaking at 250 rpm in Rosetta pLysS and p60 for various
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times, as detailed in the results section. Once grown cells are spun down at 6,700 g for
20 min at 4 oC and frozen at -80 oC until needed.
2.2.2.2 Sf21 Insect Cells Expression via Baculovirus Infection
Protocols in this section are based on protocols from Dr I Berger (Fitzgerald et al., 2006,
2007; Trowitzsch et al., 2010). Basic cell culture technique was used as described in "Guide
to Baculovirus Expression Vector Systems (BEVS) and Insect Cell Culture Techniques" (In-
vitrogen).
To express protein in insect cells it is necessary to generate a viral stock that can be used
to infect growing cells. To make the initial virus, a plasmid containing the gene of interest
and the Tn7L transposon element was transformed into competent E. coli containing the
MultiBac-YFP bacmid (BacY from the iACEMBL system). After electroporation as de-
scribed above 900 ml of LB was added to the tube and the cells incubated overnight at 37 oC,
with shaking at 250 rpm before being plated out onto LB-Agar containing Kan, Tet, Gent,
Xgal (40 mg/ml) and IPTG (1 mM). Incubation at 37 oC for 24-48 h gives blue and white
colonies. White colonies were re-streaked onto a fresh plate to check colour selection for
gene incorporation. Colonies that were still white after re-streaking were inoculated into
3 ml LB-Kan/Tet/Gent and incubated at 37 oC, with shaking at 250 rpm for 10-18 h then
spun down at 4000 rpm.
To extract the recombinant bacmid the cell pellet was re-suspended in 300 ml Alkaline Lysis
Buffer, 300 ml NaOH/SDS buffer was added, followed by 300 ml 3.0 M potassium acetate,
pH 5.5. The solution was then spun at full speed for 3 min in a bench-top centrifuge, and
the supernatant removed to a fresh tube. 0.7 volumes of isopropanol was added and the tube
centrifuged again at full speed for 10 min. The supernatant was then removed and the pellet
washed with 20 % (v/v) EtOH. The DNA was then air-dried under sterile conditions and
re-suspended in 20 ml sterile water.
Transfection of the recombinant bacmid was done in 6-well plates (Nunc) containing 0.5x106
cells per well. Cells were allowed to attach to the bottom of the plate for 15 min at 27 oC
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in 2 ml Sf900 II Serum Free Media (Invitrogen). Bacmid DNA was diluted 10x in media
and combined with a 20x dilution of Fugene (Roche). 150 ml was then added to the cell
plate in duplicate. The plate was incubated at 27 oC for 48-60 h. The supernatant from the
cells containing virus V0 was removed to sterile tubes. This virus was used to infect flasks
containing 25 ml of cells at 0.5x106 cells/ml and incubated at 27 oC, with shaking at 70 rpm.
The cells were then counted every 24 h until they stopped proliferating. The cells were spun
down gently at 800 rpm in a bench-top centrifuge and the supernatant removed to form V1
virus. The cells were re-suspended at 0.5x106 cells/ml and a sample of 1x106 cells was taken
every 12 h and processed to measure YFP. For future growths the V1 virus was used to infect
500 ml flasks at 0.5x106 cells/ml, 10 ml virus was usually sufficient.
To measure the YFP content the sample was spun down at full speed in a bench-top centri-
fuge for 3 min and the media removed. This was then re-suspended in 500 ml PBS, sonicated
for 10 s and a sample taken. The solution was then spun down as before and a sample of the
soluble protein taken. The remaining solution was then examined for fluorescence emission
at 515-550 nm, using a Perkin Elmer Instruments LS 55 Luminescence Spectrometer with
excitation at 513 nm, slits set at 2.5 nm and the photomultiplier voltage at 750 V. Peak fluor-
escence was measured at 530 nm. Where CFP was measured the machine was set to scan
from 450-500 nm with the peak measured at 475 nm.
Once the YFP fluorescence reached a plateau the cells were harvested by centrifugation at
4,000 rpm in a Beckman JLA-10.500 rotor. Pellets were flash frozen in liquid nitrogen and
stored at -80 oC until required.
2.2.3 Protein Purification
All proteins were purified from Sf21 insect cells unless otherwise stated.
Denaturing purifications were carried out identically to the native purification except at room
temperature and with the addition of urea to 8M after the initial centrifugation step. Samples
were bound to Ni-NTA resin (Qiagen) as described in the native purification and then washed
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from 8M to 6M to 2M and then into 0M urea in wash buffer before continuing as detailed in
the protocol.
2.2.3.1 CAF-1: HIs-p150DN/p60/CBP-p48
2.2.3.1.1 Small Scale A cell pellet from 25 ml of CAF-1 expression was lysed by re-
suspension in 14 ml CAF Lysis Buffer and spun at 48 000 g for 20 min at 4 oC. The super-
natant was added to 0.5 ml of Ni-NTA resin (Qiagen), equilibrated in CAF Lysis Buffer and
incubated on a rotating wheel for 2 h at 4 oC. This was then spun down at 360 g for 10 min
at 4 oC, washed with 30 ml CAF High Salt Buffer followed by 30 ml CAF Wash Buffer. The
resin was then washed with 5 ml CAF E20 and E40 followed by E100, and CAF E500 as
step elutions. Samples were checked for presence of the three subunits on an acrylamide gel.
2.2.3.1.2 Large Scale A cell pellet from an 1 L expression was re-suspended in 50 ml
CAF Lysis buffer and mixed gently until homogeneously re-suspended. This was passed
twice through an EmulsiFlex cell breaker (Avestin), spun at 48 000 g for 20 min at 4 oC.
The supernatant was then added to 2 ml Ni-NTA resin (Qiagen) equilibrated with CAF Lysis
Buffer and incubated on a rotating wheel for 2 h at 4 oC. The resin was then washed with
50 ml CAF High Salt Buffer and poured into an empty K 9/15 FPLC column and packed
by gravity flow. The column connected to an Äkta explorer was washed with 50 ml CAF
Wash Buffer and a linear gradient of 0-1 M imidazole in CAF lysis buffer lacking NP-40
was applied at 1 ml/min over 30 CV (column volumes). SDS-PAGE was run to analyse the
samples. During later experiments CAF-1 was eluted using sequential elutions of 0.5 ml
CAF E500. The eluate from the Ni-NTA column was collected and incubated with Chelix
resin (Bio-Rad) to remove any excess Ni2+ions from the eluate.
2.2.3.1.3 CBP based purification 500 ml of calmodulin beads were washed with CAF
lysis buffer enriched with 0.2 mM CaCl2. The protein was combined with beads and in-
cubated on a rotating wheel for 2 h at 4 oC. The solution was then spun at 500 g and the
63
supernatant removed. Beads were washed three times with 1 ml CAF wash buffer then in-
cubated with 1 ml CAF calmodulin elution buffer on a rotating wheel for 20 min at 4 oC.
Beads were spun as before and the supernatant removed and analysed by SDS-PAGE.
2.2.3.1.4 Ion Exchange Ion exchange chromatography was performed on an Äkta ex-
plorer (GE) using a MonoQ HR 5/5 column washed with 5 CV CAF IX buffer B and pre-
equilibrated with 5 CV CAF IX buffer A. The protein was diluted by half in 50 mM Tris-HCl
pH 8 to give a final salt concentration of 200 mM KCl, bound to the column in 20 % CAF
IX buffer B and eluted with a linear gradient between 20 and 100 % CAF IX buffer B over
40 CV.
2.2.3.2 His-p150DN/p60
2.2.3.2.1 Small and Large Scale Purifications The tow subunits of CAF-1 were purified
following the same protocol as the CAF-1 complex containing three subunits. In addition gel
filtration was performed using a Superdex S200 16/60 column using an Äkta Explorer (GE)
in CAF GF buffer.
2.2.3.2.2 Low Salt Purification To separate p60 from p150DN cells were lysed in CAF
lysis buffer containing 50 mM KCl and the supernatant removed from the pellet. The super-
natant was then used for ion exchange experiments using an 1 ml Q HP column (GE) with
CAF IX buffers A and B as before.
2.2.3.2.3 Dephosphorylation 2 ml of p60 supplemented to 1 mM manganese chloride
from the low salt purification was treated with 10 ml (4000 units) l protein phosphatase
(NEB) for 30 min at room temperature. This fraction was then run on a Q HP column as
before.
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2.2.3.3 p150DN
2.2.3.3.1 p150DN Native Large Scale Purification The p150DN subunit of CAF-1
was purified following the same protocol as the 2 subunit CAF-1 complex, with the addition
of an ultracentrifugation step after initial clarification. After centrifugation at 48 000 g the
lysate was spun at 100 000 g for 1 h at 4o C in a Beckman Optima LE 80 K ultracentrifuge
using a SW 28 rotor.
2.2.3.3.2 Gel Filtration A 24 ml S200 10/300 gel filtration column (GE) was run at
1 ml/min in CAF GF Buffer for 1.5 CV. Standards for estimation of molecular mass were run
by M. Chaillet on the same column used for gel filtration of p150DN. Dextran blue was run
to find the dead volumn of the colmn and beta amylase (200 kDa), alcohol deshydrogenase
(150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (28 kDa) and cytochrome C
(12.4 kDa) run to generate a calabration curve.
2.2.3.3.3 Truncated p150 Constructs Initial Purification E. coli cell pellets from 100 ml
expressions containing p150 constructs were re-suspended in 25 ml of 50 mM Tris-HCl pH 8,
50 mM KCl, 5 mM imidazole and lysed by four passes through an EmulsiFlex cell breaker
(Avestin). The lysate was clarified by centrifugation at 48,000 g for 30 min at 4 oC and
passed through 0.5 ml Ni-NTA resin pre-equilibrated with lysis buffer. This was washed
with CAF high salt buffer and eluted with a step gradient of CAF E40, E100 and E500
containing 50 mM KCl.
2.2.3.3.4 p150 Construct C Large Scale Purification An E. coli cell pellet from 1 L
expression was re-suspended in 50 ml CAF Lysis Buffer + 10 mM imidazole and lysed by
four passes through an EmulsiFlex cell breaker (Avestin) and the lysate cleared by centrifu-
gation at 48,000 g for 30 min at 4 oC. Urea was then added to 8 M and the solution passed
through 2 ml of pre-equilibrated Ni-NTA (Qiagen) resin. This was washed sequentially with
40 ml CAF Lysis buffer + 6, 4, 2 and 0 M urea. Bound beads were removed here for pull-
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downs. When protein was required in solution it was eluted with five washes of 0.5 ml CAF
E500. Gel filtration was performed in CAF GF buffer using a S200 10/300 column.
2.2.3.4 p60
2.2.3.4.1 Small Scale Myc- Based Purification A pellet from 200 ml of cell culture was
lysed by re-suspension in 20 ml CAF lysis buffer, 200 mM KCl. The lysate was cleared
by centrifugation at 48000 g for 30 min at 4 oC and incubated with 0.25 ml EZView Red
Anti-c-Myc Affinity Gel (Sigma) pre-equilibrated with CAF lysis buffer, 200 mM KCl on
a rotating wheel for 2 h at 4 oC. The beads were then washed three times with 1.5 ml CAF
lysis buffer, 200 mM KCl, 0.1 % (v/v) NP-40. To release the protein the fusion was cleaved
by addition of 2.5 mM CaCl2, 1-2 U of thrombin (sigma) and the mixture incubated on a
rotating wheel overnight at 4 oC. The supernatant was recovered and three 0.25 ml washes of
the beads were taken and treated with anti-thrombin beads (Sigma) by incubation a rotating
wheel for 2 h at 4 oC. The supernatant from this reaction was used in pull-down experiments.
2.2.3.4.2 Larger Scale Tagless Purification Cells from 500 ml culture were lysed by re-
suspension in 30 ml CAF lysis buffer, 50 mM KCl and clarified by centrifugation at 48,000 g
for 30 min at 4 oC. The clarified lysate was then run on a 1 ml HiTrap Q HP column (GE)
over 30 CV from CAF IX Buffer A to Buffer B over 40 CV. The eluate from the column
was then run through a 2 ml hydroxyapatite column (Bio-Rad) was packed and run manually
with step elutions of 5, 10, 25, 40, 70 and 100% HA Buffer B in Buffer A. Gel filtration
was then conducted on the hydroxyapatite eluate using a S200 10/300 and CAF GF buffer.
Further ion exchange was performed on the gel filtration eluate after dilution to 100 mM KCl
before running it on a MiniQ column (GE) over 30 CV from CAF IX Buffer A to Buffer B
over 40 CV.
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2.2.3.5 p48
Expression and purification of p48 was performed by either W. Zhang, A. Murthy or S. Lejon
as described in (Lejon et al., 2011).
2.2.4 Acrylamide Gel Electrophoresis
Protein content of samples was checked by acrylamide gel electrophoresis. Precast 15 well 4-
12% (w/v) Bis-Tris NuPAGE Novex gels (Invitrogen) were run according to manufacturer’s
instructions with samples supplemented to 1x with SDS-PAGE sample buffer. Gels were
stained using Instant Blue stain (Novexin) until bands were clearly visible. Silver staining
was performed according to manufacturer’s instructions (Fermentas Silver Staining kit).
2.2.5 Western Blotting
A SDS-NuPAGE gel was run and proteins transferred to a PVDF membrane (Millipore)
using the Invitrogen NuPAGE blot module according to manufacturer’s instructions. Once
blotted the membrane was removed and soaked in 5 % (w/v) milk (Marvel) in PBS, and the
remaining gel was stained with Instant Blue (Novexin) to check transfer efficiency. After an
hour of blocking in milk with gentle agitation at room temperature (or overnight at 4 oC) the
milk was removed by three 10 min washes with PBS. The primary antibody was then applied
in 10 ml 5 % (w/v) milk in PBS to the concentration recommended by the manufacturer. This
was incubated with gentle agitation for 1 hour at room temperature, the blot washed three
times in PBS and the secondary antibody applied as for the first. After the blot had been
washed again it was incubated for 1 min at room temperature in 10 ml luminol solution,
100 ml enhancer solution and 3 ml 100 % (v/v) H2O2 (Leong et al., 1986). The blot was
then quickly drained and placed in an autoradiography cassette. The membrane was used to
expose photographic film for 30 s in a darkroom and developed using a AFP Imaging Mini
Medical 90 automatic developer. Further exposures were done as required.
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2.2.6 Quantification and Concentration of Protein
Protein concentration was estimated using the absorbance at 280 nm and the Beer-Lambet
relationship A = εcl, where A is the absorbance at a given wavelength, e is the extinction
coefficient, c is the concentration and l is the path-length used to measure the absorbance.
An approximate extinction coefficient was calculated using the Expasy ProtParam program
(http://www.expasy.ch/tools/protparam.html) and this was refined using absolute quantifica-
tion when proteins were of sufficient quality to sent for amino acid analysis. For p48 e280 nm=
83670 M-1 cm-1. Values for the other proteins in the CAF-1 complex were not calculated as
it was not possible to get the protein clean enough for amino acid analysis.
Protein was concentrated using Amicon Ultra-centrifugal filter with a 10 kDa molecular
weight cut-off regenerated cellulose membrane unless otherwise stated. These were used
according to manufacturer’s instructions.
2.2.6.1 Bradford Assay
The Bradford assay was performed in 1 ml of solution containing 1x Bradford solution di-
luted from 5x stock (Bio-Rad) and 20 ml protein solution. The absorbance of the solution
was read at 595 nm using a Shidmatzu UV-1601 spectrophotometer. A standard curve was
constructed using BSA diluted to concentrations between 0 and 800 mg/ml and the slope
used to calculate protein concentration of samples. Where the protein sample analysed gave
readings outside this range it was diluted until it fell within the standard curve.
2.2.7 Pull-down Assays
Proteins for pull-down experiments were run out on a gel to gauge relative concentration.
Approximately equal concentrations of soluble and bead-bound proteins were combined in
a tube and 10 ml of well mixed solution was taken for an input sample. 0.5 ml His or Myc
pulldown buffer was then added and the mixture incubated with rotation at 4 oC for 3 hours
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or overnight. The beads were then spun down at 200 g in a benchtop centrifuge, washed
three times with 0.5 ml of pull-down buffer and re-suspended in the original volume. Input
and pull-down samples were then run on a gel and analysed by Western blot or Coomassie
staining.
2.2.8 Competition Experiments
Competition experiments were performed as for pull-downs with the additional step of mix-
ing the protein to be pulled down with a ten times excess of the competing peptide before
adding to beads.
2.2.9 Limited Proteolysis
Approximately 5 mg protein was digested with subtilisin (Sigma, stored as 1 mg/ml stock at
-20 oC) in 50 mM Tris-HCl, pH 8.0 400 mM KCl at 27 oC as indicated in the results section.
Samples were taken at 0, 15, 30, 60 and 120 min and the reaction stopped imminently by
boiling for 2 min in 1x SDS-PAGE sample buffer. Samples were stored at -20 oC prior to
analysis by SDS-PAGE.
2.2.10 Non-Specific Crosslinking
Non-specific crosslinking was performed using formaldehyde. Formaldehyde was added to
samples to a final concentration of 1 % (v/v). Reactions were incubated at 27 oC and samples
were taken at 0, 5, 10, 20 and 30 min. The reaction was quenched with 1/10 volumes of 1 M
glycine (pH 8), mixed with SDS-PAGE sample buffer to a concentration of 1x. Samples
were heated gently at 27 o instead of boiling and frozen at -20 oC .
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2.2.11 Specific Crosslinking
Specific amine crosslinking with BS3crosslinker (Thermo Scientific) was performed at 27 oC
for 30 min. A 2 mg vial of crosslinker was re-suspended in water to give a 3 % (w/v) stock
which was diluted 1 in 5, 20, 50 and 100 times. 1 ml of each dilution was added to 10 ml of
protein in buffer containing 50 mM HEPES, pH 8, 400 mM KCl. To stop the reaction 1 ml
of Tris-HCl, pH 8 was added to each reaction and incubated at 27oC for 15 min. SDS-PAGE
sample buffer was then added to 1x concentration and the samples frozen at -20 oC until
required. Where accuracy was required for superimposition of Western blots samples were
run on the same gel with Precision Plus Protein WesternC Standards (Bio-Rad), visualised
separately with appropriate antibody and a 1:20000 dilution of StrepTactin-HRP (Bio-Rad)
added to visualise the markers.
2.2.12 Crystallisation Trial Experiments
Initial screens for crystals were performed in 96-well format. Three screens were conduc-
ted: Index (Hampton), Pro Complex and JCSG+ (Qiagen). 40 ml of each well solution was
dispensed into a 96-well SwissCi 3 well SBS format crystallisation plate. An Oryx 6 robot
(Douglas Instruments) was used to pipette sitting drops of volume 0.4 ml containing 50 %
protein 50 % reservoir solution. Plates were sealed with crystal sealing film (Hampton) and
stored at 4 oC. Wells were examined directly after pipetting and then after 1 day, 3 days, 1
week and thereafter every 2 weeks. Crystals and other features were noted. Where crystals
were seen they repeated in 24-well hanging drop format of drop size 1 ml. Crystals that could
be repeated were subjected to standard tests for salt including poking with a fine needle, ex-
amining birefringence for patterns, Izit crystal dye (Hampton) and exposure to home source
X-rays.
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Chapter 3
Co-Expression of the CAF-1 Complex
3.1 Introduction
Very little biochemical data exists concerning the CAF-1 complex and so I wanted to make
recombinant CAF-1 to allow investigation of the complex using methods that require more
protein than can be purified from natural sources.
It was known that p150 is prone to degradation when expressed recombinantly in insect
cells (N. Murzina, personal communication). To try and prevent this degradation p150 was
co-expressed with the more structured and stable members of the complex (p60 and p48)
in the hope that they would protect p150 from degradation where they were bound. Full
length versions of both p60 and p48 were used as they had both been shown to be expressed
without excessive degradation (N. Murzina and S. Patel, personal communications; Lejon
et al. (2011)). The p150 construct (p150DN) used for these co-expression experiments con-
sists of the C-terminal two thirds of the protein (314-956), which have been shown to be
sufficient for chromatin assembly both in vitro and in vivo (Kaufman et al., 1995; Hoek
et al., 2011). This is more stable than full length p150 as it does not contain the PEST
region.
P150 produced in E.coli is mostly insoluble and both p60 and p48 are totally insoluble when
produced in E.coli. Expression in insect cells, however, has produced both p46 (a p48 homo-
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logue) and p48 that are fully folded and soluble (Murzina et al., 2008; Lejon et al., 2011).
Co-expression of the three subunits of CAF-1 was therefore attempted in insect cells.
Although the three subunits of CAF1 were expressed previously in insect cells using an old
Baculovirus expression system (Kaufman et al., 1995), the expression level was very low
and totally unsuitable for biochemical and structural studies. The complex was expressed
using a separate virus for each subunit, co-infecting cells with the three viruses in an attempt
to co-express the complex. This is an inefficient method of complex expression as many cells
are not infected by all three viruses, or receive multiple copies of one or two of the viruses,
resulting in differential expression patterns across a cell population. This is problematic
when one complex member is required to stabilise another as there is no guarantee that they
will both be expressed at similar levels in the same cell, resulting in degraded or aggregated
protein. Therefore different systems were investigated for co-expression.
To co-express the three subunits of CAF-1 in one virus the MultiBac/iACEMBL system
designed by I. Berger (Fitzgerald et al., 2007) was used. The MultiBac system consists of two
plasmids (pFBDM and pUCDM, see Appendix D). Each plasmid contains two promoters
for protein expression (p10 and Polh) within a “multiplication module” which can be used to
increase the number of proteins expressed from a single plasmid, see Fitzgerald et al. (2007)
for further details. The two vectors can be combined by cre-lox recombination to form a
multi-protein expression vector which is then used to generate a bacmid by site-specific
recombination. The bacmid is then purified and used to produce a single virus expressing
multiple genes. The advantage of this system is that different combinations of vectors can be
used to produce a single virus. This means that multiple proteins can be reliably expressed
in one go and that different combinations of proteins can be expressed without further gene
cloning being required.
The later developed iACEMBL is a continuation and improvement on the same system in-
corporating more plasmids (Berger et al., 2004; Trowitzsch et al., 2010). Further to this, the
MultiBac viral DNA has been modified to remove a protease and a chitinase, reducing protein
degradation and cell lysis. The bacmid also includes a YFP gene under the same promoter
(Polh) as the protein cloned into the major expression sites of the plasmids. This allows pro-
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tein expression to be monitored without the need for Western blotting as the expression of
YFP peaks at the same time as expression of the protein of interest without affecting protein
production (Trowitzsch et al., 2010).
Originally our plan was to to clone and express CAF-1 using the MultiBac system as a
binary complex of p150 and p60 with p48 being added later, either by cloning in a further
gene or by addition of purified protein to reconstitute the complex. We hoped that p60 would
protect p150 from degradation and that we would be able to make deletion mutants of both
p150 and p60 to identify suitable constructs for crystallisation work. p48 did not need to be
investigated as it had already proven amenable to crystallisation.
His-tagged p150DN had previously been cloned into pFBDM. Myc-tagged deletion con-
structs of p60 were to be cloned into pUCDM and used for co-expression with HIs-p150DN,
as detailed in Figure 13. When a p60 construct that bound p150DN had been identified,
deletion mutants of p150 would be designed, expressed and their interaction with p60 ex-
amined. However, problems were encountered cloning into pUCDM (as detailed in chapter
4) and therefore alternative methods of expression of the intact ternary CAF-1 complex were
also investigated, see below.
A self-cleaving fusion protein containing all three members of the CAF-1 complex was there-
fore also expressed in collaboration with the I. Berger laboratory, alongside work in Cam-
bridge, to co-express a binary complex consisting of p150 and p60 from a single plasmid.
For the latter, our intention was to reconstitute the complex with p48, expressed and purified
separately.
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Figure 13: Cloning Plan for Co-expression of p60 and p150.
Deletion constructs of p60 were designed for cloning into pUCDM containing a Myc-tag.
The p60 constructs would then be combined with p150 for co-expression and identification
of interacting constructs. This method would then be used in further experiments to test
various p150 deletion constructs.
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3.2 CAF-1 Fusion Protein
3.2.1 Cloning
A construct expressing the ternary CAF-1 complex as a single, self-cleaving polypeptide
was designed to ensure that all proteins in the complex were expressed at the same level.
The protein contains the TEV protease, the three CAF-1 subunits, and a C-terminal cyan
fluorescent protein (CFP) molecule (to provide a check that the whole fusion protein was
being expressed), as illustrated in Figure 14, was constructed by Y. Ni in the Berger lab. All
polypeptide components are separated by TEV cleavage sites. This was then used to express
the ternary CAF-1 complex. To allow for purification of the complex p150 was tagged with
a hexa-his tag and p48 was tagged with a calmodulin binding peptide (CBP).
Figure 14: Structure of the CAF-1 Co-Expression Cassette.
A single polypeptide containing all three subunits of the CAF-1 complex, a CFP marker and
TEV protease were used to express the ternary CAF-1 complex. All proteins were separated
by a TEV cleavage site allowing the fusion protein to self-cleave into the proteins of interest.
Figure constructed using DOG 1.0 (Ren et al., 2009).
3.2.2 Expression and Small Scale Purification
After initial expression trials performed by F. Garzioni in the Berger lab as described in sec-
tion 2.2.2.2, the virus expressing the ternary CAF-1 fusion protein was used to infect a 25 ml
culture of Sf21 cells. Cells were counted daily and once cell growth had arrested (denoted
dpa, day post arrest) YFP and CFP expression was followed by fluorescence spectroscopy
until expression peaked and the cells were harvested (Figure 15). Both YFP and CFP ex-
pression follow the same pattern and peak at the same time, indicating that YFP is a good
indicator of protein expression and that the whole complex is being translated and expressed
as CFP is the C-terminal peptide (Figure 15 A). Total and soluble protein production was as-
sessed by SDS-PAGE (Figure 15 B). A distinct band at the expected size p150DN (indicated
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by arrow) was observed to increase in intensity over the expression time-course (compare B
lane 3 to lane 13, Figure 15), however the other proteins could not be seen as they run at the
same size as cellular proteins. Western blotting (Figure 15 C) confirmed this with a discrete
band for each protein and a double band for TEV as it self-cleaves.
Figure 15: Expression of CAF-1 Fusion Protein.
A: Fluorescence of YFP and CFP over time. 1 x 106 cells were lysed in 0.5 ml PBS and the
fluorescence maxima measured at 530 nm for YFP and 475 nm for CFP. Dpa: day of growth
arrest. Fluorescence was measured in arbitrary units. B: 10 % acrylamide SDS-PAGE of
total (T) and soluble (S) cell extract at each time point. The control was uninfected cells.
Molecular Weight markers are in kDa. C: Western blot of total lysate from Dpa+60. Anti-his
antibodies were used to detect p150 as no specific antibody is available against p150DN.
After the cells were harvested the complex was purified using a standard protocol for nuclear
proteins as described in section 2.2.3.1. This contains 400 mM KCl to enhance removal of
chromatin bound proteins. Figure 16 shows a typical SDS-PAGE analysis of the resulting
purification. The cells were lysed using NP-40 and spun to remove cell debris. His-tagged
p150DN with it’s associated proteins was purified by affinity chromatography with Ni-NTA
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resin (Figure 16, lanes 3 and 5). The resin was washed to remove non-specifically bound
proteins and the bound complex eluted with an imidazole step gradient (Figure 16, lanes
9-11). SDS-PAGE analysis showed that three bands were eluted from the beads at sizes
corresponding to those expected for p150DN, p60 and p48.
Figure 16: Small Scale Purification of Co-expressed CAF-1 Complex.
Cells expressing the CAF-1 fusion protein were lysed and the proteins were bound to Ni-
NTA beads in batch, washed and eluted. The eluted proteins were then dialysed to remove
imidazole. 10% acrylamide SDS-PAGE analysis shows three bands can be seen p150DN,
p60 and p48 and were confirmed by Western Blotting (data not shown). Markers are in kDa.
To assess the concentration of imidazole required to elute CAF-1 fusion protein from beads
a further purification was performed as before, but the washed beads were packed into a
column and eluted using a continuous imidazole gradient between 0 and 1 M (Figure 17).
This showed that the complex elutes over several fractions (Figure 17, lanes 4-10) but is
eluted by the time the gradient has reached 400 mM imidazole. P60 appears to elute earlier
and in smaller amounts than the other proteins, assuming each protein binds coomassie dye
equally. Trials of methods to concentrate the eluted protein revealed that the addition of 5 %
(v/v) glycerol and use of regenerated cellulose membranes reduced losses to around 20 %.
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Figure 17: Elution of the CAF-1 Complex from a Ni-NTA Column.
Clarified lysate of cells expressing the CAF-1 fusion protein were bound to Ni-NTA beads
and the complex eluted in buffer containing a 0-1 M imidazole gradient over 30 CV and
collected in 1 ml fractions. A: Elution Profile, Imidazole absorbs UV at 280 nm, causing an
increasing baseline. B: 100 ml of each fraction was analysed by 10 % acrylamide SDS-PAGE
after being concentrated by evaporation. Markers are in kDa.
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3.2.3 Large Scale Purification
Initial attempts at larger scale expression using cell pellets from a 1 L expression and purific-
ation resulted in a less pure sample compared to the small scale purifications. One reason for
this may be a lower protein expression and therefore a reduced complex:cellular protein ra-
tio. This was not improved by adding more virus when infecting cells to increase expression.
A variety of methods were trialled to clean the sample further after affinity purification. As a
first approach, the second tag in the complex, CBP, which was fused to p48 was used (Figure
18). It proved possible to bind the complex to calmodulin beads although the subsequent
elution was less clean than expected with some of the His-tagged TEV clearly binding to
the beads (Figure 18, lanes 5 and 6). This was not removed by washing with high salt buf-
fer, unlike p60 which is lost even before the stringent wash (compare lane 2 with lane 5).
Further to this the protein elution from the beads was very inefficient and subsequent experi-
mentation yielded no better results. Consequently, this was not used as a further purification
technique. Similar experiments using p48 specific antibodies bound to protein A beads also
did not provide better results (data not shown).
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Figure 18: Purification of the CAF-1 Complex Using Calmodulin Beads.
Protein eluted from a Ni-NTA column was supplemented with CaCl2 and bound to calmod-
ulin beads. TEV self-cleaves to give a double band. Markers are in kDa.
An alternative purification based on protein net charge was attempted using a MonoQ column
at pH 8 (section 2.2.3.1). However it was not possible to lower the salt concentration below
200 mM KCl, (which may have improved binding of the protein complex to the column)
because the protein precipitates out of solution if the salt concentration is less than 200 mM
KCl.
Purification on the MonoQ column revealed p60 eluting over a wide range of salt concen-
trations (Figure 19 C, lanes 3-9) whereas p48, along with much of the p60 was eluted in
one peak (Figure 19 C, lane 9). Two bands were visualised by anti-p60, one at the expected
size, around 60 kDa and a larger band at around 85 kDa. The larger band is of unknown
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composition and not seen in other purifications (e.g. Figure 23 and Figure 25) so may be an
artefact of this expression method.
The Western blot using anti-his to visualise p150DN did not visualise any protein, this is
because p150DN transfers poorly onto the membrane and at the concentrations here is in-
sufficient to react with the antibody. Ensuring that the gel was in the transfer tank with
the higher molecular weight bands at the bottom increased transfer efficiency but was still
insufficient for this particular blot.
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Figure 19: Anion Exchange Chromatography of the CAF-1 Complex.
A: Elution profile of Ni-NTA purified CAF-1 complex eluted from a MonoQ column with
a salt gradient from 0.2 to 1 M KCl over 40 CV. B: Silver stained SDS-PAGE gel of un-
bound sample (FT) and relevant fractions from the column with fraction number indicated
at top of the gel. Arrows indicate expected sizes of proteins. C: Western blot of gel frac-
tions. The Western blot was probed with anti-p60 (reacting bands labelled p60) followed by
anti-p48 (reacted band labelled CFP-p48). Anti-His did not visualise p150DN as there was
insufficient protein concentration (not shown). Markers are in kDa.
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Attempts to lower the amount of salt used in the CAF-1 fusion protein purification in an effort
to preserve the complex revealed that extraction of p150DN requires 400 mM KCl , which
is characteristic for a chromatin bound nuclear protein (Dignam, 1990); extraction using less
salt (200 mM or 50 mM) results in insoluble p150DN (Figure 20), compared to 400 mM KCl
where sufficient protein is extracted to be visible on a Coomassie stained SDS-PAGE (See
Figure 17). It was however observed that a fraction of p60 and p48 was soluble in the lower
salt conditions, indicating that some of these proteins are not bound to chromatin (Figure 20,
compare lanes 2 and 3 for p60 and p48). It was not however possible to purify the soluble
protein further as p60 is not tagged and as seen before CBP-p48 cannot be efficiently eluted
from calmodulin columns (Figure 18).
Figure 20: Low Salt Solubility of CAF-1 Complex Subunits.
Cells expressing CAF-1 fusion protein were lysed in buffer containing 50 mM KCl, separ-
ated into soluble and insoluble fractions and analysed by Western blot with antibodies as
indicated. Asterisks (*) indicate degraded proteins. Markers are indicated on the left in kDa.
83
These results show that whilst we have produced CAF-1 as a self-cleaving fusion protein
in insect cells it is not possible to purify the complex to homogeneity, mainly due to low
yield making it difficult to remove impurities, which seem to interact with the complex as a
anion exchange purification does not remove them. If the yield of the virus was increased
this may help, however the tendency of the complex to form non-specific interactions with
other proteins which would have to be overcome.
The separation of the parts of the CAF-1 fusion protein into components that appear to be
stable separately suggested that it might be possible to use the MultiBac system to express
the proteins individually. Expression of the binary p150DN/p60 complex is discussed below
and individual protein expression is discussed in Chapter 4.
3.3 p150DN/p60 Co-expression
Concurrent with expression of the CAF-1 self-cleaving fusion protein a binary complex con-
taining p150 and p60 was expressed and examined. The p150DN/p60 co-expression vector
was made by N. Murzina and consisted of His-tagged p150DN expressed from the Polh pro-
moter and untagged p60 expressed from the weaker promoter (see Appendix D). The His-tag
on p150 should selectively purify p150 that has not been N-terminally degraded along with
p60 which it was hoped would stabilise the C-terminal end of the protein.
3.3.1 Expression and Purification
The complex was expressed and an initial purification performed as for the CAF-1 fusion
protein (see section 2.2.3.1). The initial purification is shown in Figure 21. The yield of
protein from this virus was higher than that of the CAF-1 fusion protein virus (compare
Figure 21 lanes 7 and 8 with Figure 16, lanes 10 and 11), allowing a gel filtration column to
be run after purification on Ni-NTA resin (Figure 22). There appears to be some aggregated
p150DN (lanes 2-5) in the initial peak but p150DN/p60 complex can be purified (lanes 6-
12).
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Figure 21: Small Scale Purification of p150DN/p60 Binary Complex
SDS-PAGE of purification from 25 ml of Sf21 cell culture infected with p150DN/p60 virus
using Ni-NTA resin. Markers are in kDa.
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Figure 22: Gel Filtration of p150DN/p60.
Eluate from the Ni-NTA beads was concentrated and loaded onto a S200 16/60 size exclusion
column, Elution fractions of 1.5 ml were collected. A: Elution Profile B: SDS-PAGE analysis
of 50 ml of each fraction. The fraction numbers are indicated at the top of the gel. Markers
are in kDa.
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3.3.2 Ion Exchange Chromatography
While small scale expression and purification resulted in a relatively pure complex, scaling
up to a purification from 1 L of cell culture revealed many containments. In an attempt to
remove contaminants ion exchange chromatography was performed: the protein eluted from
Ni-NTA beads was diluted to 200 mM KCl and loaded onto a MonoQ HR 5/5 column at pH
8.0. The eluate was analysed for the presence of p60 and His-p150DN by Western blotting
(Figure 23). This showed that a significant fraction of protein did not bind to the column (lane
3 of gel and 2 of Western blot) and the protein that did was spread across the whole elution
profile (lanes 4-13 of gel, lanes 3-10 of Western blot). Changing the salt concentration of
the starting buffer did not make any difference as the complex precipitates out of solution
irreversibly at lower salt concentrations. Therefore ion exchange could not be used to purify
the p150/p60 complex.
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Figure 23: Anion Exchange Chromatography of Ni-NTA Purified p150DN/p60.
A: Elution profile of p150DN/p60 eluted from MonoQ column with 0-1 M KCl gradient over
40 CV B: SDS-PAGE of fractions as indicated at the top of the gel, (15 ml of each fraction
was loaded). C: Western blot of the indicated fractions using anti-His or anti-p60 antibodies
to identify His-p150DN and p60, respectively. Markers are indicated on the right in kDa.
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The proteins eluted from the ion exchange column over wide range of salt concentration.
This indicates that there may be different charge species present. It was obvious from the
Western blot that there is some degradation of p150DN, which could account for it eluting in
multiple peaks but p60 is spread more widely in both this experiment and also when isolated
separately from p150DN in low salt, as described below.
p60 is known to be hyperphosphorylated under certain circumstances (Martini et al., 1998).
Multiple phosphorylation sites would cause different charge species, therefore a fraction
of p60 isolated in low a low salt condition was treated with l phosphatase as described in
section 2.2.3.2. This treated fraction was run through an anion exchange column under the
same conditions as an untreated sample and the two elution profiles were compared. The
results are shown in Figure 24. If multiple phosphorylation states were the main cause of the
wide distribution of p60 in the elution profile then the l phosphatase treatment should have
resulted in a narrower peak. However, whilst phosphatase treatment does alter the profile of
p60 elution from an ion exchange column it spreads it out even further, indicating that there
are likely other reasons behind this wide distribution of charges, such as clipping of charged
C-terminal residues from the unstructured tail of p60 or binding to other proteins such as
various chaperones.
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Figure 24: Comparison of p60 Treated and Untreated with l Phosphatase.
An aliquot of p60 was treated with l phosphatase and the elution profile after running through
a Q HP column was compared to untreated sample. A: profiles of both p60 elutions from the
anion exchange columns. B: Western blot of fractions from elutions visualised using an anti-
p60 antibody. Fraction numbers are indicated on the top of the blot, markers are indicated
on the right in kDa.
As it was not possible to further purify the p150DN/p60 complex by ion exchange, the Ni-
NTA elution was optimised to remove as much contamination from the complex as possible
(Figure 25). After using a spin column (Generon) for the Ni-NTA beads and 50 CV of lysis
buffer without NP-40 as a wash step, the protein produced was more concentrated and cleaner
giving a yield of approximately 4 mg total protein per litre of cells (estimated by Bradford
protocol, see section 2.2.6.1). At least 75% (3 mg) of this is p150DN and p60 (estimated
from gel, Figure 25). This protein exhibits no degradation of p150DN (see Western blot,
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Figure 25). Concentration of this protein complex was still not efficient, hence gel filtration
was not used to purify the complex further. This protein was used in the experiments detailed
in Chapter 5. Crystal trials were set up as described in section 2.2.12 using E500 fraction 3
(well 8) but did not provide protein crystals. The protein likely needs to be cleaner and more
homogeneous before crystallisation can be undertaken successfully.
Figure 25: Concentrated Preparation of p150DN/p60 from Ni-NTA Beads.
p150DN/p60 expressing cells from one litre of cell culture were lysed by incubation with
NP-40 and loaded onto Ni-NTA resin by passing through a spin column. After extensive
washing the bound proteins were eluted with buffer containing 500 mM imidazole A: SDS-
PAGE analysis of the purification. B: Western blot of E500 fraction 3. Markers are on the
right of each gel and are in kDa. Markers used for Western blotting are pre-stained and hence
run at a slightly higher molecular weight.
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3.4 Conclusions
In this chapter attempts to produce the CAF-1 complex by co-expression are discussed. It
proved possible to express both the full complex and a binary complex containing p150 and
p60 in insect cells using a baculovirus based co-expression system. The optimised expres-
sion was relatively low for the whole complex and slightly better for the binary complex.
Purification strategies were examined and it was discovered that high salt (400 mM KCl or
higher) was required to extract p150 from the cells and that it was possible to extract and
partially purify p150DN in the presence of p60 with or without p48. This problem is also
described in Hoek et al. (2011) and is believed to be due to the tight binding of p150 to
chromatin.
Whilst the protein complex produced from these methods is not totally homogeneous it is a
large improvement in quantity over previous work. 16.3 mg of CAF-1 was purified from 64
litres of human 293 cells (Smith and Stillman, 1989) and previous work in insect cells previ-
ously produced 0.75 mg of p150 (Kaufman et al., 1995) from a volume of cells approximately
equivalent to a 0.5 L cell pellet as grown in this study, compared to an yield of at least 3 mg
of p150DN/p60 purified from 1 L of insect cells here. Whilst the Bradford method is not an
accurate measurement of protein concentration it illustrates a significant increase in protein
yield compared to previous work.
Work of other groups has focused mainly on protein produced either in cells at low levels
(Takami et al., 2007), tagged endogenous protein (Smith and Stillman, 1991; Nabatiyan
and Krude, 2004), in vitro transcription translation (Quivy et al., 2001) or small, synthetic
peptides (Tang et al., 2006). This higher yield purification if the purity of the final sample can
be improved has the potential to allow studies of CAF-1 that were previously not possible
with low-yield proteins, such as kinetic measurements and crystallographic studies.
Ion exchange of the complex and individual proteins revealed that p60 consists of a variety of
charged species. These species may include both degradation products, post-translationally
modified protein and complexes with other proteins. Full-length p60 contains a PEST box
which targets proteins for degradation and the elution profile of p60 from an ion exchange
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column does not improve on treatment with phosphatase, suggesting that whilst some protein
may be phosphorylated it is not the main problem encountered during purification. As the
PEST box is in the long unstructured C-terminal tail of p60 (Marheineke and Krude 1998;
NCBI protein record Q13112) a method to improve the behaviour of the protein would be to
make constructs lacking all or part of this tail. This is investigated in the next chapter.
Unexpectedly, there was very little C-terminal degradation of p150DN seen as Western blots,
for example Figure 25 shows no ladder of degraded protein. The deletion of two known
proteases from the baculoviral genome in the MultiBac system may account for this. As the
major reason for expressing p150DN in a complex was to prevent this degradation it may
be possible to express p150DN alone in this system. This offered the prospect of being able
to examine the interactions of p150DN with other members of the CAF-1 complex and to
be able to express further truncated constructs. Production of p150DN alone and of shorter
constructs of p150 are described in Chapter 4.
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Chapter 4
Individual CAF-1 Subunits: Constructs
Design, Protein Expression and
Purification
4.1 Introduction
After the investigation of co-expression of the CAF-1 complex it was thought that it would be
possible to express the subunits of the complex individually. Previous work in this laboratory
has shown that it is possible to produce pure p48 from insect cells (Lejon et al., 2011). Work
in this thesis has suggested that p150DN can be expressed without degradation and therefore
may be stable alone and that p60 can also be separated from the complex but is subject to
degradation.
Deletion mutants of p150 and p60 were also designed and constructs were produced for ex-
pression in E. coli. Constructs of p150 were designed to locate minimal binding regions to
either p60 or p48 and constructs of p60 were designed to remove the C-terminal unstruc-
tured tail that we thought might have caused problems initially. As p48 has been stably
expressed the established protocol could be used and intact protein produced at high quality
and quantity.
94
For E. coli based expression of constructs the Ligation Independent Cloning (LIC) vector
pNIC-Bsa4 was used as it allows for fast generation of constructs (Savitsky et al., 2010).
Insect cell expression was performed as detailed in chapter 3.
4.2 p150DN Production and Purification
P150DN was produced with the aid of the Berger laboratory at EMBL Grenoble using meth-
ods as described for the CAF-1 fusion protein. An initial purification using nickel resin was
performed using the same protocol as for the fusion protein (see section 2.2.3.1), with and
without the presence of urea to remove as much background as possible and to show that
the protein was being purified via the His-tag. This is shown in Figure 26. The total protein
yield appeared to be slightly higher than previously seen for the whole complex (compare
lane 7 Figure 26with lane 10 Figure 16, section 3.2.2). As seen previously, p150DN was not
soluble in low salt solutions and required 400 mM KCl to extract it from chromatin. The
purified protein appears to be of a larger size than predicted when analysed by SDS-PAGE,
running at around 100 kDa where expected to 77 kDa. This is not unusual as full length
p150, named for its approximate mass by SDS-PAGE analysis, has an estimated mass of
107 kDa and unstructured proteins tend to run at larger molecular weights. Western blotting
using anti-His antibodies was used to confirm that the band was His-tagged p150DN.
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Figure 26: Denaturing and Native Purifications of p150DN.
A: SDS-PAGE analysis of the purification p150DN in the presence of 6M urea B: SDS-
PAGE analysis of the purification of p150DN under native conditions. C: Western blot of
the 100 mM Imidazole elution (lane 8), visualised using anti-His antibodies. Molecular
weight markers are in kDa.
To examine the stability and quality of the purified protein gel filtration was performed, as
shown in Figure 27. This shows some of the protein is bound to DNA as indicated by the
260:280nm ratio (first peak) but the second, smaller peak appears to contain protein of 70-
80 kDa. As p150DN is around 70 kDa this is correct for a monomer.
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Figure 27: Gel Filtration of Native p150DN.
p150DN eluted from Ni-NTA resin was run on a S200 10/300 column, 0.5 ml fractions
were collected. A: Elution Profile B: SDS-PAGE analysis100 ml of each fraction. Fraction
numbers are indicated above the SDS-PAGE analysis. Markers are in kDa.
To scale up the production of p150DN a pellet from 0.5 L culture of cells was treated as
described in section 2.2.3.3, however the protein eluted from the beads was dilute and con-
tained many contaminants when concentrated (Figure28 lane 10). Attempts were made to
purify p150DN further by ion exchange but this chromatography method proved impossible
as p150DN is unstable in low salt and precipitated immediately. Gel filtration was possible,
as seen above, however when concentrated by centrifugation p150DN precipitates onto the
membrane. Alternative membranes and concentration methods were tried as for CAF-1 (sec-
tion 3.2.3). However, neither changing the membrane, removing imidazole, addition of gly-
cerol nor sucrose based dehydration allowed concentration of protein. In most cases the
protein totally precipitated on the membrane and the final concentration of p150DN as seen
by SDS-PAGE was lower than initially, e.g. Figure 27, lane 16 .
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Figure 28: Initial Purification of 0.5 L p150DN Pellet.
SDS-PAGE analysis of purification. A 0.5 L culture of cells expressing p150DN was lysed,
clarified by centrifugation at two speeds and purified by interaction with Ni-NTA beads.
Markers are in kDa.
These results indicate that whilst it is possible to produce p150DN alone it is not a stable pro-
tein and has a tendency to aggregate. This was also seen when attempting to store p150DN
at -80 oC after flash-freezing in liquid nitrogen as it aggregates on defrosting, meaning that
it had to be freshly purified each time before use. Despite these problems sufficient protein
was purified via nickel beads to use in pull-down and crosslinking experiments, as detailed
in Chapter 5.
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4.3 p150 Deletion Mutant Design, Production and Purific-
ation
4.3.1 Bioinformatic Analysis of p150
Bioinformatic analysis predicts p150 to be a mostly unstructured protein with no predicted
motifs other than a coiled-coil region covering the KER rich region in the middle of the pro-
tein predicted by SMART analysis (http://smart.embl-heidelberg.de/). Constructs to isolate
the p60 and p48 binding region(s) were designed based on sequence alignments of p150
from various species produced using Phyre (http://www.sbg.bio.ic.ac.uk/~phyre/), predicted
structural motifs using PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) and the information on
the interactions between p150/p60 and p150/p48 published by Krude (1995) and Takami
et al. (2007) (Figure 29). The resulting constructs A-D take into account the highly con-
served regions seen between species with the removal of some repetitive regions. Construct
E is based on the minimal region for interaction with p60 from Takami et al. (2007).
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Figure 29: Bioinformatic Analysis of p150 Sequence Showing the Constructs.
A: Fold Index (http://bip.weizmann.ac.il/fldbin/findex, Prilusky et al., 2005) prediction for
p150, showing it is predicted to be mostly unfolded (red). B: Summary schematic of the
p150 peptide where the constructs made are indicated.
4.3.2 PCR Primer Design
Longer p150 constructs were His-tagged to allow for large scale purification as required.
Construct E is a short peptide and therefore was produced fused to a GST tag to increase
solubility and stability in the cell. The LIC vector pNIC-Bsa4 was used for production of
His-tagged proteins containing a TEV cleavage site. The GST-tagged protein was incorpor-
ated into pGEX-2T using the SLIC cloning method (Li and Elledge, 2007). Primers were
designed as described in Chapter 2, and are shown in Appendix E.
4.3.3 Cloning
The p150 fragments were generated by PCR using the standard method described in section
2.2.1.9. Plasmids were digested with BsaI (Constructs A-D) or BamHI and EcoRI (Construct
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E) as described in section 2.2.1.5 until less than 10 colonies were observed on transformation
of the digested plasmid into Top10 cells (section 2.2.1.3). These were then treated accord-
ing to the (S)LIC protocols (sections 2.2.1.12 and 2.2.1.13) and the resulting mixtures trans-
formed into Top10 cells and plated on appropriate antibiotic. Colonies were grown overnight
and checked by restriction digest and sequencing (section 2.2.1.15). Plasmids containing the
correct genes were used in expression trials.
4.3.4 E. coli Expression Trials and Purification
His-tagged p150 constructs A-D were transformed into the E. coli expression strain Rosetta
2 pLysS (Invitrogen). 10 ml LB was inoculated with a single colony and grown to an O.D.
(600 nm) of 0.4-0.6. The cells were then induced with 1 mM IPTG and grown at 20oC for
3 hours. Samples were taken and lysed using Bugbuster, the soluble and insoluble fractions
were analysed by SDS-PAGE and Western blot. Construct E could theoretically be expressed
directly from Top10 cells as the GST vector contains a Tac promoter recognised by bacterial
RNA polymerase. However, cells containing construct E would not readily grow in suspen-
sion culture and when induced were seen to lyse, indicating the construct E is lethal to E.
coli, therefore only the His-tagged constructs were taken forward for further purification.
The His-tagged proteins were expressed in larger culture volumes and used for purification.
A protocol similar to that used for the purification of p150 from insect cells (section 2.2.3.3)
was applied but with a lower salt concentration in the lysis and purification buffers as the
proteins were soluble when lysed with Bugbuster. Each cell pellet was lysed, spun and
the soluble supernatant run over 1 ml Ni-NTA beads. A SDS-PAGE gel of the purification
results is shown in Figure 30. Constructs A-C appear to have been expressed and purified
at a low but usable level (lanes 6, 12 and 18). Construct D did not appear to be present
above background levels (lane 25) and was therefore not used in further experiments. When
analysed by SDS-PAGE the proteins appear to be larger than predicted, as has been seen
previously for p150DN. The proteins were shown to contain a His-tag by Western blot (data
not shown). These proteins were used for experiments in chapter 5.
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Figure 30: Initial Purification of p150 Deletion Mutants.
Each construct was purified by binding to Ni-NTA beads, washed with 1 M KCl and eluted
with increasing concentrations of imidazole. Protein samples were analysed by SDS-PAGE.
* indicates the protein of interest, purified proteins were shown to contain a His-tag by
Western blot (results not shown). Construct D has not been purified. Markers are in kDa.
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4.4 p60 Constructs
4.4.1 Bioinformatic Analysis of p60
To assess the conserved domain composition of p60 a variety of bioinformatic analyses were
performed as for p150. P60 is predicted to be a WD repeat containing protein which would
form a beta propeller structure similar to that of p48 with an unstructured tail which is known
to interact with ASF-1 (Malay et al., 2008). Visual representations of some of this data and
the chosen constructs are shown in Figure 31. Using this data five constructs were designed.
Three constructs containing the WD repeat region, a construct containing the C-terminal tail
and full length p60. The whole of p60 was sampled to make constructs as it is currently
unknown which section interacts with p150 and the various end sites for the WD containing
constructs reflect the uncertainty as to where the final WD repeat needs to be cut to maintain
a stable structure.
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Figure 31: Bioinformatic Analysis of the p60 Sequence Showing the Location of Con-
structs.
A: FoldIndex prediction of structured regions of p60 (Prilusky et al., 2005). B: peptide dia-
gram summarising key features of p60. WD denotes predicted locations of beta propeller
blades. P, predicted phosphorylation sites. Below the protein the constructs chosen for clon-
ing are indicated, the numbers denote the amino acid residues.
4.4.2 E. coli Expression
4.4.2.1 PCR Primer Design
Constructs were to be cloned into both E. coli and insect cell expression vectors. Previous
work showed that full length p60 did not express solubly in bacteria (N. Murzina, personal
communication). For expression in E. coli the plasmid pNIC-Bsa4 was used. Primers were
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designed to contain the LIC sequence followed by a section of p60 and are described in
Appendix E.
4.4.2.2 Cloning
The p60 fragments were synthesised by PCR using the basic protocol described in section
2.2.1.9. The reactions were purified with a PCR clean up kit and used for LIC reactions. The
vector pNIC-Bsa4 was linearised by treatment with BsaI. Constructs and linearised vector
were treated with T4 DNA polymerase and combined. The DNA was transformed into Top10
cells and colonies growing on LB-agar supplemented with kanamycin and sucrose were
isolated, grown overnight for minipreps and confirmed by sequencing to contain the correct
gene.
4.4.2.3 p60 E. coli Expression Trials
Several p60 expression trials were undertaken using Rosetta and Arctic Express E. coli
strains. Cells were grown at 37 oC for 3 hours, 27 C for 8 hours and 15 oC overnight
with IPTG concentrations of 1, 0.4 and 0.1 mM IPTG. None of these conditions produced
soluble protein and as this had previously been the case with p48 in this laboratory it was de-
cided to concentrate on insect cell expression. Figure 32 shows an example of an expression
profile from the expression in Rosetta cells at 27 oC for 8 hours using 0.4 mM IPTG.
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Figure 32: Trial Expression of p60 in E. coli.
Rosetta cells containing p60 expression plasmids were grown at 27 oC for 8 hours and in-
duced with 0.4 mM IPTG, lysed with Bugbuster and spun down to separate soluble and
insoluble proten. Protein samples were analysed using SDS-PAGE. T = Total cell extract,
S = Soluble and I = Insoluble. Expected sizes are 47kDa for construct 1 (1-386), 49 kDa
for construct 2 (1-400), 50 kDa for construct 3 (1-409), 66 kDa for construct 4 (1-559, full
length) and 22 kDa for construct 5 (387-559). Black arrows indicate insoluble constructs 1
and 3. Constructs 2, 4 and 5 are less obvious.
4.4.3 Insect Cell Based Expression of p60
As E. coli based expression did not produce soluble protein the constructs were cloned into
the MultiBac system for expression in insect cells (Berger et al., 2004). To allow for future
work co-expressing p60 with other proteins, primers were designed to clone constructs 1-5
into pUCDM containing a Myc-tag. For this we used the In-Fusion cloning system which
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allows for sequence and ligation independent cloning (SLIC). Primers were designed to in-
sert a Myc-tag into the BamHI site of pUCDM and the gene of interest between the BamHI
and XbaI restriction sites of the vector and are detailed in Appendix E.
4.4.3.1 pUCDM Plasmid Preparation
The MultiBac system consists of two plasmids: pFBDM which has a standard E. coli ori-
gin of replication and pUCDM, which contains the conditional origin of replication R6Kg
that requires cells to express the pir+ gene product for plasmid propagation. The E. coli
strain BW23474 was used for this propagation but initially provided very low yields of plas-
mid (<20 ng/ml on elution in 30 ml water). A variety of different miniprep kits were tried
(Macherny-Nagel, Anachem and Qiagen) but did not improve the yield. Midipreps (Qiagen)
did produce larger quantities of DNA, but at similar concentrations (up to 20 ng/ml), and were
unreliable with some preps failing to produce any DNA. Alkaline lysis (section 2.2.1.1) pro-
duced large amounts of DNA but did not remove low molecular weight nucleic acids even
when large amounts of RNAse was added to the reaction. To increase the concentration of
DNA produced from a midiprep the lysed and centrifuged solution (stage 7 in the Qiagen
manual) was passed through a miniprep spin column (rather than a midiprep column) and
eluted in 50 ml water, this produced reasonable quality DNA with a 260/280 nm ratio greater
than 1.8. The results from both methods is shown in Figure 33.
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Figure 33: Alternate Preparation Methods of pUCDM.
Agarose gel analysis of pUCDM samples. DNA was prepared from BW23474 cells contain-
ing pUCDM using the alkaline lysis method and the midi-to-mini prep method where the
contents of a midiprep was transferred to a miniprep spin column and treated as a miniprep.
When sufficient DNA had been produced, digestions were set-up (section 2.2.1.5) but it was
discovered that the plasmids did not digest to completion. The majority of the pUCDM plas-
mid digested except for a supercoiled sub-population that is not removed even on addition
of a second (or third) portion of enzyme. Increasing the enzyme concentration and diges-
tion time did not make any difference. Different sources of pUCDM were examined but the
lower yield BW23473 cells, pir+ cells from Epicentre Biotechnologies and a fresh batch of
BW23474 cells from the Berger laboratory both produced very low yield plasmids which
also were not susceptible to digestion.
After consultation with I. Berger it was also suggested that pUCDM containing cells should
be grown for 8 hours and harvested whilst in exponential phase rather than stationary phase.
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A comparison of these two methods are show in Figure 34. Whilst the yield and purity of
the plasmid is affected, this DNA did not digest readily either. However the DNA from the
concentrated midiprep could be digested to a certain extent and was therefore used for the
Myc cloning experiment as it was sufficient to make colonies containing the correct inserts.
Figure 34: Comparison of Exponentially Growing and Stationary Phase Cells for Mini-
preps.
DNA was prepared from cultures grown overnight or for 8 hours and compared by agarose
gel electrophoresis. Markers are kbp.
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4.4.3.2 Insertion of Myc Tag into pUCDM
The sequence encoding a Myc-tag following a thrombin cleavage site was inserted at the
BamH1 cleavage site of pUCDM, introducing an NdeI cleavage site which is absent in
pUCDM. Complimentary oligos containing the Myc-tag were designed (Appendix E) and
annealed by plunging a mixture of oligos into a beaker of boiling water and leaving them
to cool slowly and anneal. Annealing was checked by 8 % (w/v) acrylamide gel and the
DNA was ligated into pUCDM prepared as described above, cut with BamHI and cleaned
using a PCR clean-up kit. The ligation reaction was transformed into pir+ cells and left
to grow overnight. There were many colonies seen on control plates due to poor digestion
of pUCDM, but as ligation plates contained around ten times as many colonies as the con-
trols, colonies were picked, grown overnight and the plasmid DNA prepared. Plasmids were
then digested with NdeI and PmeI, giving a 600 bp fragment in correct integrants, shown in
Figure 35. Colonies appearing correct by digestion analysis were confirmed by sequencing
with a PolH primer. The final pUCDM-Myc plasmid contained a double insert of the Myc
fragment. Nevertheless it was used for p60 cloning as the double direct Myc repeat did not
introduce a reading frame shift.
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Figure 35: Digestion of Possible Myc Integrants.
Plasmids were digested with NdeI and PmeI to check for inserted fragments and separated
on a 1 % agarose gel. c = circular, d = digested with NdeI and PmeI. Expected band size is
0.6kb. Marker is in kb.
4.4.3.3 PCR of p60 Fragments
The p60 fragments were synthesised by PCR. The basic protocol described in section 2.2.1.9
amplified all the fragments to sufficient concentrations of DNA when the number of cycles
was increased to 30. The reactions were cleaned with a PCR clean up kit and used for
In-Fusion reactions with pUCDM-Myc.
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4.4.3.4 In-Fusion of Fragments with Vector
Linearised pUCDM-Myc digested with BamHI and XbaI was combined with fragments of
p60 and integrated using an In-Fusion reaction. As described previously, pUCDM is resistant
to linearisation and a large number of colonies were seen on control plates. To prevent many
minipreps being performed colony PCR using the PolH sequencing primer and a specific
reverse primer was used to identify correct colonies as described in section 2.2.1.14. Once
a fragment was identified the colony was grown overnight and a miniprep performed for
analysis of plasmids by DNA sequencing.
4.4.3.5 Lox-Based Recombination and Bacmid Creation
As p60 was cloned into the donor vector of the MultiBac system it was necessary to re-
combine it with an acceptor vector to provide the Tn7 recombination element required for
insertion into Baculoviral DNA. The various p60 constructs were combined with pFL from
the iACEMBL derivatives if the MultiBac plasmids (section 2.2.1.17). pFL is an acceptor
vector very similar to pFBDM, containing a lox site which allows combination of two plas-
mids containing identical sites into one on addition of the Cre enzyme. Recombined plas-
mids were selected for by plating onto agar containing both ampicillin and chloramphenicol
and transforming into cells lacking the pir+ origin of replication. Colonies were grown
overnight and the plasmid DNA extracted from cells. The correct combinations of plasmids
was confirmed by restriction digestion. Recombined plasmids were then integrated into the
baculoviral genome by transforming into EmBacY cells and blue/white selection performed
to check integration into the bacmid (section 2.2.2.2).
4.4.3.6 Baculoviral Expression
The bacmid was transfected into adherent Sf21 insect cells and a virus generated. This virus
was amplified and the YFP time course followed, as described in section 2.2.2.2. Once YFP
production had peaked a Western blot was performed to check for the presence of Myc-
tagged protein, shown in Figure 36. Each construct had two separate viruses made, noted
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as n and n’. Construct numbers refer to the constructs shown in Figure 31. Using anti-Myc
antibody it was apparent that the full length version of p60 exists in several forms (lanes
8-11) whereas the truncated version 1 appears to have only one form (lanes 2-5). Only
two constructs expressed, full length p60 and the most truncated version of the WD region,
construct 1. It is thought that construct 5 may have degraded in cells rapidly due to the
presence of the PEST box motif. All non-expressing constructs were prepared again from
sequenced pUCDM but still did not express. Probing the blot with anti-p60 only visualised
full-length protein, indicating that the recognised antigen is in the unstructured C-terminal
tail. Therefore anti-Myc was used to visualise construct 1 in further experiments. As only
construct 1 expressed it is hereafter known as p60_WD as it contains the WD region of the
protein. Full length p60 is denoted p60_FL.
Figure 36: Anti-Myc Visualisation of Myc-p60 Constructs.
Western blot of of Myc-p60 constructs expressed in Sf21 insect cells. Each construct was
made into two viruses noted n and n’. Numbers above the gel refer to constructs as shown
in Figure 31. Markers are in kDa. Asterisks (*) indicate non-specific antibody activity to an
unknown protein . Arrows indicate expressed protein. M = Marker, T = Total cell lysate, S
= Soluble lysate.
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4.4.3.7 Purification of p60 _FL
The initial purification of p60_FL for pull-down experiments was performed by lysing cells
using NP-40, clarifying the lysate by centrifugation and incubating with anti-Myc antibodies
attached to beads, as described in section 2.2.3.4. The beads were harvested from the solution
by centrifugation and washed. SDS-PAGE analysis of the purification is shown in Figure
37. The presence and gel position of p60_FL was confirmed by Western blotting (data not
shown) and beads were then used for pull-down experiments. To remove p60_FL from the
beads the protein was cleaved overnight with thrombin and then the thrombin removed by
incubation with anti-thrombin beads. The concentration of protein pulled down using Myc-
beads is low as the beads have a low binding capacity.
Figure 37: Purification of Myc-p60_FL using Anti-Myc Beads.
SDS-PAGE analysis protein samples collected during Myc-p60_FL purification. The pres-
ence of p60_FL was confirmed by Western blotting using anti-Myc and anti-p60 (data not
shown). Markers are in kDa.
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4.4.3.8 p60_WD Purification
Purification of Myc-tagged p60_WD (Construct 1 in Figure 31) was attempted using meth-
ods other than affinity purification as the Myc-beads are not re-usable and are prohibitively
expensive in amounts sufficient for large scale purification. The Myc-tag was however used
to visualise p60_WD. It was thought that as Construct 1 appears to only have one form on a
Western blot (Figure 36, lanes 2-5) it would behave better than full length p60 during puri-
fication. Initial fractionation of the clarified lysate was done using a Q HP column (Figure
38).
Fractions A3-A9 were combined for further purification was attempted using a hydroxyapat-
ite column, to which neither p60_WD nor its contaminants bound and then by gel filtration,
shown in Figure 39. This separated p60_WD into several species, as seen by Western blot,
including a heavy species containing DNA (peak with high absorbance at 260 nm), however
these were not visible on a Coomassie-stained SDS-PAGE gel (Figure 39 lanes B15 and
B14). A second ion exchange column was then run on gel filtration fractions B15 and B14 in
an attempt to purify further and concentrate p60_WD but it did not bind well to the column
and was at a very low concentration.
The amount of p60_WD produced in these cells is low and for maximum efficiency of future
experiments it would be desirable to move the gene into a his-tagged vector for easier puri-
fication before optimising the virus for better expression. However the p60_WD purified on
anti-Myc beads using small scale methods was sufficient for pull-down experiments.
115
Figure 38: Initial Purification of p60_WD.
A: Elution profile of clarified whole cell extract containing p60_WD run on a 1 ml Q HP
ion exchange column over 30 CV. 1 ml fractions were collected. B: Western blot showing
anti-Myc visualisation of the fractions. C: SDS-PAGE gel analysis of fractions, suspected
p60 bands are indicated by asterisks. Markers are in kDa.
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Figure 39: Gel Filtration of p60_WD.
A: Elution profile of Fractions A3-A9 from the Q HP column run on a S200 10/300 gel filtra-
tion column B: Western blot using anti-Myc to visualise p60_WD. C: SDS-PAGE analysis
of fractions from column. Markers are in kDa.
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4.5 p48
P48 had previously been produced in our laboratory to a very high purify using a protocol
designed by N. Murzina and W. Zhang. Protein used in these experiments was kindly pur-
ified by S. Lejon, A. Murthy or W. Zhang, according to the protocol detailed in section
2.2.3.5. Purified protein was flash frozen in 10 % (v/v) glycerol and stored at -80oC. This
was defrosted on ice before use in assays. Previously frozen p48 can be crystallised (S. Le-
jon, personal communication), which indicates that it is not damaged by the freezing and
defrosting process.
4.5.1 His-p48
His-tagged p48 was purified in the same way as normal p48 with the exception of the throm-
bin cleavage step, which was skipped. Where His-p48 was required bound to beads the
purified protein was re-bound to Ni-NTA resin after purification and elution.
4.6 Conclusions
It has proved possible to express all the components of the CAF-1 complex in insect cell
based baculovirus expression systems, albeit in low amounts for p150 and p60. Purification
of p150DN was only possible on a nickel affinity resin before the protein began to aggregate,
indicating that is it not very stable alone, possibly due to being largely unstructured. Work
in the previous chapter indicates that this problem might be solved by addition of other
components of the complex which stabilise the protein enough to make concentration of the
complex possible. It may be possible in future to purify the other components of the complex
separately then add them back to p150 to produce more concentrated, cleaner complex than
is possible with co-expression. Shorter constructs of p150 have been successfully produced
in E. coli to allow investigation of their binding properties.
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E. coli expression of p60 was unsuccessful so constructs were cloned into plasmids for in-
sect cell expression.The MultiBac system was utilised to create several p60 constructs, two
of which were successfully expressed in insect cells. The reasons for the problems with
pUCDM production and digestion are still not fully understood as when the work was re-
peated on a visit to the Berger lab using the same methods, cell lines and enzymes procured
from the same company this resulted in much more efficient cloning. Despite these prob-
lems, cloning was eventually successful to produce Myc-tagged versions of full length p60
and a shorter construct lacking the PEST motif.
Western-blot analysis of the p60 constructs using an antibody to the Myc-tag showed that the
full length protein is expressed in several different forms, where the shorter p60_WD only
has one. When anti-p60 is used to visualise full length p60 only one band is seen on the
Western blot, this is likely because the antibody does not recognise the modified versions of
the protein. This theory is supported by the knowledge that the antigen is in the C-terminal
tail, known to be an unstructured phosphorylation target (Smith and Stillman, 1991).
The small p60 construct p60_WD is produced as one form, which should be more amenable
to purification. However at current levels of expression and without a cost-effective method
for affinity purification this was not feasible. The most efficient method for further purifica-
tion is likely to be to change the tag to one that allows affinity purification, such as a his-tag
and optimisation of the virus to increase the yield. A high yield would be vital for structural
methods such as crystallisation as relatively large amounts of protein are required.
The reasons for lack of expression of the other three p60 constructs are unclear. It is likely
that the construct containing the PEST region was unstable (construct 5) and degraded. Con-
structs 2 and 3 contained the more stable WD region but were not expressed. This could also
be due to stability issues or the virus not retaining the DNA. However the latter is less likely
as several attempts were made to express the proteins using different viruses. This suggests
the protein is simply not stable.
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Chapter 5
Interactions Within the CAF-1 Complex
5.1 Introduction
The interactions within the CAF-1 complex are not well characterised biochemically. The
interaction of the p150 subunit with p60 has previously been demonstrated (Smith and Still-
man, 1991) and the region of interaction narrowed down (Kaufman et al., 1995). The pres-
ence of p48 in the complex has also been reported (Verreault et al., 1996), however neither
the precise regions of the proteins involved nor the binding mode of the interactions between
p150 and p60 or p48 have been conclusively identified (Takami et al., 2007). The interaction
between p48 and p60 has never been investigated.
The stoichiometry of the CAF-1 complex is also unknown. It is known that when phos-
phorylated, monomeric p150 binds PCNA and that dephosphorylated p150, which exists in
a dimer/monomer equilibrium has chromatin assembly activity (Gerard et al., 2006). The
ratio of p60 and p48 within the CAF-1 complex is however unknown. This section describes
investigation of the interactions between the subunits of CAF-1 using previously purified
recombinant protein components, as described in earlier chapters.
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5.2 p150 Dimerisation
5.2.1 p150DN
As p150 is known to dimerise (Quivy et al., 2001) we assessed whether the constructs de-
scribed here have this ability. As part of the purification trials gel filtration was performed on
p150DN. This gave very low concentration protein peaks as it was not possible to concen-
trate p150DN (see section 4.2) and the elution profiles were not consistent between protein
preparations. Generally, a high molecular weight peak containing aggregated protein was
seen with a wide single peak containing p150DN elution at around 12 ml on a Sephadex
S200 10/300 column (e.g. Figure 27, section 4.2 on page 95). Using a standard curve for
the column (see section 2.2.3.3) an approximate molecular mass of 200 kDa was estimated
for p150DN. This is likely to be an over estimate as CAF-1 has previously been seen to run
on a gel filtration column at a much higher mass than expected (Smith and Stillman, 1989).
Due to both the apparent mass of p150DN and the inconsistency between runs, which could
be due to different amounts of monomer and dimer at the low protein concentration it is not
possible to infer anything conclusive from this data.
Crosslinking experiments were trialled to investigate if a dimer of p150DN could be trapped.
Purified p150DN after elution from Ni-NTA beads was crosslinked with BS3, a specific
amide crosslinker with a spacer of 11 Å, or formaldehyde, a non-specific amide-nitrogen
crosslinker with minimal spacer. The crosslinked products were analysed using SDS-PAGE
and Western blotting. This revealed the same crosslinking pattern for both crosslinkers. The
results for BS3 crosslinking are shown in Figure 40. There are three main bands indicated
on the Figure of approximate sizes 70, 120 and >200 kDa. The smallest band is monomeric
p150DN which is 75 kDa, as estimated from the raw sequence and which runs around 75 kDa
when analysed by SDS-PAGE. The second band is consistent with dimeric protein (150 kDa).
The third band is either an aggregate or a higher order oligomer, possibly a tetramer. As the
higher band fades at lower concentrations of crosslinker it may be a result of non-specific
crosslinking between existing dimers. This result suggests that p150DN dimerises as expec-
ted when produced in insect cells. However the proportion of the protein crosslinking is very
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low (in comparison to proteins known to form dimers, e.g. histones H3 and H4), which may
be explained by the low protein concentrations used in these experiments.
Figure 40: Crosslinking of p150DN with BS3.
After elution from a Ni-NTA column (Lanes 1 and 6) p150DN was treated with at 0.15 (lanes
3 and 8), 0.06 (Lanes 4 and 9) and 0.03% (Lanes 5 and 10) (w/v) BS3 crosslinker for 30 min.
Samples were run using SDS-PAGE, transferred to a PVDF membrane and a Western blot
was used to visualise His-tagged p150DN. Suspected stoichiometry is indicated for each
band. Markers (Lanes 2 and 7) are in kDa, due to the SDS-PAGE being silver stained the
markers are over-exposed.
5.2.2 p150 Construct C
As a representative of E. coli produced p150, construct C (residues 545-956) was examined.
Gel filtration again did not give consistent results as peaks were at a similar elution volume
to p150DN although p150_C is only 49_kDa in size. Crosslinking was repeated as for
p150DN and gave a similar pattern with the monomer running around 55 kDa, suspected
dimer at 83 kDa and larger aggregates. Less higher-order crosslinking is seen compared
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to p150DN with high molecular weight species only seen at the highest concentration of
crosslinker (compare Figure 40 lanes 8-10 with Figure 41 lanes 8-10). Some dimer can be
seen in the un-crosslinked sample of p150_C, which is likely to be due to the formation of
disulphide bridges between cysteine residues if the reducing agent was insufficient.
Figure 41: Crosslinking of p150 Construct C with BS3.
After elution from a Ni-NTA column p150_C (lanes 2 and 7) was treated with 0.15 (lanes 3
and 8), 0.06 (lanes 4 and 9) and 0.03% (lanes 5 and 10) (w/v) BS3 crosslinker for 30 min.
Samples were separated by SDS-PAGE, transferred to a PVDF membrane and a Western
blot was used to visualise His-tagged p150DN. Suspected stoichiometry is indicated for
each band. Markers (lanes 1 and 6) are in kDa.
5.3 Interaction of p150 with p60
Full length p60 binds to p150DN as it is possible to co-purify untagged p60 by affinity puri-
fication of His-tagged p150DN from clarified lysate (section 3.3). To assess the interaction
of the different p150 constructs with full length p60, pull-downs were performed between
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the insect cell expressed p60 bound to anti-Myc beads and all expressed p150 constructs
(Figure 42). Myc-p60 bound to beads was combined with different His-tagged truncated
p150 constructs in solution and incubated at 4oC for 2 h. The beads were washed to remove
unbound protein and samples visualised by Western blotting. To control for different expres-
sion methods, full length p150 expressed in E.coli was also purified using the same methods
as for the other constructs. Full length p150 is C-terminally His-tagged, which is not visu-
alised by the anti-His antibody used, therefore anti-p150, which recognises an N-terminal
epitope not present in p150DN was used (Smith and Stillman, 1991).
P60 only binds to protein that was expressed in insect cells (Figure 42, lanes 10 and 11).
This indicates that p60 binds to something that is present when the protein is translated in
eukaryotic cells, likely either a folded structural motif or a post-translational modification.
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Figure 42: Pull-down of His-p150 Constructs by Myc-p60_FL.
A: p150 proteins were added to p60_FL bound to anti-Myc beads, incubated at 4oC, washed
and visualised by Western blotting with antibodies as indicated on the right. Constructs of
p150 A-C, produced in E.coli and p150DN (dN) purified from insect cells were visualised
using anti-His antibody. Full length p150 (Fl) was visualised by an anti-p150 antibody. B:
Control pull-downs were done using Sepharose 4B beads. I = Input, P= Pull-down. Molecu-
lar markers (lanes 1 and 12) are in kDa.
To determine whether p60 binds to a structure requiring eukaryotic chaperones to fold or
a post-translational modification, p150DN expressed in insect cells was denatured. The
protein was purified from clarified insect cell lysate using Ni-NTA beads in 8 M urea to
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remove all structure and then washed back into native buffer (section 2.2.3). This protein
was then either left on beads or eluted and pull-downs performed using p60 bound to beads.
Native p150DN was used as a positive control (Figure 43, compare lane 2 with 4 and lane 6
with 8). This showed that p60_FL does not bind to denatured p150, indicating that it interacts
with a structured region in p150 which requires eukaryotic expression systems to form.
Figure 43: Native and Denatured p150DN Pull-downs of p60_FL.
Either His-p150DN, purified in a native state (N) and denatured in urea (D) or Myc-p60_FL
were bound to beads and used to pull-down the other soluble protein. Western blotting was
used to visualise the resulting bound protein with antibodies as indicated. Control pull-downs
used clean Ni-NTA beads (binding to p150) and Sepharose 4B (binding to p60). I = Input,
P= Pull-down.
To assess whether the binding of p60 to p150 is mediated by its WD region or through its
unstructured tail, pull-downs were performed using p60_WD. The epitope recognised by
anti-p60 is on the tail which is missing from this shorter construct, therefore anti-Myc was
used to visualise p60_WD. Fortuitously, where p60_WD was eluted from beads by thrombin
cleavage a small percentage of the protein appears be eluted without cleavage of the tag,
allowing visualisation by anti-Myc. As shown in Figure 44, p60_WD behaves in the same
way as p60_FL, suggesting that the WD region of p60 binds to a structural motif on p150.
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Figure 44: Native and Denatured p150DN Pull-downs of p60_WD.
Either native p150DN (N), p150DN denatured in urea (D) or Myc-p60_WD were bound to
beads and used to pull-down the other soluble protein. Western blotting was used to visualise
the bound protein with antibodies as indicated. Control pull-downs used clean Ni-NTA beads
(binding to p150) and Sepharose 4B (binding to p60). I = Input, P= Pull-down.
5.4 Interaction of p150 with p48
To examine the interaction between p48 and p150 the E. coli expressed p150 constructs were
used for pull-downs experiments. As both the p150 constructs and p48 are purified using the
same tag we needed to cleave the His-tag off from one protein prior to the pull-downs. P48
was chosen to be in solution as its tag is cleaved off during the standard purification pro-
tocol (section 1.5.2.3) and the untagged protein can be visualised using anti-p48 antibodies,
whereas attempts to cleave the tag from p150 constructs resulted in protein degradation (sec-
tion 4.2).
Initially, p48 was seen to bind to Ni-NTA in the absence of any protein. Investigation of
the conditions revealed that the presence of 10 mM imidazole and absence of glycerol from
the reaction buffer prevents most p48 binding to the beads (His Pull-down Buffer, section
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B). The pull-down is shown in Figure 45 and whilst a small amount of binding of p48 to
beads can be observed in the negative control (Fig 45, lanes 13 and 14), it binds much more
strongly to p150 (compare Figure 45, lanes 8, 10 and 14). The binding of p48 appears to be
to a sequence motif in p150 as it binds to all the constructs including the one purified in urea
(lanes 11 and 12). The results for anti-p48 on this blot are slightly over-exposed due to the
antibody used having to be re-titrated after accidental desiccation, there is also evidence of a
bubble having prevented optimal transfer of the p48 in lane 5.
Figure 45: Pull-down of p48 by p150 Constructs.
Pull-downs were performed with p150 constructs bound to beads and tagless p48 in solution.
Western blotting was used to visualise the result with antibodies as indicated. Constructs of
p150 are denoted A-C, full length p150 expressed in E.coli is denoted Fl, p150DN expressed
in insect cells is p150DN. p150DN Denatured was purified in urea from insect cells. Negat-
ive control (-) was clean Ni-NTA beads. I = Input, P= Pull-down.
5.4.1 Interaction of p48 with p150_C
All the constructs of p150 were seen to bind to p48. The smallest of these is construct C,
which is still a relatively large protein at 49 kDa. For further investigation more protein was
required so a large scale purification protocol was developed for p150_C. The concentration
of KCl used in the purification was increased to 400 mM, the same as for purification of
insect cell expressed p150DN as it increased protein yield. A denaturing purification was
used (section 2.2.3.3) as p48 binds p150 purified in this manner and the purification removed
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the majority of contaminating proteins, which appeared to decrease the affinity of p48 for
p150_C. A typical purification is shown in Figure 46.
Figure 46: SDS-PAGE Analysis of a Large Scale Purification of p150_C.
p150_C was purified by adding urea to clarified lysate, binding to Ni-NTA beads and washing
in decreasing concentrations of urea back to native conditions as described in section 2.2.3.
To locate the fragment of p150_C responsible for binding to p48 limited proteolysis was
investigated. Excess p48 was added to p150_C bound to 0.5 ml Ni-NTA beads and washed
with His Pull-down Buffer (section B) to remove surplus p48. The resulting complex eluted
from the beads appears to be 1:1 p48 : p150_C by SDS-PAGE analysis (Figure 47, lanes
7-11).
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Figure 47: Large Scale Preparation of the p150_C/p48 Complex.
p150_C was purified under denaturing conditions bound to Ni-NTA beads (Bound). Purified
p48 was then added to the beads and excess protein washed off. I= Input, P =pull-down,
Remaining = proteins remaining on beads after elution. A control pull-down between p48
and Ni-NTA beads was also done (Negative Control). The protein was then eluted in 0.5 ml
binding buffer containing 500 mM Imidazole. Markers are in kDa.
Limited proteolysis was attempted with a series of dilutions of subtilisin to find a concen-
tration where p48 remained intact whilst digesting unstructured and non-protected parts of
p150_C. Unfortunately, p48 was seen to be digested at similar rates to p150_C (data not
shown). At the final subtilisin concentrations of 0.6 ng/ml neither p48 nor p150_C were
digested whereas at higher concentrations both proteins were affected. It was not possible
to use this technique to define a p150 interaction fragment. This is likely due to the struc-
ture of p48, a 7 blade beta propeller where the linker regions between the blades are readily
accessible to protease and as such digest quickly.
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5.4.1.1 Bioinformatic Investigations
Comparison of the binding region for p48 examined here (construct C, residues 545-956)
with that previously published by Takami et al. (2007) (residues 442-642 when normalised
to full length p150) gives a region of overlap of 97 amino acids. Manual examination of this
region comparing it to other known p48 binding motifs revealed a RRK (arginine, arginine,
lysine) sequence motif at residues 551-553, which was notable as there have recently been
shown to be the critical residues in FOG1 required for interaction with p48 (Lejon et al.,
2011; Hong et al., 2005).
Sequence Region
FOG1 MSRRKQXXP 1-9
p150 PERRKFGRM 549-557
Alignment hXRRKXXXh
Table 6: Manual Alignment of the FOG1 Consensus Interaction Motif with a Putative
Motif in p150. h = hydrophobic residue, X = any amino acid
5.4.1.2 Competition Experiments
To assess if this motif was responsible for the binding of p150 to p48 a competition experi-
ment was performed. The FOG1 peptide (residues 1-15, Lejon et al., 2011) was mixed to ten
times excess with p48 and used in a pull-down experiment with p150_C bound to Ni-NTA
beads. As a control an identical amount of p48 diluted with buffer was also used. The results
are shown in Figure 48. The addition of FOG1 clearly reduces the amount of p48 that binds
to p150.
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Figure 48: Competition of FOG1 1-15 Peptide with p150 for Binding to p48.
A pull-down was performed using Ni-NTA beads bound to p150_C with either p48 alone or
p48 pre-mixed with 5 x excess of FOG1 peptide. The resulting proteins were analysed by
Western blot using anti-p48 and anti-His antibodies to visualise p48 and p150_C respectively.
Markers are in kDa.
5.4.1.3 Mutagenesis of the RRK Motif in p150_C
The essential residues for binding of FOG1 to p48 are the second arginine and the lysine of
the RRK motif, mutation of either to a glycine or alanine respectively, completely removes
binding to p48 (Hong et al., 2005). Site directed mutagenesis of p150_C was undertaken to
mutate these residues. Primers were designed to mutate R552A and K553G and a double
mutation of R552GK553A (Appendix E) and the plasmid mutated by PCR using the Quik
Change Mutagenesis Kit II (Agilent). Correct plasmids were transformed into Rosetta 2
pLysS cells and expressed as wild type p150_C.
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5.4.1.4 Pull-downs of Mutated p150_C with p48
Protein was prepared bound to Ni-NTA beads as for wild type p150_C (see section 2.2.3.3.4).
Purified p48 was added to each mutant and wild type p150_C (positive control) and a pull-
down performed as in section 5.4. The result is shown in Figure 49. This reveals that
mutation of arginine 552 to alanine has a negligible effect on the binding of p48 to p150_C
whereas mutating lysine 553 to glycine diminishes the binding. However, surprisingly, the
double mutant R552GK553A binds with an intensity similar to that of the full length protein.
Figure 49: Pull-downs of p48 by Mutant p150_C Proteins.
Pull-downs were performed with His-p150_C constructs bound to beads and tagless p48 in
solution. The results were analysed by Western blot using anti-p48 and anti-His antibodies
to visualise p48 and p150_C, respectively. The negative control was clean Ni-NTA beads. I
= Input, P= Pull-down.
5.5 Interaction of p60 with p48
To assess if p60 interacts with p48 in the absence of p150, a pull-down was performed as
described in section 2.2.7 using p48 bound to Ni-NTA beads to bind p60 in solution. His-
p48 beads were incubated with p60_FL at 4oC then washed to remove unbound protein. No
interaction is observed between p48 and p60 (Figure 50). It was only possible to perform
this experiment in one direction as p48 runs on SDS-PAGE at the same size as rabbit IgG
heavy chain, which is used to bind p60 to anti-Myc beads. This is also visualised by the
same secondary antibody as used for p48, making it impossible to tell the two proteins apart.
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Also it was not possible to show that the presence of p150 in this pull-down would cause p60
to bind His-p48 as it is not possible to remove the His-tag from p150.
Figure 50: Pull-downs of p60 by p48.
Ni-NTA beads bound to p48 were mixed with full length p60 and a pull-down performed.
The results were analysed by Western blot using anti-p60 and anti-His antibodies to visualise
p60 and His-p48, respectively. Top: Pull-down of p60 in solution by His-p48 bound to beads.
Bottom: Negative control of binding p60_FL to Ni-NTA beads. I = Input, P = Pull-down.
The lack of a detectable interaction between p60 and p48 is also seen during the purification
of CAF-1. When the CAF-1 complex is purified by use of a tag on p48 (Figure 18, section
3.2.3, compare lane 2 to 6 and 7), p150DN is reliably pulled out of solution but p60 is lost.
5.6 Stoichiometry of CAF-1 complexes
To investigate the stoichiometry of the CAF-1 complex crosslinking was performed. Samples
were crosslinked using both BS3 and formaldehyde which were seen to give the same results.
The results from BS3crosslinking are shown in the figures as samples could be boiled without
reducing the crosslinker, making SDS-PAGE and Western blot analysis more repeatable.
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5.6.1 p150_C and p48
A Coomassie stained SDS-PAGE gel is shown in Figure 51. P150_C with and without
p48 was crosslinked with increasing concentrations of BS3. In both cases high molecular
weight crosslinked species were observed, along with the original monomeric proteins as
there was insufficient crosslinker to drive the reaction to completion. The pattern observed
in the presence and absence of p48 is very similar (compare Figure 51 lane4 with lane 8).
Due to the presence of contaminants in the purification of p150_C a Western blot was used
to more accurately analyse the results.
Figure 51: Crosslinking of p150_C with p48 using BS3.
P150 in the presence or absence of p48 was incubated at 27oC for 30 min with 0.6, 0.15,
0.06 and 0.03% (w/v) crosslinker. The reaction was stopped by addition of Tris-HCl pH 8 to
0.1 M. Samples were analysed by SDS-PAGE. Markers are in kDa.
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Western blots were performed on the samples containing the highest concentration of cross-
linker, as initial experiments showed that the maximum amount of complex was trapped at
this concentration (Figure 52). Lane 20 shows the overlay of the p150_C and p48 Western
blots. The crosslinking of p150 to itself is as before, with some dimeric p150_C seen in the
un-crosslinked protein. P48 alone does not crosslink strongly to itself. Crosslinking of p48
to p150_C produces a small overlap at around 110 kDa. This mass corresponds to either a
p150_C monomer bound to a p48 monomer (predicted 97 kDa) or a p48 dimer. However
crosslinking of p48 alone at the same crosslinker concentration (Figure 52, lanes 13, 18 and
26) only shows very faint crosslinking, indicating it is more likely to be a p150/p48 complex.
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Figure 52: Western Blot of 150_C Crosslinking with p48.
Protein samples were crosslinked with 0.6 % (w/v) BS3 were run on the same SDS-PAGE gel
and transferred to a PVDF membrane. A Western blot was performed using the antibodies
indicated at the bottom of the diagram. Western blots were aligned using markers and over-
layed using GIMP and ImageJ for image processing, p150_C is green and p48 red. Markers
are in kDa. Markers for the Western blots were taken from the blot at different exposure
lengths to the protein samples and have been aligned based on overlays.
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5.6.2 p150DN/p60 with and without p48
Insect cell p150DN/p60 was crosslinked alone, with the addition of p48 and with excess p48
to examine if p60 was displaced. Samples were crosslinked with increasing concentrations of
BS3 and analysed by Coomassie stained SDS-PAGE gel (Figure 53). p150DN/p60 appears
to crosslink more efficiently than p150_C (compare Figure 53 lane 4 to Figure 51 lane 4).
However, addition of p48 did not influence the results in a major way, with the majority of the
protein remaining uncrosslinked, even at higher concentrations of crosslinker. Western blots
were attempted to analyse the data (not shown), but as most of the protein either remained
monomeric or was seen to be aggregated the results could not be readily interpreted.
Figure 53: SDS-PAGE of p150DN/p60 Crosslinking with and without p48.
Ni-NTA purified p150DN/p60 in the presence and absence of p48 (at 1:1 ratio and in 3 fold
excess) was treated with 0.6, 0.15, 0.06 and 0.03% (w/v) BS3 crosslinker for 30 min at 27oC.
The reaction was stopped by addition of Tris-HCl pH 8 to 0.1 M. Samples were analysed by
Coomassie stained SDS-PAGE. Markers are in kDa.
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5.7 Conclusions
The results in this chapter examine the interactions between subunits and the stoichiometry
of the CAF-1 complex. Firstly the interactions between subunits were examined by pull-
down experiments and the binding mode assessed using denatured protein, competition and
mutagenesis experiments. Secondly, crosslinking reactions were used to look for high mo-
lecular weight complexes.
p150 has been shown to exist as a homodimer by crosslinking of both p150DN produced in
insect cells and p150_C purified from E. coli, supporting the data from glycerol sedimenta-
tion (Quivy et al., 2001). The preservation of the interaction in p150_C is to be noted as the
purification was performed using 8 M urea, indicating that the interaction motif is likely to
have refolded on return to native conditions. There is less high molecular weight crosslink-
ing of p150_C compared to p150DN at the same concentrations of crosslinker, which may
indicate less aggregation in the protein produced in E. coli. The decrease in high molecu-
lar weight aggregates may be due to the urea removing non-specifically interacting proteins
from p150_C which otherwise increased protein aggregation.
Investigation of the interaction between p150 and p60 revealed that p60 binds exclusively
to protein expressed in insect cells. Treatment of p150DN from insect cells with 8 M urea
during purification also prevented the binding of p60. Treatment with urea removes struc-
ture that may require chaperones to refold effectively on return to native conditions. This
indicates that p60 binds to a structural motif and that further work will require the use of eu-
karyotic expression systems. In particular, Takami et al. (2007) identify the region 624-714
as binding p60, which is predicted to have a small region of ordered structure (Figure 31,
section 4.3). We intended to express this as p150 construct E, but it did not express in E.
coli (section 4.3.4). However, this construct could be used for further work using insect cell
expression.
The p60_WD construct appears to bind to p150DN in the same manner as full length protein,
indicating that it is the WD region that facilitates the interaction between the proteins. This
has not been investigated before, with the only previously characterised interaction of p60
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being that to ASF1, which is mediated via the unstructured C-terminal tail (Tang et al., 2006).
The interaction of p150 constructs with p48 was examined and showed that p48 binds to all
the constructs produced in E. coli and insect cells, even when treated with urea. Limited
proteolysis was attempted to locate a minimal binding fragment but this was unsuccessful.
It may be possible to use other enzymes to improve this in future, however bioinformatic
analysis of the sequence revealed a further line of enquiry.
Using information from Takami et al. (2007) and Lejon et al. (2011) a putative interaction
motif was identified containing a RRK motif, through which FOG1 is known to bind p48.
Competition of the FOG1 peptide with p150_C showed a decrease in the binding of p150 to
p48 in the presence of the peptide. Mutagenesis of the residues thought to be key for this
interaction (Hong et al., 2005) showed a negligible decrease in binding to the R552G mutant
but a more significant decrease when K553 was mutated to alanine. However, the double
mutant appears to bind to p48 at a similar level to the control. The lack of a decrease on
mutation of R552 can be explained given the new structure of H3 binding to Nurf55 (p55,
the D. melanogaster homologue of p48) (Schmitges et al., 2011). The H3 peptide binds to
the same site as FOG1, but the second arginine of the RRK motif is threonine in H3, allowing
the preceding arginine to bind in the cleft. The binding of the lysine residue in both peptides
however is to a deep cleft which is required for the interaction. This is illustrated in Figure
54 - compare backbone position of cyan H3 to green FOG1.
The reversion on double mutation is less easy to understand. It may be that there is a second
potential binding site in CAF-1 that is only employed on mutation of the first or, that the
site investigated here is not responsible for binding. The fact that the decrease in binding
was reliably observed in the lysine mutant makes this less likely. Further investigation of
this using peptides in a similar manner to that employed in the investigation of the FOG1
interaction should provide greater insight into this problem. Either way, given the data from
competition experiments it is very likely that p150 binds in the same cleft on p48 as the
FOG1 peptide, indicating a more general role for this interaction site in the assembly of
chromatin complexs.
There was no interaction observed between p60 and p48 in the absence of p150, using meth-
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Figure 54: Superimposition of FOG1 and H3 Peptides Binding to p48.
Superimposition of PDB ID 2XU7 (FOG1) and 2YBA (H3) Green: FOG1 peptide, visible
sequence: MSRRKQS . Cyan: H3 fragment, visible sequence: ARTKQT . Figure aligned
and constructed using PyMol
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ods such as the pull-downs described above or indirectly observed from purifications of the
CAF-1 complex. This has not been discussed in the literature and highlights the role of p150
in recruiting both proteins to sites of chromatin assembly. Whether both proteins can bind
simultaneously to one molecule of p150 remains to be confirmed, but purification of the pro-
tein complex section 3.2) suggests a 1:1:1 ratio, assuming all proteins bind Coomassie dye
in equal quantities. It appears unlikely that there are two pools of proteins, containing p150
bound to either p48 or p60 as p60 was seen during the p48-based calmodulin purification of
the CAF-1 complex (section 3.2.3).
Based on the information above, the putative binding sites on p150 for itself, p60 and p48
are indicated in Figure 55. There is overlap between the binding site of p60 and the p150
dimerisation domain, which may suggest that the location of the p60 binding site of p60
corresponds to the p150 dimerisation domain.
Figure 55: Fragment of p150 That Binds p60 and p48.
All three subunits of the CAF-1 complex bind over a 187 aa region. The putative p48 binding
RRK motif is indicated in dark blue. Image constructed using information from (Takami
et al., 2007; Quivy et al., 2001) using DOG 1.0 (Ren et al., 2009).
The data from crosslinking of the CAF-1 complex was difficult to interpret due to what
appears to be excessive crosslinking of p150, a protein rich in lysine residues masking other
signals except at high concentrations of crosslinker. The p150 dimer is clearly seen even
at the lowest concentrations of crosslinker. The aggregation of p150DN and heterogeneity
of the p60 produced in the p150DN/p60 complex did not allow confident identification of
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p150/60 crosslinking products. The crosslinking between p150_C and p48 produced one
band of overlap at a size that could correspond to a dimer of p150, a dimer of p48 or a binary
complex containing both proteins. Crosslinking the whole complex using p150DN/p60 and
p48 produced two bands of overlap that could not be identified accurately due to the lack of
coherent bands for p60. Further work with more homogeneous protein may provide better
data.
143
Chapter 6
Summary and Perspectives
This thesis describes the production and purification of components of the CAF-1 complex
and characterisation of the interactions between them. The original aims of this project were
structural studies of the CAF-1 complex and its subunits (p150, p60 and p48). To achieve
this it was necessary to produce recombinant CAF-1 reliably and stably at a quantity and
purity suitable for biochemical and structural experiments. Whilst CAF-1 has been reliably
produced at levels above what was previously possible it is not as homogeneous as is desired
for structural work. This was due to a variety of factors.
Firstly, CAF-1 was cloned and produced as a complex (described in chapter 3). The trimeric
complex was produced as a self-cleaving fusion protein in Sf21 cells and purified by affinity
resin. Further purification was undertaken but it was discovered that the complex could
not be purified using the second affinity tag (calmodulin) and that the TEV protease, which
cleaved the peptide into its constituent parts co-purified with the complex. Ion exchange
revealed many impurities and low levels of expression which prevented further purification.
It was also seen that p150 was only extracted from CAF-1 expressing cells at high concen-
trations of KCl, indicating that it is strongly bound to chromatin. As p150 is known to be
involved in heterochromatin formation as well as chromatin assembly it is possible that it is
being sequestered via interactions with HP-1.
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Expression of a binary complex containing a truncated form of p150 and p60, using the same
expression system was also undertaken (described in chapter 3). The overall yield from this
expression was higher than that for the whole CAF-1 complex, but ion exchange revealed that
p60 was phosphorylated and eluted over a wide range. Analysis of the phosphorylation sites
could be performed by mass spectrometry, although the current phosphorylation pattern may
be due to over-expression in insect cells and not biologically relevant. A more homogeneous
and concentrated sample that could be used for future experiments was prepared by extensive
washing of the affinity resin. This sample is still not of a quality required for structural studies
but provided insight into the interactions between the subunits discussed in chapter 5.
The ability to separate p150 from the other subunits of CAF-1 was observed during the puri-
fication of both complexes, indicating that p150DN was relatively stable when produced
using the insect cell expression MultiBac system . The subunits were therefore produced
individually with truncation constructs designed for p150 and p60 (described in chapter 4).
Production of p150DN alone revealed a protein that could be purified by affinity purification
but with a tendency to aggregate that made concentration of the protein impossible. The
aggregation of p150 is thought to be due to the unstructured nature of the protein with ex-
posed hydrophobic residues and highly charged patches such as the KER region tending to
interact non-specifically with other proteins. Truncation constructs of p150 were produced
in E.coli with some success, although the smaller constructs designed did not express, and
the smallest was lethal on expression.
Four truncation constructs of p60 were designed for expression in insect cells, of which only
one expressed, containing the WD region of the protein. Full length p60 protein was also
expressed. The WD protein appeared to be more homogeneous as it did not exist in the two
forms seen for full length protein. However, p60_WD could not be purified effectively in
large quantities due to low expression and lack of a suitable purification tag.
The structure of p48 used in this study to examine the interactions between the subunits of
CAF-1 was solved by crystallography in our laboratory (Lejon et al., 2011).
As it was not possible to produce the CAF-1 fusion protein or its p150/p60 subunits at quant-
ities and the quality required for structural studies, the project concentrated on characterising
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the interaction between the subunits, discussed in chapter 5.
P150 is known to dimerise with itself (Quivy et al., 2001). Crosslinking experiments con-
firmed this for both full length protein and construct_C, consisting of residues 545-596 of
p150, the smallest construct that could be expressed and purified, as detailed in section 4.3.
The minimal region for dimerisation of p150 has already been reported and the results show
that the p150 constructs made here also dimerise when produced in E. coli and refolded after
denaturation. It therefore may be possible to examine the structure of this motif by NMR as
a labelled protein could be produced of a size amenable to study. The predicted structure of
the p150 dimerisation domain involves a short helix of 7-12 aa followed by two more weakly
predicted beta-strands (PSI-PRED, Jpred3). It is possible that the helices refold on removal
of urea and facilitate the dimerisation of p150.
The interaction between p60 and p150 was seen to be mediated by the WD-region of p60
binding to a structured region of p150. The interaction is lost on treatment of p150 with urea.
Further investigation of this will require p150 deletion mutants to be expressed in eukaryotic
expression systems.
P48 was seen to bind to all p150 constructs, whether generated in insect cells or E. coli. Lim-
ited proteolysis was unsuccessful in locating minimal binding fragments but bioinformatic
investigation of the interaction revealed a putative p48 interaction motif: R551 R552 K553,
in p150, similar to that identified for the interaction of FOG1 with p48 (Lejon et al., 2011).
Competition binding experiments revealed that p150_C could be displaced from p48 by the
FOG1 peptide. Also mutation of the critical K553 residue of the RRK motif greatly reduced
p150 binding to p48. However, mutation of R552 and mutation of both R552 and K553 did
not reduce binding. The retention of binding by the single R552 mutant is explained by the
recently published p55/histone H3 structure (Schmitges et al., 2011), where the binding of
the H3 peptide to the same site as FOG1 is mediated by a RTK motif. In this structure the
first arginine binds to the same cleft as the second arginine in the FOG1 RRK motif, with the
threonine facing away from the molecule and contributing little to the binding. The reason
for the binding of the double mutant to p48 is however a mystery. It is possible that mutation
of the main binding residue allows the protein to utilise less favourable binding sites as there
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are other RXK motifs within the sequence of p150_C.
Pull-down experiments showed no interaction between p48 and p60, indicating that they
require the presence of p150 to assemble into the CAF-1 complex.
Investigation of the stoichiometry of the CAF-1 complex gave a complex picture. The cross-
linking data indicate that p150 and p48 appear to bind for form a 1:1 complex but further
conclusions could not be drawn. Judging from the intensity of the protein bands on SDS-
PAGE analyses an equal ratio of components (1:1:1 or 2:2:2) is likely from purification of
the complex, providing that all subunits bind the coomassie dye equally. To further assess
the stoichiometry of the complex, experiments such as further analytical gel filtration and
analytical ultra-centrifugation (AUC) may provide a more accurate insight into the complex
as well as showing the state of the p150 monomer/dimer equilibrium when p60 and p48
are bound. However these methods require more homogeneous protein (particularly p60) in
larger quantities than have been produced so far.
The issues encountered and overcome for the first time in this dissertation provide the basis
for many possible future experiments in both the short and long term. The constructs pro-
duced show that the WD region of p60 is stable and binds p150. The addition of an affinity
purification tag, such as a His-tag and subsequent optimisation of the virus produced, should
provide a much more homogeneous protein that may be amenable to both crystallisation
studies and further investigation of the interaction with p150. To this end, the fragments of
p150, including those that did not express in E. coli, could also be expressed in insect cells
or using other systems such as in vitro transcription translation and the interaction with p60
assessed. Once the minimal region of interaction of p150 for p60 is identified they could be
co-expressed using the MultiBac system either in pFBDM or using both pUCDM and pFL
for Cre-based recombination.
Further work investigating the interaction of p150 with p48 is ongoing. P150 peptides con-
taining the putative p48 interaction region are currently being produced. If the peptides are
shown to bind to p48 then the structure of a p48/p150 complex may be solved in a similar
manner to that of p48/FOG1. This new role for the FOG1 binding site of p48 indicates that
it may have a generic role for complex formation and explain how p48 interacts with so
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many different complexes. This interaction is seen in the NuRD (FOG-1) and CAF-1 (p150)
complexes. HAT1, which binds a histone H3/H4 dimer with p48 (Verreault et al., 1998) also
contains a RXK motif (I. Le Guillou, personal communication) its C-terminal tail and ERa,
which binds to p48 as part of the Rb complex (Creekmore et al., 2008) also contains a RRK
motif, although the residues involved in either interaction have not yet been identified.
Once the interactions between the subunits of the complex have been more firmly established
it would be possible to examine the proteins closely associated with CAF-1 in the context of
replication dependent chromatin assembly, namely histones H3 and H4, ASF-1 and PCNA.
The interaction between p150 and PCNA localises CAF-1 to the replication fork and has
been well characterised (Ben-Shahar et al., 2009) with work to solve the structure of the
PCNA/p150 peptide ongoing within this laboratory (S. Lejon, unpublished data).
The interplay between CAF-1, histones and ASF1 is less well understood. Recent work in
this laboratory shows that ASF1 can form a quaternary complex with p48 mediated via a
histone H3/H4 dimer, although some re-arrangement of the H4 helix is required (Murzina
et al., 2008; English et al., 2006). CAF-1 also interacts with ASF1 through the C-terminal
tail of p60 (Malay et al., 2008) at the opposite side to the histone binding site. A model
of the putative CAF1/H3/H4/ASF1 complex is summarised in Figure 56 with the position
of the FOG1 peptide indicating the putative p150 binding site. Whether all the interactions
shown in the model are simultaneous or if binding of p60 and p48 to ASF1 via H3/H4 are
mutually exclusive remains to be investigated.
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Figure 56: Models of the Interactions Between CAF-1, H3/H4 and ASF1
A: Cartoon illustrating interactions in the CAF-1 complex. P150 acts as a scaffold for as-
sembly of the complex, locating the other proteins to sites of DNA replication via interaction
with PCNA. B: Molecular model of the interactions. ASF1 is green, H3 red, H4 yellow, H4
peptide pale yellow, p48 aqua, p60 dark blue and FOG-1 peptide indicating p150 binding site
is mid-blue. Aligned and visualised using PyMol, (p48/ASF1/H3/H4 model A Murzin, per-
sonal communication). p48/FOG1 PDBID: 2XU7, p46/H4 Fragment PDBID: 3CFS, ASF-
1/H3/H4 PDBID: 2HUE and ASF-1/p60 PDBID: 2Z3F.
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To study the movement of histones within the CAF-1 complex the interactions of p60 and
p150 with histones should be investigated, in the presence and absence of ASF1 as this
should shed light on one of the main questions of replication dependent assembly: Why do
we only see a H3/H4 tetramer assembled onto DNA when nearly all known chaperones bind
a H3/H4 dimer? It is possible that different subunits of the CAF-1 complex associate with
separate dimers of the H3/H4 complex and deposit them onto replicated DNA. It is likely
that these histones are provided by ASF1, however whether it acts as a shuttle or is directly
involved in histone deposition awaits further investigation.
The mechanism by which CAF-1 deposits histones may not be unique. The tethering of p150
to the replication fork by PCNA provides replication dependency, however HIRA, which
deposits H4 and H3.3 outside of replication binds to ASF1 using a similar mechanism to p60
(Tang et al., 2006; Malay et al., 2008). However the direct interaction with p48 exhibited by
the WD motif of HIRA (Ahmad et al., 2004) is not seen with p60, which may explain the
lack of a p150-like scaffold for HIRA related deposition.
The work described here identifies and overcomes the major pitfalls of expression of the
CAF-1 complex to provide information on the interactions within the complex. These exper-
iments provide the groundwork for a variety of future experiments to dissect the movement
and interactions that take place when histones are assembled onto newly replicated DNA.
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Appendix A
Abbreviations
aa Amino Acid
Amp Ampicillin
BME Beta Mercaptoethanol
BSA Bovine Serum Albumin
bp base pair
CAF-1 Chromatin Assembly Factor 1
Cam Chloramphenicol
CFP Cyan Fluorescent Protein
CV Column Volumes
DNAPC DNA Polymerase Complex
DTT Dithiothreitol
EDTA Ethylenediaminetetraacetic acid
EtOH Ethanol
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Gent Genetamycin
GST Glutathione S-Transferase
HCMV Human Cytomegalovirus
HRP Horseradish Peroxidase
IPTG Isopropyl Thiogalactoside
Kan Kanamycin
kDa Kilodalton
kb kilobase
MeOH Methanol
MNase Micrococcal Nuclease
MOPS 3-(N-morpholino)propanesulfonic acid
NP-40 Nonylphenyl Polyethylene Glycol, NP-40 alternative (Calbiochem)
nt nucleotides
OD Optical Density (Apparent absorbance at 600 nm)
p48 RbAp48 (Retinoblastoma Associated protein of 48 kDa)
PCNA Proliferating Cell Nuclear Antigen
RNAse A Ribonuclease A
SDS Sodium Dodecyl Sulphate
SDS-PAGE Sodium Dodecyl Sulphate - PolyAcrylamide Gel Electrophoresis
SV40 Simian Virus 40
Tet Tetracyclin
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TEV Tobacco Etch Virus
Tris-HCl Tris(hydroxymethyl)aminomethane, titrated to pH with HCl
UV Ultraviolet
XGal 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside
YFP Yellow Fluorescent Protein
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Appendix B
Buffers and Solutions
p48-His Buffer 20 mM Tris-HCl, pH 8.0, 150 mM NaCl
3x SDS-PAGE Sample
Buffer
40 % (v/v) glycerol, 4 % (w/v) lithium dodecyl
sulphate, 4 % (w/v) Ficoll-400, 0.8 M
triethanolamine-Cl pH 7.6, 0.025 % (w/v) phenol red,
0.025 % (w/v) coomassie G250, 2 mM EDTA
disodium
5x DNA Loading Buffer 0.25 % (w/v) Bromophenol Blue, 0.25 % (w/v) Xylene
cyanol FF, 15 % (w/v) Ficoll-400
10x Protease Inhibitor
Solution
1 Roche protease inhibitor set tablet (EDTA-free)
re-suspended in 5 ml MilliQ H2O
Alkaline Lysis Buffer 50 mM Glucose, 25 mM Tris-HCl, pH 8.0, 10 mM
EDTA
CAF Calmodulin Elution
Buffer
50 mM Tris-HCl, pH 8.0, 400 mM KCl, 5 mM EDTA
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p48-His Buffer 20 mM Tris-HCl, pH 8.0, 150 mM NaCl
CAF E20/40/100/500 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 5 mM
Beta-mercaptoethanol , 20/40/100/250/500 mM
Imidazole
CAF GF Buffer 50 mM Tris-HCl, pH 8.0 400 mM KCl
CAF High Salt Buffer 50 mM Tris-HCl, pH 7.5, 1 M KCl, 5 mM Imidazole
CAF IX Buffer A 50 mM Tris-HCl, pH 8.0
CAF IX Buffer B 50 mM Tris-HCl, pH 8.0, 1 M KCl
CAF Lysis Buffer 50 mM Tris-HCl, pH 7.5, 400 mM KCl, 0.5 % (v/v)
NP-40
CAF Wash Buffer 50 mM Tris-HCl, pH 7.5, 100 mM KCl, 5 mM
Imidazole
Enhancer Solution 0.58 mM para-hydroxy coumarin acid (11 mg in 10 ml
100 % (v/v) nDEMISE)
HA Buffer A 50 mM Tris-HCl, pH 8.0, 200 mM KCl, 10 mM
K2HPO4
HA Buffer B 50 mM Tris-HCl, pH 8.0, 200 mM KCl, 0.5 M
K2HPO4
His Pull-down Buffer 50 mM Tris-HCl, pH 8.0, 200 mM KCl, 10 mM
Imidazole
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p48-His Buffer 20 mM Tris-HCl, pH 8.0, 150 mM NaCl
LB 0.5 % (w/v) Yeast Extract, 1 % (w/v) Tryptone, 1 %
(w/v) NaCl (autoclaved)
LB-Agar LB + 1.5 % (w/v) Agar (autoclaved)
Luminol 0.1 M Tris-HCl, pH 8.6, 1.4 mM luminol
Myc Pull-down Buffer 50 mM Tris-HCl, pH 8.0, 200 mM KCl, 0.1 % (v/v)
NP-40
NaOH/SDS Buffer 0.2M NaOH, 1% (w/v) SDS
Nu-PAGE Running Buffer 50 mM MOPS, 50 mM Tris base, 0.1 %(w/v) SDS,
1 mM EDTA, pH 7.7
p48-His Lysis Buffer 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM
MgCl2, 1 mM Beta-mercaptoethanol
p48-His Dialysis Buffer 10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 2.5 mM
CaCl2
p48-His Buffer A 20 mM Tris-HCl, pH 7.5
p48-His Buffer B 20 mM Tris-HCl, pH 7.5, 1 M NaCl
PBS 137 mM NaCl, 2.7 mM KCl, 10 mM NaH2PO4, 2 mM
KH2PO4, pH 7.4
Phenol:CIA Extraction
Solution
25:24:1 mixture of Tris-buffered
Phenol:Chloroform:Isoamyl Alcohol
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p48-His Buffer 20 mM Tris-HCl, pH 8.0, 150 mM NaCl
TE 10 mM Tris-HCl, pH 7.5, 1 mM EDTA
TES Buffer 0.1 M NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA
TFB1 30 mM potassium acetate, 10 mM calcium chloride,
50 mM manganese chloride, 100 mM rubdinium
chloride, 15 % (v/v) glycerol. Adjusted to pH 5.8 with
1 M acetic acid and filter sterilised.
TFB2 10 mM MOPS pH 6.5, 75 mM calcium chloride,
10 mM rubdinium chloride, 15 % (v/v) glycerol.
Adjusted to pH 6.5 with 1 M potassium hydroxide and
filter sterilised.
Transfer Buffer 20 % (v/v) Methanol, 33 mM Tris-base, 16 mM
glycine
50x TAE 2 M Tris-Acetate, 50 mM EDTA
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Appendix C
E.coli Genotypes
Cell Line Genotype Source
BW23474
F-D(argF-lac)169 rpoS(Am) robA1 creC510 hsdR514
uidA(MluI)::pir-116, endA(BT333) recA1
Gift from I Berger
(EMBL, Grenoble,
France)
BW23473
F-D(argF-lac)169 rpoS(Am) robA1 creC510 hsdR514
DuidA3::pir+ endA(BT333) recA1
Gift from I Berger
(EMBL, Grenoble,
France)
Top10
F-mcrA ∆(mrr-hsdRMS-mcrBC) ϕ80dlacZ∆M15
∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU galK
rpsL (StrR) endA1 nupG
Invitrogen
Rosetta2
pLysS
F-ompT hsdSB(r-Bm
-
B) gal dcm (DE3) pLysSRARE2
(CamR)
Novagen
BacY
F-mcrA ∆(mrr-hsdRMS-mcrBC) ϕ80dlacZ∆M15
∆lacX74 recA1 endA1 araD139 ∆(ara-leu)7697 galU
galK λ -rpsL nupG/bMON14272/pMON7124 yfp+
Gift from I Berger
(EMBL, Grenoble,
France)
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Appendix D
Plasmids Used in this Study
Plasmid
Resistance
Gene
Promoter Tag Gene(s) Source
pFL Amp/Gent PolH/p10 N/A N/A I Berger
pUCDM Cam PolH/p10 N/A N/A I Berger
pGEXT2 Amp T7 His GST 1-232 In House
pNIC-Bsa4 Kan T7 His N/A
SGC
Oxford
pBAC-Caf1 Gent PolH/p10
His and
Strep
p150 304-938, p60
1-599 and p48 1-425
This
Study
pFBDM-p60-His-
p150ΔN
Amp/Gent PolH/p10 His
p150 304-938 and
p60 1-599
In House
pFBDM-His-
p150ΔN
Amp/Gent PolH/p10 His p150 302-955 In House
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Plasmid
Resistance
Gene
Promoter Tag Gene(s) Source
pNIC-Bsa4-
p150_A
Kan T7 His p150 436-956
This
Study
pNIC-Bsa4-
p150_B
Kan T7 His p150 465-913
This
Study
pNIC-Bsa4-
p150_C
Kan T7 His p150 545-956
This
Study
pNIC-Bsa4-
p150_D
Kan T7 His p150 545-770
This
Study
pGEX-2T-p150_E Amp T7 GST p150 652-732
This
Study
pUCDM-Myc Cam PolH/p10 Myc N/A
This
Study
pUCDM-Myc-
p60_1
(pUCDM-
p60_WD)
Cam PolH/p10 Myc p60 1-386
This
Study
pUCDM-Myc-
p60_2
Cam PolH/p10 Myc p60 1-400
This
Study
pUCDM-Myc-
p60_3
Cam PolH/p10 Myc p60 1-409
This
Study
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Plasmid
Resistance
Gene
Promoter Tag Gene(s) Source
pUCDM-Myc-
p60_4
(pUCDM-p60_FL)
Cam PolH/p10 Myc p60 1-559 (FL)
This
Study
pUCDM-Myc-
p60_5
Cam PolH/p10 Myc p60 387-559
This
Study
pFBDM-His-p48 Amp/Gent PolH/p10 His p48 1-425 In House
pNIC-Bsa4-
p150_C RG
mutant
Kan T7 His p150 545-956 R552G
This
Study
pNIC-Bsa4-
p150_C KA
mutant
Kan T7 His p150 545-956 K553A
This
Study
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Figure 57: Map of pNIC-Bsa4
Figure 58: Map of pGEX-2T
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Figure 59: Map of pFBDM
Figure 60: Map of pUCDM
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Figure 61: Map of pFBDM-p60-His-p150DN
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Appendix E
Primers
E.1 LIC Primers for E. coli Expression in BsaI Digested
pNIC-Bsa4
Primer Design
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Table of Primers
Primer Name Sequence
p150_LIC_F_436 TACTTCCAATCCATGAAGCGCATTAAAGCGAGAAG
p150_LIC_F_465 TACTTCCAATCCATGGGGAAGTTTGCCCCCTTG
p150_LIC_F_545 TACTTCCAATCCATGGGCGACGGTGTTCCCGAG
p150_LIC_R_770 TATCCACCTTTACTGCTAGGTGTGGTTGCTGAGCAGTC
p150_LIC_R_912 TATCCACCTTTACTGCTAGTCGCCCTCCTCCTCTTC
p150_LIC_R_956 TATCCACCTTTACTGCTAGGATGCACCCAGTGGGCTC
p60_LIC_F _1 TACTTCCAATCCATGAAAGTCATCACTTGTG
p60_LIC_F _387 TACTTCCAATCCATGAAGCCAGTTTTGAAC
p60_LIC_R _386 TATCCACCTTAACTGTCACTCTTTCAAAGGAATTC
p60_LIC_R _400 TATCCACCTTTACTGTCATTTCTTTGCTGTATC
p60_LIC_R _409 TATCCACCTTTACTGTCAAGACCCTCGATGTGT
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E.2 SLIC Cloning into BamHI/EcoRI Digested pGEX2T
E.3 SLIC Cloning into BamHI/XbaI Digested pUCDM Us-
ing the In-Fusion System
Primer Design
197
Table of Primers
Primer Name Sequence
p60_IF_1_F CACGTGGTTCGGATCCTATGAAAGTCATCACTTGTG
p60_IF_387_F CACGTGGTTCGGATCCTAAGCCAGTTTTGAACATG
p60_IF_386_R GACTGCAGGCTCTAGATCACTCTTTCAAAGGAATTCC
p60_IF_400_R GACTGCAGGCTCTAGATCATTTCTTTGCTGTATCAGG
p60_IF_409_R GACTGCAGGCTCTAGATCAAGACCCTCGATGTGTCTG
p60_IF_559_R GACTGCAGGCTCTAGATCAAGGGTCCAGACTTTC
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E.4 Oligos for Annealing to Create Myc Insert
E.5 Mutagenesis Primers for p150_C
Mutated base pairs are in bold and underlined.
Name Sequence
p150C_R552G_F GACGGTGTTCCCGAGAGGGGGAAGTTTGGCAGGATG
p150C_R552G_R CATCCTGCCAAACTTCCCCCTCTCGGGAACACCGTC
p150C_K553A_F GTTCCCGAGAGGAGGGCGTTTGGCAGGATGAAG
p150C_K553A_R CTTCATCCTGCCAAACGCCCTCCTCTCGGGAAC
p150C_RK552GA_F GCGACGGTGTTCCCGAGAGGGGGGCGTTTGGCAGGATGAAGCTCC
p150C_RK552GA_R GGAGCTTCATCCTGCCAAACGCCCCCTCTCGGGAACACCGTCGC
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Appendix F
Sequences
p150DN (305-938) (Homo sapiens, NCBI Q13111)
MPPKQHSSTS PFPTSTPLRR ITKKFVKGST EKNKLRLQRD QERLGKQLKL RAEREEKEKL
KEEAKRAKEE AKKKKEEEKE LKEKERREKR EKDEKEKAEK QRLKEERRKE RQEALEAKLE
EKRKKEEEKR LREEEKRIKA EKAEITRFFQ KPKTPQAPKT LAGSCGKFAP FEIKEHMVLA
PRRRTAFHPD LCSQLDQLLQ QQSGEFSFLK DLKGRQPLRS GPTHVSTRNA DIFNSDVVIV
ERGKGDGVPE RRKFGRMKLL QFCENHRPAY WGTWNKKTAL IRARDPWAQD TKLLDYEVDS
DEEWEEEEPG ESLSHSEGDD DDDMGEDEDE DDGFFVPHGY LSEDEGVTEE CADPENHKVR
QKLKAKEWDE FLAKGKRFRV LQPVKIGCVW AADRDCAGDD LKVLQQFAAC FLETLPAQEE
QTPKASKRER RDEQILAQLL PLLHGNVNGS KVIIREFQEH CRRGLLSNHT GSPRSPSTTY
LHTPTPSEDA AIPSKSRLKR LISENSVYEK RPDFRMCWYV HPQVLQSFQQ EHLPVPCQWS
YVTSVPSAPK EDSGSVPSTG PSQGTPISLK RKSAGSMCIT QFMKKRRHDG QIGAEDMDGF
QADTEEEEEE EGDCMIVDVP DAAEVQAPCG AASGAGGGVG VDTGKATLTA SPLGAS
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p60 (Homo sapiens, NCBI Q13112)
MKVITSEIAW HNKEPVYSLD FQHGTAGRIH RLASAGVDTN VRIWKVEKGP DGKAIVEFLS
NLARHTKAVN VVRFSPTGEI LASGGDDAVI LLWKVNDNKE PEQIAFQDED EAQLNKENWT
VVKTLRGHLE DVYDICWATD GNLMASASVD NTAIIWDVSK GQKISIFNEH KSYVQGVTWD
PLGQYVATLS CDRVLRVYSI QKKRVAFNVS KMLSGIGAEG EARSYRMFHD DSMKSFFRRL
SFTPDGSLLL TPAGCVESGE NVMNTTYVFS RKNLKRPIAH LPCPGKATLA VRCCPVYFEL
RPVVETGVEL MSLPYRLVFA VASEDSVLLY DTQQSFPFGY VSNIHYHTLS DISWSSDGAF
LAISSTDGYC SFVTFEKDEL GIPLKEKPVL NMRTPDTAKK TKSQTHRGSS PGPRPVEGTP
ASRTQDPSSP GTTPPQARQA PAPTVIRDPP SITPAVKSPL PGPSEEKTLQ PSSQNTKAHP
SRRVTLNTLQ AWSKTTPRRI NLTPLKTDTP PSSVPTSVIS TPSTEEIQSE TPGDAQGSPP
ELKRPRLDEN KGGTESLDP
p48 (Homo sapiens, NCBI Q09028)
MADKEAAFDD AVEERVINEE YKIWKKNTPF LYDLVMTHAL EWPSLTAQWL PDVTRPEGKD
FSIHRLVLGT HTSDEQNHLV IASVQLPNDD AQFDASHYDS EKGEFGGFGS VSGKIEIEIK
INHEGEVNRA RYMPQNPCII ATKTPSSDVL VFDYTKHPSK PDPSGECNPD LRLRGHQKEG
YGLSWNPNLS GHLLSASDDH TICLWDISAV PKEGKVVDAK TIFTGHTAVV EDVSWHLLHE
SLFGSVADDQ KLMIWDTRSN NTSKPSHSVD AHTAEVNCLS FNPYSEFILA TGSADKTVAL
WDLRNLKLKL HSFESHKDEI FQVQWSPHNE TILASSGTDR RLNVWDLSKI GEEQSPEDAE
DGPPELLFIH GGHTAKISDF SWNPNEPWVI CSVSEDNIMQ VWQMAENIYN DEDPEGSVDP
EGQGS
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CAF-1 Poly Protein (cleaved)
TEV Protease
MGMGHHHHHH GESLFKGPRD YNPISSTICH LTNESDGHTT SLYGIGFGPF IITNKHLFRR
NNGTLLVQSL HGVFKVKNTT TLQQHLIDGR DMIIIRMPKD FPPFPQKLKF REPQREERIC
LVTTNFQTKS MSSMVSDTSC TFPSSDGIFW KHWIQTKDGQ CGSPLVSTRD GFIVGIHSAS
NFTNTNNYFT SVPKNFMELL TNQEAQQWVS GWRLNADSVL WGGHKVFMSK PEEPFQPVKE
ATQLMNELVY SQGNHENLYF Q
p150
GVHHHHHHHH HHGPLVPRGS QDPSKQHSST SPFPTSTPLR RITKKFVKGS TEKNKLRLQR
DQERLGKQLK LRAEREEKEK LKEEAKRAKE EAKKKKEEEK ELKEKERREK REKDEKEKAE
KQRLKEERRK ERQEALEAKL EEKRKKEEEK RLREEEKRIK AEKAEITRFF QKPKTPQAPK
TLAGSCGKFA PFEIKEHMVL APRRRTAFHP DLCSQLDQLL QQQSGEFSFL KDLKGRQPLR
SGPTHVSTRN ADIFNSDVVI VERGKGDGVP ERRKFGRMKL LQFCENHRPA YWGTWNKKTA
LIRARDPWAQ DTKLLDYEVD SDEEWEEEEP GESLSHSEGD DDDDMGEDED EDDGFFVPHG
YLSEDEGVTE ECADPENHKV RQKLKAKEWD EFLAKGKRFR VLQPVKIGCV WAADRDCAGD
DLKVLQQFAA CFLETLPAQE EQTPKASKRE RRDEQILAQL LPLLHGNVNG SKVIIREFQE
HCRRGLLSNH TGSPRTPSTT YLHTPTPSED AAIPSKSRLK RLISENSVYE KRPDFRMCWY
VHPQVLQSFQ QEHLPVPCQW SYVTSVPSAP KEDSGSVPST GPSQGTPISL KRKSAGSMCI
TQFMKKRRHD GQIGAEDMDG FQADTEEEEE EEGDCMIVDV PDAVEVQAPC GAASGAGGGV
GVDTGKATLT ASPLGASENL YFQ
p60
GKVITCEIAW HNKEPVYSLD FQHGTAGRIH RLASAGVDTN VRIWKVEKGP DGKAIVEFLS
NLARHTKAVN VVRFSPTGEI LASGGDDAVI LLWKVNDNKE PEQIAFQDED EAQLNKENWT
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VVKTLRGHLE DVYDICWATD GNLMASASVD NTAIIWDVSK GQKISIFNEH KSYVQGVTWD
PLGQYVATLS CDRVLRVYSI QKKRVAFNVS KMLSGIGAEG EARSYRMFHD DSMKSFFRRL
SFTPDGSLLL TPAGCVESGE NVMNTTYVFS RKNLKRPIAH LPCPGKATLA VRCCPVYFEL
RPVVETGVEL MSLPYRLVFA VASEDSVLLY DTQQSFPFGY VSNIHYHTLS DISWSSDGAF
LAISSTDGYC SFVTFEKDEL GIPLKEKPVL NMRTPDTAKK TKSQTHRGSS PGPRPVEGTP
ASRTQDPSSP GTTPPQARQA PAPTVIRDPP SITPAVKSPL PGPSEEKTLQ PSSQNTKAHP
SRRVTLNTLQ AWSKTTPRRI NLTPLKTDTP PSSVPTSVIS TPSTEEIQSE TPGDAQGSPP
ELKRPRLDEN KGGTESLDPE NLYFQ
p48
GMKRRWKKNF IAVSAANRFK KISSSGLVPR GSADKEAAFD DAVEERVINE EYKIWKKNTP
FLYDLVMTHA LEWPSLTAQW LPDVTRPEGK DFSIHRLVLG THTSDEQNHL VIASVQLPND
DAQFDASHYD SEKGEFGGFG SVSGKIEIEI KINHEGEVNR ARYMPQNPCI IATKTPSSDV
LVFDYTKHPS KPDPSGECNP DLRLRGHQKE GYGLSWNPNL SGHLLSASDD HTICLWDISA
VPKEGKVVDA KTIFTGHTAV VEDVSWHLLH ESLFGSVADD QKLMIWDTRS NNTSKPSHSV
DAHTAEVNCL SFNPYSEFIL ATGSADKTVA LWDLRNLKLK LHSFESHKDE IFQVQWSPHN
ETILASSGTD RRLNVWDLSK IGEEQSPEDA EDGPPELLFI HGGHTAKISD FSWNPNEPWV
ICSVSEDNIM QVWQMAENIY NDEDPEGSVD PEGQGSRSGG ENLYFQG
CFP
GVSKGEELFT GVVPILVELD GDVNGHKFSV SGEGEGDATY GKLTLKFICT TGKLPVPWPT
LVTTLTWGVQ CFSRYPDHMK QHDFFKSAMP EGYVQERTIF FKDDGNYKTR AEVKFEGDTL
VNRIELKGID FKEDGNILGH KLEYNYISHN VYITADKQKN GIKANFKIRH NIEDGSVQLA
DHYQQNTPIG DGPVLLPDNH YLSTQSALSK DPNEKRDHMV LLEFVTAAGI TLGMDELYKS
GLRSRRAH
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